SEC Info - Signify Health, Inc. - ‘10-Q’ for 3/31/21

SEC Info℠

Home

Help

Please Sign In

Signify Health, Inc. – ‘10-Q’ for 3/31/21 – ‘JSON’

On: Wednesday, 5/12/21, at 4:46pm ET · For: 3/31/21 · Accession #: 1828182-21-17 · File #: 1-40028

  As Of               Filer                 Filing    For·On·As Docs:Size

 5/12/21  Signify Health, Inc.              10-Q        3/31/21   94:7.7M

Quarterly Report — Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    754K 
 2: EX-10.1     Material Contract                                   HTML     68K 
 3: EX-10.2     Material Contract                                   HTML     67K 
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     27K 
 5: EX-31.2     Certification -- §302 - SOA'02                      HTML     27K 
 6: EX-32.1     Certification -- §906 - SOA'02                      HTML     25K 
 7: EX-32.2     Certification -- §906 - SOA'02                      HTML     25K 
14: R1          Cover Page                                          HTML     78K 
15: R2          Condensed Consolidated Balance Sheets               HTML    153K 
16: R3          Consolidated Balance Sheets (Parenthetical)         HTML     32K 
17: R4          Condensed Consolidated Statements of Operations     HTML    111K 
18: R5          Condensed Consolidated Statements of Changes in     HTML     73K 
                Stockholders' / Members? Equity                                  
19: R6          Condensed Consolidated Statements of Cash Flows     HTML    126K 
20: R7          Nature of Operations                                HTML     34K 
21: R8          Significant Accounting Policies                     HTML     55K 
22: R9          The COVID-19 Pandemic                               HTML     33K 
23: R10         Variable Interest Entities                          HTML     45K 
24: R11         Revenue Recognition                                 HTML     96K 
25: R12         Property and Equipment                              HTML     36K 
26: R13         Intangible Assets                                   HTML     46K 
27: R14         Accounts Payable and Accrued Expenses               HTML     34K 
28: R15         Long-Term Debt                                      HTML     44K 
29: R16         Fair Value Measurements                             HTML     82K 
30: R17         Shareholders' Equity                                HTML     38K 
31: R18         Noncontrolling Interest                             HTML     31K 
32: R19         Equity-Based Compensation                           HTML     36K 
33: R20         Loss Per Share                                      HTML     35K 
34: R21         Transaction-related Expenses                        HTML     26K 
35: R22         Commitment and Contingencies                        HTML     40K 
36: R23         Income Taxes                                        HTML     34K 
37: R24         Segment Reporting                                   HTML     56K 
38: R25         Concentrations                                      HTML     27K 
39: R26         Related Party Transactions                          HTML     30K 
40: R27         Significant Accounting Policies (Policies)          HTML     74K 
41: R28         Significant Accounting Policies (Tables)            HTML     40K 
42: R29         Variable Interest Entities (Tables)                 HTML     47K 
43: R30         Revenue Recognition (Tables)                        HTML     93K 
44: R31         Property and Equipment (Tables)                     HTML     35K 
45: R32         Intangible Assets (Tables)                          HTML     47K 
46: R33         Accounts Payable and Accrued Expenses (Tables)      HTML     34K 
47: R34         Long-Term Debt (Tables)                             HTML     46K 
48: R35         Fair Value Measurements (Tables)                    HTML     86K 
49: R36         Noncontrolling Interest (Tables)                    HTML     30K 
50: R37         Loss Per Share (Tables)                             HTML     32K 
51: R38         Commitment and Contingencies (Tables)               HTML     29K 
52: R39         Segment Reporting (Tables)                          HTML     50K 
53: R40         Nature of Operations (Details)                      HTML     54K 
54: R41         Significant Accounting Policies - Narrative         HTML     47K 
                (Details)                                                        
55: R42         Significant Accounting Policies - Cash, Cash        HTML     33K 
                Equivalents and Restricted Cash (Details)                        
56: R43         Variable Interest Entities - Narrative (Details)    HTML     38K 
57: R44         Variable Interest Entities - Schedule of Variable   HTML     86K 
                Interest Entities (Details)                                      
58: R45         Revenue Recognition - Narrative (Details)           HTML     26K 
59: R46         Revenue Recognition - Disaggregation of Revenue     HTML     40K 
                (Details)                                                        
60: R47         Revenue Recognition - Schedule of Related Balance   HTML     54K 
                Sheets Account (Details)                                         
61: R48         Revenue Recognition - Contract Assets (Details)     HTML     28K 
62: R49         Revenue Recognition - Contract Liabilities          HTML     32K 
                (Details)                                                        
63: R50         Revenue Recognition - Deferred Revenue (Details)    HTML     30K 
64: R51         Revenue Recognition - Shared Savings Payable        HTML     29K 
                (Details)                                                        
65: R52         Property and Equipment - Property and Equipment,    HTML     43K 
                net (Details)                                                    
66: R53         Property and Equipment - Narrative (Details)        HTML     28K 
67: R54         Intangible Assets - Schedule of Intangible Assets   HTML     44K 
                (Details)                                                        
68: R55         Intangible Assets - Narrative (Details)             HTML     30K 
69: R56         Intangible Assets - Schedule of Expected            HTML     39K 
                Amortization Expense (Details)                                   
70: R57         Accounts Payable and Accrued Expenses (Details)     HTML     39K 
71: R58         Long-Term Debt - Schedule of Long-Term Debt         HTML     48K 
                (Details)                                                        
72: R59         Long-Term Debt - Narrative (Details)                HTML     44K 
73: R60         Long-Term Debt - Future Principal Maturities of     HTML     37K 
                Long-Term Debt (Details)                                         
74: R61         Fair Value Measurements - Schedule of Assets and    HTML     46K 
                Liabilities Measured at Fair Value on a Recurring                
                Basis (Details)                                                  
75: R62         Fair Value Measurements - Changes in Contingent     HTML     40K 
                Consideration and Customer Equity Appreciation                   
                Rights (Details)                                                 
76: R63         Fair Value Measurements - Schedule of Valuation     HTML     55K 
                Techniques and Significant Unobservable Inputs                   
                (Details)                                                        
77: R64         Shareholders' Equity (Details)                      HTML     48K 
78: R65         Noncontrolling Interest (Details)                   HTML     39K 
79: R66         Equity-Based Compensation (Details)                 HTML     94K 
80: R67         Loss Per Share - Schedule of Earnings (Loss) Per    HTML     70K 
                Share (Details)                                                  
81: R68         Loss Per Share - Narrative (Details)                HTML     34K 
82: R69         Transaction-related Expenses - Narrative (Details)  HTML     31K 
83: R70         Commitment and Contingencies - Narrative (Details)  HTML     65K 
84: R71         Commitment and Contingencies - Summary of SEU       HTML     35K 
                Activity (Details)                                               
85: R72         Income Taxes (Details)                              HTML     49K 
86: R73         Segment Reporting - Narrative (Details)             HTML     25K 
87: R74         Segment Reporting - Schedule of Operating Segment   HTML     69K 
                Results (Details)                                                
88: R75         Concentrations (Details)                            HTML     43K 
89: R76         Related Party Transactions (Details)                HTML     38K 
90: R9999       Uncategorized Items - sgfy-20210331.htm             HTML     80K 
92: XML         IDEA XML File -- Filing Summary                      XML    165K 
13: XML         XBRL Instance -- sgfy-20210331_htm                   XML   1.68M 
91: EXCEL       IDEA Workbook of Financial Reports                  XLSX    112K 
 9: EX-101.CAL  XBRL Calculations -- sgfy-20210331_cal               XML    236K 
10: EX-101.DEF  XBRL Definitions -- sgfy-20210331_def                XML    727K 
11: EX-101.LAB  XBRL Labels -- sgfy-20210331_lab                     XML   1.59M 
12: EX-101.PRE  XBRL Presentations -- sgfy-20210331_pre              XML   1.03M 
 8: EX-101.SCH  XBRL Schema -- sgfy-20210331                         XSD    183K 
93: JSON        XBRL Instance as JSON Data -- MetaLinks              402±   573K 
94: ZIP         XBRL Zipped Folder -- 0001828182-21-000017-xbrl      Zip    318K

‘JSON’ — XBRL Instance as JSON Data — MetaLinks

This File is an XBRL Instance as JavaScript Object Notation (JSON) Data.

{
"instance":  {
    "sgfy-20210331.htm":  {
        "axisCustom":  2,
        "axisStandard":  34,
        "contextCount":  214,
        "dts":  {
            "calculationLink":  {
                "local":  [
                    "sgfy-20210331_cal.xml"
                    ]
                },
            "definitionLink":  {
                "local":  [
                    "sgfy-20210331_def.xml"
                    ]
                },
            "inline":  {
                "local":  [
                    "sgfy-20210331.htm"
                    ]
                },
            "labelLink":  {
                "local":  [
                    "sgfy-20210331_lab.xml"
                    ],
                "remote":  [
                    "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-doc-2021-01-31.xml"
                    ]
                },
            "presentationLink":  {
                "local":  [
                    "sgfy-20210331_pre.xml"
                    ]
                },
            "referenceLink":  {
                "remote":  [
                    "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-ref-2021-01-31.xml"
                    ]
                },
            "schema":  {
                "local":  [
                    "sgfy-20210331.xsd"
                    ],
                "remote":  [
                    "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
                    "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
                    "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
                    "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
                    "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
                    "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
                    "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
                    "http://www.xbrl.org/2005/xbrldt-2005.xsd",
                    "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
                    "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
                    "https://xbrl.sec.gov/country/2021/country-2021.xsd",
                    "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
                    "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
                    "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
                    "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
                    "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
                    "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
                    "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
                    "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
                    "https://xbrl.fasb.org/us-gaap/2021/elts/us-parts-codification-2021-01-31.xsd",
                    "https://xbrl.sec.gov/dei/2021/dei-2021_ref.xsd",
                    "https://xbrl.sec.gov/dei/2021/dei-2021_doc.xsd"
                    ]
                }
            },
        "elementCount":  539,
        "entityCount":  1,
        "hidden":  {
            "http://fasb.org/us-gaap/2021-01-31":  1,
            "http://xbrl.sec.gov/dei/2021":  5,
            "total":  6
            },
        "keyCustom":  47,
        "keyStandard":  314,
        "memberCustom":  41,
        "memberStandard":  49,
        "nsprefix":  "sgfy",
        "nsuri":  "http://signifyhealth.com/20210331",
        "report":  {
            "R1":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "dei:DocumentType",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "document",
                "isDefault":  "true",
                "longName":  "0001001 - Document - Cover Page",
                "role":  "http://signifyhealth.com/role/CoverPage",
                "shortName":  "Cover Page",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "dei:DocumentType",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R10":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:VariableInterestEntityDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2109104 - Disclosure - Variable Interest Entities",
                "role":  "http://signifyhealth.com/role/VariableInterestEntities",
                "shortName":  "Variable Interest Entities",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:VariableInterestEntityDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R11":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:RevenueFromContractWithCustomerTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2113105 - Disclosure - Revenue Recognition",
                "role":  "http://signifyhealth.com/role/RevenueRecognition",
                "shortName":  "Revenue Recognition",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:RevenueFromContractWithCustomerTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R12":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2122106 - Disclosure - Property and Equipment",
                "role":  "http://signifyhealth.com/role/PropertyandEquipment",
                "shortName":  "Property and Equipment",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R13":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:IntangibleAssetsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2126107 - Disclosure - Intangible Assets",
                "role":  "http://signifyhealth.com/role/IntangibleAssets",
                "shortName":  "Intangible Assets",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:IntangibleAssetsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R14":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2131108 - Disclosure - Accounts Payable and Accrued Expenses",
                "role":  "http://signifyhealth.com/role/AccountsPayableandAccruedExpenses",
                "shortName":  "Accounts Payable and Accrued Expenses",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R15":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:LongTermDebtTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2134109 - Disclosure - Long-Term Debt",
                "role":  "http://signifyhealth.com/role/LongTermDebt",
                "shortName":  "Long-Term Debt",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:LongTermDebtTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R16":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:FairValueDisclosuresTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2139110 - Disclosure - Fair Value Measurements",
                "role":  "http://signifyhealth.com/role/FairValueMeasurements",
                "shortName":  "Fair Value Measurements",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:FairValueDisclosuresTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R17":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2144111 - Disclosure - Shareholders' Equity",
                "role":  "http://signifyhealth.com/role/ShareholdersEquity",
                "shortName":  "Shareholders' Equity",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R18":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:MinorityInterestDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2146112 - Disclosure - Noncontrolling Interest",
                "role":  "http://signifyhealth.com/role/NoncontrollingInterest",
                "shortName":  "Noncontrolling Interest",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:MinorityInterestDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R19":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2149113 - Disclosure - Equity-Based Compensation",
                "role":  "http://signifyhealth.com/role/EquityBasedCompensation",
                "shortName":  "Equity-Based Compensation",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R2":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
                        "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i083eb103f18f48abb493b2f53a205cef_I20210331",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CashAndCashEquivalentsAtCarryingValue",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "1001002 - Statement - Condensed Consolidated Balance Sheets",
                "role":  "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets",
                "shortName":  "Condensed Consolidated Balance Sheets",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i083eb103f18f48abb493b2f53a205cef_I20210331",
                    "decimals":  "-5",
                    "lang":  "en-US",
                    "name":  "us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R20":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:EarningsPerShareTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2151114 - Disclosure - Loss Per Share",
                "role":  "http://signifyhealth.com/role/LossPerShare",
                "shortName":  "Loss Per Share",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:EarningsPerShareTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R21":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2155115 - Disclosure - Transaction-related Expenses",
                "role":  "http://signifyhealth.com/role/TransactionrelatedExpenses",
                "shortName":  "Transaction-related Expenses",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R22":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2157116 - Disclosure - Commitment and Contingencies",
                "role":  "http://signifyhealth.com/role/CommitmentandContingencies",
                "shortName":  "Commitment and Contingencies",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R23":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:IncomeTaxDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2161117 - Disclosure - Income Taxes",
                "role":  "http://signifyhealth.com/role/IncomeTaxes",
                "shortName":  "Income Taxes",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:IncomeTaxDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R24":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SegmentReportingDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2163118 - Disclosure - Segment Reporting",
                "role":  "http://signifyhealth.com/role/SegmentReporting",
                "shortName":  "Segment Reporting",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SegmentReportingDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R25":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ConcentrationRiskDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2167119 - Disclosure - Concentrations",
                "role":  "http://signifyhealth.com/role/Concentrations",
                "shortName":  "Concentrations",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ConcentrationRiskDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R26":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2169120 - Disclosure - Related Party Transactions",
                "role":  "http://signifyhealth.com/role/RelatedPartyTransactions",
                "shortName":  "Related Party Transactions",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R27":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2204201 - Disclosure - Significant Accounting Policies (Policies)",
                "role":  "http://signifyhealth.com/role/SignificantAccountingPoliciesPolicies",
                "shortName":  "Significant Accounting Policies (Policies)",
                "subGroupType":  "policies",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R28":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2305301 - Disclosure - Significant Accounting Policies (Tables)",
                "role":  "http://signifyhealth.com/role/SignificantAccountingPoliciesTables",
                "shortName":  "Significant Accounting Policies (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R29":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2310302 - Disclosure - Variable Interest Entities (Tables)",
                "role":  "http://signifyhealth.com/role/VariableInterestEntitiesTables",
                "shortName":  "Variable Interest Entities (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R3":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "us-gaap:CommonStockParOrStatedValuePerShare",
                        "span",
                        "div",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "ie4c9e2efc0324a62ab42e682920daf48_I20210331",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CommonStockParOrStatedValuePerShare",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usdPerShare",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "1002003 - Statement - Consolidated Balance Sheets (Parenthetical)",
                "role":  "http://signifyhealth.com/role/ConsolidatedBalanceSheetsParenthetical",
                "shortName":  "Consolidated Balance Sheets (Parenthetical)",
                "subGroupType":  "parenthetical",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "us-gaap:CommonStockParOrStatedValuePerShare",
                        "span",
                        "div",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "ie4c9e2efc0324a62ab42e682920daf48_I20210331",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CommonStockParOrStatedValuePerShare",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usdPerShare",
                    "xsiNil":  "false"
                    }
                },
            "R30":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:DisaggregationOfRevenueTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2314303 - Disclosure - Revenue Recognition (Tables)",
                "role":  "http://signifyhealth.com/role/RevenueRecognitionTables",
                "shortName":  "Revenue Recognition (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:DisaggregationOfRevenueTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R31":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:PropertyPlantAndEquipmentTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2323304 - Disclosure - Property and Equipment (Tables)",
                "role":  "http://signifyhealth.com/role/PropertyandEquipmentTables",
                "shortName":  "Property and Equipment (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:PropertyPlantAndEquipmentTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R32":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2327305 - Disclosure - Intangible Assets (Tables)",
                "role":  "http://signifyhealth.com/role/IntangibleAssetsTables",
                "shortName":  "Intangible Assets (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R33":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2332306 - Disclosure - Accounts Payable and Accrued Expenses (Tables)",
                "role":  "http://signifyhealth.com/role/AccountsPayableandAccruedExpensesTables",
                "shortName":  "Accounts Payable and Accrued Expenses (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R34":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2335307 - Disclosure - Long-Term Debt (Tables)",
                "role":  "http://signifyhealth.com/role/LongTermDebtTables",
                "shortName":  "Long-Term Debt (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R35":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2340308 - Disclosure - Fair Value Measurements (Tables)",
                "role":  "http://signifyhealth.com/role/FairValueMeasurementsTables",
                "shortName":  "Fair Value Measurements (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R36":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2347309 - Disclosure - Noncontrolling Interest (Tables)",
                "role":  "http://signifyhealth.com/role/NoncontrollingInterestTables",
                "shortName":  "Noncontrolling Interest (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R37":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2352310 - Disclosure - Loss Per Share (Tables)",
                "role":  "http://signifyhealth.com/role/LossPerShareTables",
                "shortName":  "Loss Per Share (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R38":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2358311 - Disclosure - Commitment and Contingencies (Tables)",
                "role":  "http://signifyhealth.com/role/CommitmentandContingenciesTables",
                "shortName":  "Commitment and Contingencies (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R39":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2364312 - Disclosure - Segment Reporting (Tables)",
                "role":  "http://signifyhealth.com/role/SegmentReportingTables",
                "shortName":  "Segment Reporting (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R4":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "1003004 - Statement - Condensed Consolidated Statements of Operations",
                "role":  "http://signifyhealth.com/role/CondensedConsolidatedStatementsofOperations",
                "shortName":  "Condensed Consolidated Statements of Operations",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  "-5",
                    "lang":  "en-US",
                    "name":  "us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R40":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:NumberOfOperatingSegments",
                    "reportCount":  1,
                    "unitRef":  "segment",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2402401 - Disclosure - Nature of Operations (Details)",
                "role":  "http://signifyhealth.com/role/NatureofOperationsDetails",
                "shortName":  "Nature of Operations (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  "INF",
                    "lang":  "en-US",
                    "name":  "sgfy:NumberOfClassesOfNonVotingCommonUnits",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "class",
                    "xsiNil":  "false"
                    }
                },
            "R41":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:NumberOfOperatingSegments",
                    "reportCount":  1,
                    "unitRef":  "segment",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2406402 - Disclosure - Significant Accounting Policies - Narrative (Details)",
                "role":  "http://signifyhealth.com/role/SignificantAccountingPoliciesNarrativeDetails",
                "shortName":  "Significant Accounting Policies - Narrative (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "lang":  "en-US",
                    "name":  "sgfy:RestrictedCashAgreementReturnOfFundsFollowingConclusionOfEffectivePeriodPeriod",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R42":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
                        "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i083eb103f18f48abb493b2f53a205cef_I20210331",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CashAndCashEquivalentsAtCarryingValue",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2407403 - Disclosure - Significant Accounting Policies - Cash, Cash Equivalents and Restricted Cash (Details)",
                "role":  "http://signifyhealth.com/role/SignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails",
                "shortName":  "Significant Accounting Policies - Cash, Cash Equivalents and Restricted Cash (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  null
                },
            "R43":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i083eb103f18f48abb493b2f53a205cef_I20210331",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "sgfy:NumberOfPhysicianPractices",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "physicianpractice",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2411404 - Disclosure - Variable Interest Entities - Narrative (Details)",
                "role":  "http://signifyhealth.com/role/VariableInterestEntitiesNarrativeDetails",
                "shortName":  "Variable Interest Entities - Narrative (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i083eb103f18f48abb493b2f53a205cef_I20210331",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "sgfy:NumberOfPhysicianPractices",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "physicianpractice",
                    "xsiNil":  "false"
                    }
                },
            "R44":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
                        "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i083eb103f18f48abb493b2f53a205cef_I20210331",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CashAndCashEquivalentsAtCarryingValue",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2412405 - Disclosure - Variable Interest Entities - Schedule of Variable Interest Entities (Details)",
                "role":  "http://signifyhealth.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails",
                "shortName":  "Variable Interest Entities - Schedule of Variable Interest Entities (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i1324e16368a54579b4ee9093eb563540_I20210331",
                    "decimals":  "-5",
                    "lang":  "en-US",
                    "name":  "us-gaap:CashAndCashEquivalentsAtCarryingValue",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R45":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:NumberOfOperatingSegments",
                    "reportCount":  1,
                    "unitRef":  "segment",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2415406 - Disclosure - Revenue Recognition - Narrative (Details)",
                "role":  "http://signifyhealth.com/role/RevenueRecognitionNarrativeDetails",
                "shortName":  "Revenue Recognition - Narrative (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  null
                },
            "R46":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2416407 - Disclosure - Revenue Recognition - Disaggregation of Revenue (Details)",
                "role":  "http://signifyhealth.com/role/RevenueRecognitionDisaggregationofRevenueDetails",
                "shortName":  "Revenue Recognition - Disaggregation of Revenue (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:DisaggregationOfRevenueTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i6c4931898d67444d97328fa06500a972_D20210101-20210331",
                    "decimals":  "-5",
                    "lang":  "en-US",
                    "name":  "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R47":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i083eb103f18f48abb493b2f53a205cef_I20210331",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:AccountsReceivableNetCurrent",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2417408 - Disclosure - Revenue Recognition - Schedule of Related Balance Sheets Account (Details)",
                "role":  "http://signifyhealth.com/role/RevenueRecognitionScheduleofRelatedBalanceSheetsAccountDetails",
                "shortName":  "Revenue Recognition - Schedule of Related Balance Sheets Account (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i55b615094b1549e584bc11501ec3db52_I20210331",
                    "decimals":  "-5",
                    "lang":  "en-US",
                    "name":  "sgfy:SharedSavingsPayable",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R48":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "ie3c1925d91854452bf77af16e024be38_I20201231",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ContractWithCustomerAssetNetCurrent",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2418409 - Disclosure - Revenue Recognition - Contract Assets (Details)",
                "role":  "http://signifyhealth.com/role/RevenueRecognitionContractAssetsDetails",
                "shortName":  "Revenue Recognition - Contract Assets (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "ix:continuation",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  "-5",
                    "lang":  "en-US",
                    "name":  "sgfy:ContractWithCustomerAssetPerformanceObligationSatisfiedInPeriod",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R49":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "ie3c1925d91854452bf77af16e024be38_I20201231",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ContractWithCustomerRefundLiabilityCurrent",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2419410 - Disclosure - Revenue Recognition - Contract Liabilities (Details)",
                "role":  "http://signifyhealth.com/role/RevenueRecognitionContractLiabilitiesDetails",
                "shortName":  "Revenue Recognition - Contract Liabilities (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "ix:continuation",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  "-5",
                    "lang":  "en-US",
                    "name":  "sgfy:ContractWithCustomerRefundLiabilityPaymentsMadeToCustomer",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R5":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i7b94b19154a2485082fe7c139b90e0cb_I20191231",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:MembersEquity",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "1004005 - Statement - Condensed Consolidated Statements of Changes in Stockholders' / Members\u2019 Equity",
                "role":  "http://signifyhealth.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquity",
                "shortName":  "Condensed Consolidated Statements of Changes in Stockholders' / Members\u2019 Equity",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i7b94b19154a2485082fe7c139b90e0cb_I20191231",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:MembersEquity",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R50":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "ie3c1925d91854452bf77af16e024be38_I20201231",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ContractWithCustomerLiabilityCurrent",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2420411 - Disclosure - Revenue Recognition - Deferred Revenue (Details)",
                "role":  "http://signifyhealth.com/role/RevenueRecognitionDeferredRevenueDetails",
                "shortName":  "Revenue Recognition - Deferred Revenue (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "ix:continuation",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  "-5",
                    "lang":  "en-US",
                    "name":  "sgfy:ContractWithCustomerLiabilityPaymentsReceivedFromCustomers",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R51":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "ie3c1925d91854452bf77af16e024be38_I20201231",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "sgfy:SharedSavingsPayable",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2421412 - Disclosure - Revenue Recognition - Shared Savings Payable (Details)",
                "role":  "http://signifyhealth.com/role/RevenueRecognitionSharedSavingsPayableDetails",
                "shortName":  "Revenue Recognition - Shared Savings Payable (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "ix:continuation",
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  "-5",
                    "lang":  "en-US",
                    "name":  "sgfy:SharedSavingsPayablePaymentsToCustomer",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R52":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:PropertyPlantAndEquipmentTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i083eb103f18f48abb493b2f53a205cef_I20210331",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:PropertyPlantAndEquipmentGross",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2424413 - Disclosure - Property and Equipment - Property and Equipment, net (Details)",
                "role":  "http://signifyhealth.com/role/PropertyandEquipmentPropertyandEquipmentnetDetails",
                "shortName":  "Property and Equipment - Property and Equipment, net (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:PropertyPlantAndEquipmentTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i083eb103f18f48abb493b2f53a205cef_I20210331",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:PropertyPlantAndEquipmentGross",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R53":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:Depreciation",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2425414 - Disclosure - Property and Equipment - Narrative (Details)",
                "role":  "http://signifyhealth.com/role/PropertyandEquipmentNarrativeDetails",
                "shortName":  "Property and Equipment - Narrative (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:Depreciation",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R54":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i083eb103f18f48abb493b2f53a205cef_I20210331",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:FiniteLivedIntangibleAssetsGross",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2428415 - Disclosure - Intangible Assets - Schedule of Intangible Assets (Details)",
                "role":  "http://signifyhealth.com/role/IntangibleAssetsScheduleofIntangibleAssetsDetails",
                "shortName":  "Intangible Assets - Schedule of Intangible Assets (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i083eb103f18f48abb493b2f53a205cef_I20210331",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:FiniteLivedIntangibleAssetsGross",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R55":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CapitalizedComputerSoftwareAdditions",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2429416 - Disclosure - Intangible Assets - Narrative (Details)",
                "role":  "http://signifyhealth.com/role/IntangibleAssetsNarrativeDetails",
                "shortName":  "Intangible Assets - Narrative (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CapitalizedComputerSoftwareAdditions",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R56":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "ix:continuation",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i083eb103f18f48abb493b2f53a205cef_I20210331",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2430417 - Disclosure - Intangible Assets - Schedule of Expected Amortization Expense (Details)",
                "role":  "http://signifyhealth.com/role/IntangibleAssetsScheduleofExpectedAmortizationExpenseDetails",
                "shortName":  "Intangible Assets - Schedule of Expected Amortization Expense (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "ix:continuation",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i083eb103f18f48abb493b2f53a205cef_I20210331",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R57":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i083eb103f18f48abb493b2f53a205cef_I20210331",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "sgfy:SharedSavingsPayable",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2433418 - Disclosure - Accounts Payable and Accrued Expenses (Details)",
                "role":  "http://signifyhealth.com/role/AccountsPayableandAccruedExpensesDetails",
                "shortName":  "Accounts Payable and Accrued Expenses (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i083eb103f18f48abb493b2f53a205cef_I20210331",
                    "decimals":  "-5",
                    "lang":  "en-US",
                    "name":  "us-gaap:EmployeeRelatedLiabilitiesCurrentAndNoncurrent",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R58":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i083eb103f18f48abb493b2f53a205cef_I20210331",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:DebtInstrumentCarryingAmount",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2436419 - Disclosure - Long-Term Debt - Schedule of Long-Term Debt (Details)",
                "role":  "http://signifyhealth.com/role/LongTermDebtScheduleofLongTermDebtDetails",
                "shortName":  "Long-Term Debt - Schedule of Long-Term Debt (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i083eb103f18f48abb493b2f53a205cef_I20210331",
                    "decimals":  "-5",
                    "lang":  "en-US",
                    "name":  "us-gaap:DeferredFinanceCostsNet",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R59":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i5296c51e581b4a5ea497274ca70d4427_D20200301-20200331",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ProceedsFromLinesOfCredit",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2437420 - Disclosure - Long-Term Debt - Narrative (Details)",
                "role":  "http://signifyhealth.com/role/LongTermDebtNarrativeDetails",
                "shortName":  "Long-Term Debt - Narrative (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i5296c51e581b4a5ea497274ca70d4427_D20200301-20200331",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ProceedsFromLinesOfCredit",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R6":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ProfitLoss",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "1005006 - Statement - Condensed Consolidated Statements of Cash Flows",
                "role":  "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows",
                "shortName":  "Condensed Consolidated Statements of Cash Flows",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  "-5",
                    "lang":  "en-US",
                    "name":  "us-gaap:ShareBasedCompensation",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R60":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i083eb103f18f48abb493b2f53a205cef_I20210331",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2438421 - Disclosure - Long-Term Debt - Future Principal Maturities of Long-Term Debt (Details)",
                "role":  "http://signifyhealth.com/role/LongTermDebtFuturePrincipalMaturitiesofLongTermDebtDetails",
                "shortName":  "Long-Term Debt - Future Principal Maturities of Long-Term Debt (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i083eb103f18f48abb493b2f53a205cef_I20210331",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R61":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i083eb103f18f48abb493b2f53a205cef_I20210331",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "sgfy:StockAppreciationRightsLiability",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2441422 - Disclosure - Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)",
                "role":  "http://signifyhealth.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
                "shortName":  "Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "ia24066afb7244356a7a1244acb16462d_I20210331",
                    "decimals":  "-5",
                    "lang":  "en-US",
                    "name":  "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R62":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i1fb9bc5881b342f8ac43b2864a862059_I20201231",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2442423 - Disclosure - Fair Value Measurements - Changes in Contingent Consideration and Customer Equity Appreciation Rights (Details)",
                "role":  "http://signifyhealth.com/role/FairValueMeasurementsChangesinContingentConsiderationandCustomerEquityAppreciationRightsDetails",
                "shortName":  "Fair Value Measurements - Changes in Contingent Consideration and Customer Equity Appreciation Rights (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i1fb9bc5881b342f8ac43b2864a862059_I20201231",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R63":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i083eb103f18f48abb493b2f53a205cef_I20210331",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "sgfy:StockAppreciationRightsLiability",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2443424 - Disclosure - Fair Value Measurements - Schedule of Valuation Techniques and Significant Unobservable Inputs (Details)",
                "role":  "http://signifyhealth.com/role/FairValueMeasurementsScheduleofValuationTechniquesandSignificantUnobservableInputsDetails",
                "shortName":  "Fair Value Measurements - Schedule of Valuation Techniques and Significant Unobservable Inputs (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i68060b3639c8430d9d49dd4a8bbe60ad_I20210331",
                    "decimals":  "-5",
                    "lang":  "en-US",
                    "name":  "sgfy:StockAppreciationRightsLiability",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R64":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "sgfy:NumberOfClassesOfCommonStock",
                    "reportCount":  1,
                    "unitRef":  "class",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2445425 - Disclosure - Shareholders' Equity (Details)",
                "role":  "http://signifyhealth.com/role/ShareholdersEquityDetails",
                "shortName":  "Shareholders' Equity (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "ic09d89fa5de9421789b6d6d61603bee9_I20210331",
                    "decimals":  "INF",
                    "lang":  "en-US",
                    "name":  "sgfy:CommonStockNumberOfVotesPerShare",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "vote",
                    "xsiNil":  "false"
                    }
                },
            "R65":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "ia5eff6eafffb485391751fd0b8d3da44_I20210331",
                    "decimals":  "3",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:MinorityInterestOwnershipPercentageByParent",
                    "reportCount":  1,
                    "unitRef":  "number",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2448426 - Disclosure - Noncontrolling Interest (Details)",
                "role":  "http://signifyhealth.com/role/NoncontrollingInterestDetails",
                "shortName":  "Noncontrolling Interest (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "ia5eff6eafffb485391751fd0b8d3da44_I20210331",
                    "decimals":  "3",
                    "lang":  "en-US",
                    "name":  "sgfy:NoncontrollingInterestOwnershipPercentage",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "number",
                    "xsiNil":  "false"
                    }
                },
            "R66":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i083eb103f18f48abb493b2f53a205cef_I20210331",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "shares",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2450427 - Disclosure - Equity-Based Compensation (Details)",
                "role":  "http://signifyhealth.com/role/EquityBasedCompensationDetails",
                "shortName":  "Equity-Based Compensation (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i083eb103f18f48abb493b2f53a205cef_I20210331",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "shares",
                    "xsiNil":  "false"
                    }
                },
            "R67":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i1d8a49d5227a4a0b91a8151b2de3086f_D20210216-20210331",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ProfitLoss",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2453428 - Disclosure - Loss Per Share - Schedule of Earnings (Loss) Per Share (Details)",
                "role":  "http://signifyhealth.com/role/LossPerShareScheduleofEarningsLossPerShareDetails",
                "shortName":  "Loss Per Share - Schedule of Earnings (Loss) Per Share (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i1d8a49d5227a4a0b91a8151b2de3086f_D20210216-20210331",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ProfitLoss",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R68":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i977ed6a05baf4f8db16d76ba4bc43fbb_D20210101-20210331",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "shares",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2454429 - Disclosure - Loss Per Share - Narrative (Details)",
                "role":  "http://signifyhealth.com/role/LossPerShareNarrativeDetails",
                "shortName":  "Loss Per Share - Narrative (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i977ed6a05baf4f8db16d76ba4bc43fbb_D20210101-20210331",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "shares",
                    "xsiNil":  "false"
                    }
                },
            "R69":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:BusinessCombinationAcquisitionRelatedCosts",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2456430 - Disclosure - Transaction-related Expenses - Narrative (Details)",
                "role":  "http://signifyhealth.com/role/TransactionrelatedExpensesNarrativeDetails",
                "shortName":  "Transaction-related Expenses - Narrative (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:BusinessCombinationAcquisitionRelatedCosts",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R7":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2101101 - Disclosure - Nature of Operations",
                "role":  "http://signifyhealth.com/role/NatureofOperations",
                "shortName":  "Nature of Operations",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R70":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i083eb103f18f48abb493b2f53a205cef_I20210331",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:LettersOfCreditOutstandingAmount",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2459431 - Disclosure - Commitment and Contingencies - Narrative (Details)",
                "role":  "http://signifyhealth.com/role/CommitmentandContingenciesNarrativeDetails",
                "shortName":  "Commitment and Contingencies - Narrative (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i083eb103f18f48abb493b2f53a205cef_I20210331",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:LettersOfCreditOutstandingAmount",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R71":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i3d3d677b708246609b35007232f089e2_I20201231",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2460432 - Disclosure - Commitment and Contingencies - Summary of SEU Activity (Details)",
                "role":  "http://signifyhealth.com/role/CommitmentandContingenciesSummaryofSEUActivityDetails",
                "shortName":  "Commitment and Contingencies - Summary of SEU Activity (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "ic328bb1c2b444a499e5fb5f858ba6e42_D20210101-20210331",
                    "decimals":  "-5",
                    "lang":  "en-US",
                    "name":  "sgfy:ShareBasedPaymentArrangementNonvestedAwardPayments",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R72":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:IncomeTaxExpenseBenefit",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2462433 - Disclosure - Income Taxes (Details)",
                "role":  "http://signifyhealth.com/role/IncomeTaxesDetails",
                "shortName":  "Income Taxes (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  "3",
                    "lang":  "en-US",
                    "name":  "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "number",
                    "xsiNil":  "false"
                    }
                },
            "R73":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:NumberOfReportableSegments",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "segment",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2465434 - Disclosure - Segment Reporting - Narrative (Details)",
                "role":  "http://signifyhealth.com/role/SegmentReportingNarrativeDetails",
                "shortName":  "Segment Reporting - Narrative (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:NumberOfReportableSegments",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "segment",
                    "xsiNil":  "false"
                    }
                },
            "R74":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2466435 - Disclosure - Segment Reporting - Schedule of Operating Segment Results (Details)",
                "role":  "http://signifyhealth.com/role/SegmentReportingScheduleofOperatingSegmentResultsDetails",
                "shortName":  "Segment Reporting - Schedule of Operating Segment Results (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "ix:continuation",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  "-5",
                    "lang":  "en-US",
                    "name":  "us-gaap:BusinessCombinationIntegrationRelatedCosts",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R75":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i350e503dc46c4266be5bfe5f67c42b10_D20210101-20210331",
                    "decimals":  "2",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ConcentrationRiskPercentage1",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "number",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2468436 - Disclosure - Concentrations (Details)",
                "role":  "http://signifyhealth.com/role/ConcentrationsDetails",
                "shortName":  "Concentrations (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i350e503dc46c4266be5bfe5f67c42b10_D20210101-20210331",
                    "decimals":  "2",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ConcentrationRiskPercentage1",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "number",
                    "xsiNil":  "false"
                    }
                },
            "R76":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i759d3d227d1e447c9705b3283bc2e541_D20190307-20190307",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:RelatedPartyTransactionAmountsOfTransaction",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2470437 - Disclosure - Related Party Transactions (Details)",
                "role":  "http://signifyhealth.com/role/RelatedPartyTransactionsDetails",
                "shortName":  "Related Party Transactions (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i759d3d227d1e447c9705b3283bc2e541_D20190307-20190307",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:RelatedPartyTransactionAmountsOfTransaction",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R8":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SignificantAccountingPoliciesTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2103102 - Disclosure - Significant Accounting Policies",
                "role":  "http://signifyhealth.com/role/SignificantAccountingPolicies",
                "shortName":  "Significant Accounting Policies",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SignificantAccountingPoliciesTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R9":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:UnusualOrInfrequentItemsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2108103 - Disclosure - The COVID-19 Pandemic",
                "role":  "http://signifyhealth.com/role/TheCOVID19Pandemic",
                "shortName":  "The COVID-19 Pandemic",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i093c8d450ad84f238593677f86eb2df7_D20210101-20210331",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:UnusualOrInfrequentItemsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R9999":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "sgfy-20210331.htm",
                    "contextRef":  "i481fdf9ac5f94660b4feaaae692dfa49_D20210101-20210215",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:LimitedLiabilityCompanyLLCMembersEquityUnitBasedCompensation",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "",
                "isDefault":  "false",
                "longName":  "Uncategorized Items - sgfy-20210331.htm",
                "role":  "http://xbrl.sec.gov/role/uncategorizedFacts",
                "shortName":  "Uncategorized Items - sgfy-20210331.htm",
                "subGroupType":  "",
                "uniqueAnchor":  null
                }
            },
        "segmentCount":  95,
        "tag":  {
            "dei_AmendmentFlag":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
                            "label":  "Amendment Flag",
                            "terseLabel":  "Amendment Flag"
                            }
                        }
                    },
                "localname":  "AmendmentFlag",
                "nsuri":  "http://xbrl.sec.gov/dei/2021",
                "presentation":  [
                    "http://signifyhealth.com/role/CoverPage"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_CityAreaCode":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Area code of city",
                            "label":  "City Area Code",
                            "terseLabel":  "City Area Code"
                            }
                        }
                    },
                "localname":  "CityAreaCode",
                "nsuri":  "http://xbrl.sec.gov/dei/2021",
                "presentation":  [
                    "http://signifyhealth.com/role/CoverPage"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_CoverAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Cover page.",
                            "label":  "Cover [Abstract]"
                            }
                        }
                    },
                "localname":  "CoverAbstract",
                "nsuri":  "http://xbrl.sec.gov/dei/2021",
                "xbrltype":  "stringItemType"
                },
            "dei_CurrentFiscalYearEndDate":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "End date of current fiscal year in the format --MM-DD.",
                            "label":  "Current Fiscal Year End Date",
                            "terseLabel":  "Current Fiscal Year End Date"
                            }
                        }
                    },
                "localname":  "CurrentFiscalYearEndDate",
                "nsuri":  "http://xbrl.sec.gov/dei/2021",
                "presentation":  [
                    "http://signifyhealth.com/role/CoverPage"
                    ],
                "xbrltype":  "gMonthDayItemType"
                },
            "dei_DocumentFiscalPeriodFocus":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Fiscal period values are FY, Q1, Q2, and Q3.   1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
                            "label":  "Document Fiscal Period Focus",
                            "terseLabel":  "Document Fiscal Period Focus"
                            }
                        }
                    },
                "localname":  "DocumentFiscalPeriodFocus",
                "nsuri":  "http://xbrl.sec.gov/dei/2021",
                "presentation":  [
                    "http://signifyhealth.com/role/CoverPage"
                    ],
                "xbrltype":  "fiscalPeriodItemType"
                },
            "dei_DocumentFiscalYearFocus":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "This is focus fiscal year of the document report in YYYY format.  For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus.  Example: 2006.",
                            "label":  "Document Fiscal Year Focus",
                            "terseLabel":  "Document Fiscal Year Focus"
                            }
                        }
                    },
                "localname":  "DocumentFiscalYearFocus",
                "nsuri":  "http://xbrl.sec.gov/dei/2021",
                "presentation":  [
                    "http://signifyhealth.com/role/CoverPage"
                    ],
                "xbrltype":  "gYearItemType"
                },
            "dei_DocumentPeriodEndDate":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
                            "label":  "Document Period End Date",
                            "terseLabel":  "Document Period End Date"
                            }
                        }
                    },
                "localname":  "DocumentPeriodEndDate",
                "nsuri":  "http://xbrl.sec.gov/dei/2021",
                "presentation":  [
                    "http://signifyhealth.com/role/CoverPage"
                    ],
                "xbrltype":  "dateItemType"
                },
            "dei_DocumentQuarterlyReport":  {
                "auth_ref":  [
                    "r566"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true only for a form used as an quarterly report.",
                            "label":  "Document Quarterly Report",
                            "terseLabel":  "Document Quarterly Report"
                            }
                        }
                    },
                "localname":  "DocumentQuarterlyReport",
                "nsuri":  "http://xbrl.sec.gov/dei/2021",
                "presentation":  [
                    "http://signifyhealth.com/role/CoverPage"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_DocumentTransitionReport":  {
                "auth_ref":  [
                    "r567"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true only for a form used as a transition report.",
                            "label":  "Document Transition Report",
                            "terseLabel":  "Document Transition Report"
                            }
                        }
                    },
                "localname":  "DocumentTransitionReport",
                "nsuri":  "http://xbrl.sec.gov/dei/2021",
                "presentation":  [
                    "http://signifyhealth.com/role/CoverPage"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_DocumentType":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc).  The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
                            "label":  "Document Type",
                            "terseLabel":  "Document Type"
                            }
                        }
                    },
                "localname":  "DocumentType",
                "nsuri":  "http://xbrl.sec.gov/dei/2021",
                "presentation":  [
                    "http://signifyhealth.com/role/CoverPage"
                    ],
                "xbrltype":  "submissionTypeItemType"
                },
            "dei_EntityAddressAddressLine1":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Address Line 1 such as Attn, Building Name, Street Name",
                            "label":  "Entity Address, Address Line One",
                            "terseLabel":  "Entity Address, Address Line One"
                            }
                        }
                    },
                "localname":  "EntityAddressAddressLine1",
                "nsuri":  "http://xbrl.sec.gov/dei/2021",
                "presentation":  [
                    "http://signifyhealth.com/role/CoverPage"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityAddressCityOrTown":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Name of the City or Town",
                            "label":  "Entity Address, City or Town",
                            "terseLabel":  "Entity Address, City or Town"
                            }
                        }
                    },
                "localname":  "EntityAddressCityOrTown",
                "nsuri":  "http://xbrl.sec.gov/dei/2021",
                "presentation":  [
                    "http://signifyhealth.com/role/CoverPage"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityAddressPostalZipCode":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Code for the postal or zip code",
                            "label":  "Entity Address, Postal Zip Code",
                            "terseLabel":  "Entity Address, Postal Zip Code"
                            }
                        }
                    },
                "localname":  "EntityAddressPostalZipCode",
                "nsuri":  "http://xbrl.sec.gov/dei/2021",
                "presentation":  [
                    "http://signifyhealth.com/role/CoverPage"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityAddressStateOrProvince":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Name of the state or province.",
                            "label":  "Entity Address, State or Province",
                            "terseLabel":  "Entity Address, State or Province"
                            }
                        }
                    },
                "localname":  "EntityAddressStateOrProvince",
                "nsuri":  "http://xbrl.sec.gov/dei/2021",
                "presentation":  [
                    "http://signifyhealth.com/role/CoverPage"
                    ],
                "xbrltype":  "stateOrProvinceItemType"
                },
            "dei_EntityCentralIndexKey":  {
                "auth_ref":  [
                    "r568"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC.  It is commonly abbreviated as CIK.",
                            "label":  "Entity Central Index Key",
                            "terseLabel":  "Entity Central Index Key"
                            }
                        }
                    },
                "localname":  "EntityCentralIndexKey",
                "nsuri":  "http://xbrl.sec.gov/dei/2021",
                "presentation":  [
                    "http://signifyhealth.com/role/CoverPage"
                    ],
                "xbrltype":  "centralIndexKeyItemType"
                },
            "dei_EntityCommonStockSharesOutstanding":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report.  Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
                            "label":  "Entity Common Stock, Shares Outstanding",
                            "terseLabel":  "Entity Common Stock, Shares Outstanding"
                            }
                        }
                    },
                "localname":  "EntityCommonStockSharesOutstanding",
                "nsuri":  "http://xbrl.sec.gov/dei/2021",
                "presentation":  [
                    "http://signifyhealth.com/role/CoverPage"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "dei_EntityCurrentReportingStatus":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days.  This information should be based on the registrant's current or most recent filing containing the related disclosure.",
                            "label":  "Entity Current Reporting Status",
                            "terseLabel":  "Entity Current Reporting Status"
                            }
                        }
                    },
                "localname":  "EntityCurrentReportingStatus",
                "nsuri":  "http://xbrl.sec.gov/dei/2021",
                "presentation":  [
                    "http://signifyhealth.com/role/CoverPage"
                    ],
                "xbrltype":  "yesNoItemType"
                },
            "dei_EntityDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "All the names of the entities being reported upon in a document.  Any legal structure used to conduct activities or to hold assets.  Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts.  This item does not include business and geographical segments which are included in the geographical or business segments domains.",
                            "label":  "Entity [Domain]",
                            "terseLabel":  "Entity [Domain]"
                            }
                        }
                    },
                "localname":  "EntityDomain",
                "nsuri":  "http://xbrl.sec.gov/dei/2021",
                "presentation":  [
                    "http://signifyhealth.com/role/NoncontrollingInterestDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "dei_EntityEmergingGrowthCompany":  {
                "auth_ref":  [
                    "r568"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate if registrant meets the emerging growth company criteria.",
                            "label":  "Entity Emerging Growth Company",
                            "terseLabel":  "Entity Emerging Growth Company"
                            }
                        }
                    },
                "localname":  "EntityEmergingGrowthCompany",
                "nsuri":  "http://xbrl.sec.gov/dei/2021",
                "presentation":  [
                    "http://signifyhealth.com/role/CoverPage"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_EntityExTransitionPeriod":  {
                "auth_ref":  [
                    "r571"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
                            "label":  "Entity Ex Transition Period",
                            "terseLabel":  "Entity Ex Transition Period"
                            }
                        }
                    },
                "localname":  "EntityExTransitionPeriod",
                "nsuri":  "http://xbrl.sec.gov/dei/2021",
                "presentation":  [
                    "http://signifyhealth.com/role/CoverPage"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_EntityFileNumber":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Commission file number.  The field allows up to 17 characters.  The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
                            "label":  "Entity File Number",
                            "terseLabel":  "Entity File Number"
                            }
                        }
                    },
                "localname":  "EntityFileNumber",
                "nsuri":  "http://xbrl.sec.gov/dei/2021",
                "presentation":  [
                    "http://signifyhealth.com/role/CoverPage"
                    ],
                "xbrltype":  "fileNumberItemType"
                },
            "dei_EntityFilerCategory":  {
                "auth_ref":  [
                    "r568"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate whether the registrant is one of the following:  Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer.  Definitions of these categories are stated in Rule 12b-2 of the Exchange Act.  This information should be based on the registrant's current or most recent filing containing the related disclosure.",
                            "label":  "Entity Filer Category",
                            "terseLabel":  "Entity Filer Category"
                            }
                        }
                    },
                "localname":  "EntityFilerCategory",
                "nsuri":  "http://xbrl.sec.gov/dei/2021",
                "presentation":  [
                    "http://signifyhealth.com/role/CoverPage"
                    ],
                "xbrltype":  "filerCategoryItemType"
                },
            "dei_EntityIncorporationStateCountryCode":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Two-character EDGAR code representing the state or country of incorporation.",
                            "label":  "Entity Incorporation, State or Country Code",
                            "terseLabel":  "Entity Incorporation, State or Country Code"
                            }
                        }
                    },
                "localname":  "EntityIncorporationStateCountryCode",
                "nsuri":  "http://xbrl.sec.gov/dei/2021",
                "presentation":  [
                    "http://signifyhealth.com/role/CoverPage"
                    ],
                "xbrltype":  "edgarStateCountryItemType"
                },
            "dei_EntityInteractiveDataCurrent":  {
                "auth_ref":  [
                    "r570"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
                            "label":  "Entity Interactive Data Current",
                            "terseLabel":  "Entity Interactive Data Current"
                            }
                        }
                    },
                "localname":  "EntityInteractiveDataCurrent",
                "nsuri":  "http://xbrl.sec.gov/dei/2021",
                "presentation":  [
                    "http://signifyhealth.com/role/CoverPage"
                    ],
                "xbrltype":  "yesNoItemType"
                },
            "dei_EntityRegistrantName":  {
                "auth_ref":  [
                    "r568"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
                            "label":  "Entity Registrant Name",
                            "terseLabel":  "Entity Registrant Name"
                            }
                        }
                    },
                "localname":  "EntityRegistrantName",
                "nsuri":  "http://xbrl.sec.gov/dei/2021",
                "presentation":  [
                    "http://signifyhealth.com/role/CoverPage"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityShellCompany":  {
                "auth_ref":  [
                    "r568"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
                            "label":  "Entity Shell Company",
                            "terseLabel":  "Entity Shell Company"
                            }
                        }
                    },
                "localname":  "EntityShellCompany",
                "nsuri":  "http://xbrl.sec.gov/dei/2021",
                "presentation":  [
                    "http://signifyhealth.com/role/CoverPage"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_EntitySmallBusiness":  {
                "auth_ref":  [
                    "r568"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicates that the company is a Smaller Reporting Company (SRC).",
                            "label":  "Entity Small Business",
                            "terseLabel":  "Entity Small Business"
                            }
                        }
                    },
                "localname":  "EntitySmallBusiness",
                "nsuri":  "http://xbrl.sec.gov/dei/2021",
                "presentation":  [
                    "http://signifyhealth.com/role/CoverPage"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_EntityTaxIdentificationNumber":  {
                "auth_ref":  [
                    "r568"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
                            "label":  "Entity Tax Identification Number",
                            "terseLabel":  "Entity Tax Identification Number"
                            }
                        }
                    },
                "localname":  "EntityTaxIdentificationNumber",
                "nsuri":  "http://xbrl.sec.gov/dei/2021",
                "presentation":  [
                    "http://signifyhealth.com/role/CoverPage"
                    ],
                "xbrltype":  "employerIdItemType"
                },
            "dei_LegalEntityAxis":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The set of legal entities associated with a report.",
                            "label":  "Legal Entity [Axis]",
                            "terseLabel":  "Legal Entity [Axis]"
                            }
                        }
                    },
                "localname":  "LegalEntityAxis",
                "nsuri":  "http://xbrl.sec.gov/dei/2021",
                "presentation":  [
                    "http://signifyhealth.com/role/NoncontrollingInterestDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "dei_LocalPhoneNumber":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Local phone number for entity.",
                            "label":  "Local Phone Number",
                            "terseLabel":  "Local Phone Number"
                            }
                        }
                    },
                "localname":  "LocalPhoneNumber",
                "nsuri":  "http://xbrl.sec.gov/dei/2021",
                "presentation":  [
                    "http://signifyhealth.com/role/CoverPage"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_Security12bTitle":  {
                "auth_ref":  [
                    "r564"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Title of a 12(b) registered security.",
                            "label":  "Title of 12(b) Security",
                            "terseLabel":  "Title of 12(b) Security"
                            }
                        }
                    },
                "localname":  "Security12bTitle",
                "nsuri":  "http://xbrl.sec.gov/dei/2021",
                "presentation":  [
                    "http://signifyhealth.com/role/CoverPage"
                    ],
                "xbrltype":  "securityTitleItemType"
                },
            "dei_SecurityExchangeName":  {
                "auth_ref":  [
                    "r565"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Name of the Exchange on which a security is registered.",
                            "label":  "Security Exchange Name",
                            "terseLabel":  "Security Exchange Name"
                            }
                        }
                    },
                "localname":  "SecurityExchangeName",
                "nsuri":  "http://xbrl.sec.gov/dei/2021",
                "presentation":  [
                    "http://signifyhealth.com/role/CoverPage"
                    ],
                "xbrltype":  "edgarExchangeCodeItemType"
                },
            "dei_TradingSymbol":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Trading symbol of an instrument as listed on an exchange.",
                            "label":  "Trading Symbol",
                            "terseLabel":  "Trading Symbol"
                            }
                        }
                    },
                "localname":  "TradingSymbol",
                "nsuri":  "http://xbrl.sec.gov/dei/2021",
                "presentation":  [
                    "http://signifyhealth.com/role/CoverPage"
                    ],
                "xbrltype":  "tradingSymbolItemType"
                },
            "sgfy_A2020IncrementalTermLoansMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "2020 Incremental Term Loans",
                            "label":  "2020 Incremental Term Loans [Member]",
                            "terseLabel":  "2020 Incremental Term Loans"
                            }
                        }
                    },
                "localname":  "A2020IncrementalTermLoansMember",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/LongTermDebtScheduleofLongTermDebtDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "sgfy_A2021LTIPMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "2021 LTIP",
                            "label":  "2021 LTIP [Member]",
                            "terseLabel":  "2021 LTIP"
                            }
                        }
                    },
                "localname":  "A2021LTIPMember",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/EquityBasedCompensationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "sgfy_AdjustmentsToAdditionalPaidInCapitalContributions":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Adjustments to Additional Paid in Capital, Contributions",
                            "label":  "Adjustments to Additional Paid in Capital, Contributions",
                            "negatedTerseLabel":  "Contribution of New Remedy Corp to Signify Health Inc."
                            }
                        }
                    },
                "localname":  "AdjustmentsToAdditionalPaidInCapitalContributions",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "sgfy_AdjustmentsToAdditionalPaidInCapitalDeferredTaxAdjustment":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Adjustments to Additional Paid in Capital, Deferred Tax Adjustment",
                            "label":  "Adjustments to Additional Paid in Capital, Deferred Tax Adjustment",
                            "terseLabel":  "Deferred tax adjustment related to Reorganization and tax receivable agreement"
                            }
                        }
                    },
                "localname":  "AdjustmentsToAdditionalPaidInCapitalDeferredTaxAdjustment",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "sgfy_AdjustmentsToAdditionalPaidInCapitalSubscriptionFeeReceivable":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Adjustments to Additional Paid in Capital, Subscription Fee Receivable",
                            "label":  "Adjustments to Additional Paid in Capital, Subscription Fee Receivable",
                            "terseLabel":  "Class B subscription fee receivable"
                            }
                        }
                    },
                "localname":  "AdjustmentsToAdditionalPaidInCapitalSubscriptionFeeReceivable",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "sgfy_AmountsWithheldUnderBPCIAProgramMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amounts Withheld Under BPCI-A Program",
                            "label":  "Amounts Withheld Under BPCI-A Program [Member]",
                            "terseLabel":  "Amounts Withheld Under BPCI-A Program"
                            }
                        }
                    },
                "localname":  "AmountsWithheldUnderBPCIAProgramMember",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/RevenueRecognitionScheduleofRelatedBalanceSheetsAccountDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "sgfy_BPCIAProgramRequirementsAxis":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "BPCI-A Program, Requirements",
                            "label":  "BPCI-A Program, Requirements [Axis]",
                            "terseLabel":  "BPCI-A Program, Requirements [Axis]"
                            }
                        }
                    },
                "localname":  "BPCIAProgramRequirementsAxis",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/CommitmentandContingenciesNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "sgfy_BPCIAProgramRequirementsDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "BPCI-A Program, Requirements [Domain]",
                            "label":  "BPCI-A Program, Requirements [Domain]",
                            "terseLabel":  "BPCI-A Program, Requirements [Domain]"
                            }
                        }
                    },
                "localname":  "BPCIAProgramRequirementsDomain",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/CommitmentandContingenciesNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "sgfy_BoardOfDirectorsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Board of Directors",
                            "label":  "Board of Directors [Member]",
                            "terseLabel":  "Board of Directors"
                            }
                        }
                    },
                "localname":  "BoardOfDirectorsMember",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/EquityBasedCompensationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "sgfy_CentersForMedicareAndMedicaidServicesMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Centers for Medicare and Medicaid Services",
                            "label":  "Centers for Medicare and Medicaid Services [Member]",
                            "terseLabel":  "Centers for Medicare and Medicaid Services"
                            }
                        }
                    },
                "localname":  "CentersForMedicareAndMedicaidServicesMember",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/ConcentrationsDetails",
                    "http://signifyhealth.com/role/RevenueRecognitionScheduleofRelatedBalanceSheetsAccountDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "sgfy_CommonStockNumberOfVotesPerShare":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Common Stock, Number of Votes Per Share",
                            "label":  "Common Stock, Number of Votes Per Share",
                            "terseLabel":  "Number of votes per share"
                            }
                        }
                    },
                "localname":  "CommonStockNumberOfVotesPerShare",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/NatureofOperationsDetails",
                    "http://signifyhealth.com/role/ShareholdersEquityDetails"
                    ],
                "xbrltype":  "integerItemType"
                },
            "sgfy_ConsultingAgreementAnnualCompensationMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Consulting Agreement, Annual Compensation",
                            "label":  "Consulting Agreement, Annual Compensation [Member]",
                            "terseLabel":  "Consulting Agreement, Annual Compensation"
                            }
                        }
                    },
                "localname":  "ConsultingAgreementAnnualCompensationMember",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/RelatedPartyTransactionsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "sgfy_ConsultingAgreementDealConsiderationMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Consulting Agreement, Deal Consideration",
                            "label":  "Consulting Agreement, Deal Consideration [Member]",
                            "terseLabel":  "Consulting Agreement, Deal Consideration"
                            }
                        }
                    },
                "localname":  "ConsultingAgreementDealConsiderationMember",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/RelatedPartyTransactionsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "sgfy_ConsultingAgreementIncrementalDealConsiderationMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Consulting Agreement, Incremental Deal Consideration",
                            "label":  "Consulting Agreement, Incremental Deal Consideration [Member]",
                            "terseLabel":  "Consulting Agreement, Incremental Deal Consideration"
                            }
                        }
                    },
                "localname":  "ConsultingAgreementIncrementalDealConsiderationMember",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/RelatedPartyTransactionsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "sgfy_ContingentConsiderationLiabilityMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Contingent Consideration, Liability",
                            "label":  "Contingent Consideration, Liability [Member]",
                            "terseLabel":  "Contingent Consideration, Liability"
                            }
                        }
                    },
                "localname":  "ContingentConsiderationLiabilityMember",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/FairValueMeasurementsChangesinContingentConsiderationandCustomerEquityAppreciationRightsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "sgfy_ContractWithCustomerAssetPerformanceObligationSatisfiedInPeriod":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Contract with Customer, Asset, Performance Obligation Satisfied in Period",
                            "label":  "Contract with Customer, Asset, Performance Obligation Satisfied in Period",
                            "terseLabel":  "Estimated revenue recognized related to performance obligations satisfied over time"
                            }
                        }
                    },
                "localname":  "ContractWithCustomerAssetPerformanceObligationSatisfiedInPeriod",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/RevenueRecognitionContractAssetsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "sgfy_ContractWithCustomerAssetRollForward":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Contract with Customer, Asset",
                            "label":  "Contract with Customer, Asset [Roll Forward]",
                            "terseLabel":  "Contract with Customer, Asset [Roll Forward]"
                            }
                        }
                    },
                "localname":  "ContractWithCustomerAssetRollForward",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/RevenueRecognitionContractAssetsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "sgfy_ContractWithCustomerLiabilityDeferredRevenueRecognized":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Contract with Customer, Liability, Deferred Revenue Recognized",
                            "label":  "Contract with Customer, Liability, Deferred Revenue Recognized",
                            "negatedTerseLabel":  "Revenue recognized upon completion of performance obligation"
                            }
                        }
                    },
                "localname":  "ContractWithCustomerLiabilityDeferredRevenueRecognized",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/RevenueRecognitionDeferredRevenueDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "sgfy_ContractWithCustomerLiabilityPaymentsReceivedFromCustomers":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Contract with Customer, Liability, Payments Received from Customers",
                            "label":  "Contract with Customer, Liability, Payments Received from Customers",
                            "terseLabel":  "Payments received from customers"
                            }
                        }
                    },
                "localname":  "ContractWithCustomerLiabilityPaymentsReceivedFromCustomers",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/RevenueRecognitionDeferredRevenueDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "sgfy_ContractWithCustomerLiabilityRollForward":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Contract with Customer, Liability",
                            "label":  "Contract with Customer, Liability [Roll Forward]",
                            "terseLabel":  "Contract with Customer, Liability [Roll Forward]"
                            }
                        }
                    },
                "localname":  "ContractWithCustomerLiabilityRollForward",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/RevenueRecognitionDeferredRevenueDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "sgfy_ContractWithCustomerRefundLiabilityPaymentsMadeToCustomer":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Contract with Customer, Refund Liability, Payments Made to Customer",
                            "label":  "Contract with Customer, Refund Liability, Payments Made to Customer",
                            "negatedTerseLabel":  "Payments made to customer"
                            }
                        }
                    },
                "localname":  "ContractWithCustomerRefundLiabilityPaymentsMadeToCustomer",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/RevenueRecognitionContractLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "sgfy_ContractWithCustomerRefundLiabilityPerformanceObligationSatisfiedInPeriod":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Contract with Customer, Refund Liability, Performance Obligation Satisfied in Period",
                            "label":  "Contract with Customer, Refund Liability, Performance Obligation Satisfied in Period",
                            "terseLabel":  "Estimated amounts due to customer related to performance obligations satisfied over time"
                            }
                        }
                    },
                "localname":  "ContractWithCustomerRefundLiabilityPerformanceObligationSatisfiedInPeriod",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/RevenueRecognitionContractLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "sgfy_ContractWithCustomerRefundLiabilityPerformanceObligationsSatisfiedAtPointInTime":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Contract with Customer, Refund Liability, Performance Obligations Satisfied at Point-in-Time",
                            "label":  "Contract with Customer, Refund Liability, Performance Obligations Satisfied at Point-in-Time",
                            "terseLabel":  "Estimated amounts due to customer related performance obligations satisfied at a point-in-time"
                            }
                        }
                    },
                "localname":  "ContractWithCustomerRefundLiabilityPerformanceObligationsSatisfiedAtPointInTime",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/RevenueRecognitionContractLiabilitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "sgfy_ContractWithCustomerRefundLiabilityRollForward":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Contract with Customer, Refund Liability",
                            "label":  "Contract with Customer, Refund Liability [Roll Forward]",
                            "terseLabel":  "Contract with Customer, Refund Liability [Roll Forward]"
                            }
                        }
                    },
                "localname":  "ContractWithCustomerRefundLiabilityRollForward",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/RevenueRecognitionContractLiabilitiesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "sgfy_CreditAgreementIncrementalTermLoanMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Credit Agreement, Incremental Term Loan",
                            "label":  "Credit Agreement, Incremental Term Loan [Member]",
                            "terseLabel":  "Credit Agreement, Incremental Term Loan"
                            }
                        }
                    },
                "localname":  "CreditAgreementIncrementalTermLoanMember",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "sgfy_CreditAgreementMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Credit Agreement",
                            "label":  "Credit Agreement [Member]",
                            "terseLabel":  "Credit Agreement"
                            }
                        }
                    },
                "localname":  "CreditAgreementMember",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/LongTermDebtNarrativeDetails",
                    "http://signifyhealth.com/role/LongTermDebtScheduleofLongTermDebtDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "sgfy_CreditAgreementTermLoanMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Credit Agreement, Term Loan",
                            "label":  "Credit Agreement, Term Loan [Member]",
                            "terseLabel":  "Credit Agreement, Term Loan"
                            }
                        }
                    },
                "localname":  "CreditAgreementTermLoanMember",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "sgfy_CureTopCoMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Cure TopCo",
                            "label":  "Cure TopCo [Member]",
                            "terseLabel":  "Cure TopCo"
                            }
                        }
                    },
                "localname":  "CureTopCoMember",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/NatureofOperationsDetails",
                    "http://signifyhealth.com/role/NoncontrollingInterestDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "sgfy_CustomerOneMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Customer One",
                            "label":  "Customer One [Member]",
                            "terseLabel":  "Customer One"
                            }
                        }
                    },
                "localname":  "CustomerOneMember",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/ConcentrationsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "sgfy_CustomerThreeMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Customer Three",
                            "label":  "Customer Three [Member]",
                            "terseLabel":  "Customer Three"
                            }
                        }
                    },
                "localname":  "CustomerThreeMember",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/ConcentrationsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "sgfy_CustomerTwoMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Customer Two",
                            "label":  "Customer Two [Member]",
                            "terseLabel":  "Customer Two"
                            }
                        }
                    },
                "localname":  "CustomerTwoMember",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/ConcentrationsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "sgfy_DebtInstrumentExcessCashFlowPaymentDueTerm":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Debt Instrument, Excess Cash Flow Payment Due, Term",
                            "label":  "Debt Instrument, Excess Cash Flow Payment Due, Term",
                            "terseLabel":  "Excess cash flow payment due, term"
                            }
                        }
                    },
                "localname":  "DebtInstrumentExcessCashFlowPaymentDueTerm",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "sgfy_DeferredIncomeTaxLiabilitiesNetCurrent":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Deferred Income Tax Liabilities, Net, Current",
                            "label":  "Deferred Income Tax Liabilities, Net, Current",
                            "terseLabel":  "Deferred tax liability"
                            }
                        }
                    },
                "localname":  "DeferredIncomeTaxLiabilitiesNetCurrent",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "sgfy_ESPPMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "ESPP",
                            "label":  "ESPP [Member]",
                            "terseLabel":  "ESPP"
                            }
                        }
                    },
                "localname":  "ESPPMember",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/EquityBasedCompensationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "sgfy_EpisodesMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Episodes",
                            "label":  "Episodes [Member]",
                            "terseLabel":  "Episodes"
                            }
                        }
                    },
                "localname":  "EpisodesMember",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/RevenueRecognitionDisaggregationofRevenueDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "sgfy_EpisodesOfCareServicesSegmentMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Episodes of Care Services, Segment",
                            "label":  "Episodes of Care Services, Segment [Member]",
                            "terseLabel":  "Episodes of Care Services"
                            }
                        }
                    },
                "localname":  "EpisodesOfCareServicesSegmentMember",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/RevenueRecognitionDisaggregationofRevenueDetails",
                    "http://signifyhealth.com/role/RevenueRecognitionScheduleofRelatedBalanceSheetsAccountDetails",
                    "http://signifyhealth.com/role/SegmentReportingScheduleofOperatingSegmentResultsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "sgfy_EvaluationsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Evaluations",
                            "label":  "Evaluations [Member]",
                            "terseLabel":  "Evaluations"
                            }
                        }
                    },
                "localname":  "EvaluationsMember",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/RevenueRecognitionDisaggregationofRevenueDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "sgfy_FairValueAdjustmentOfShareBasedCompensationAgreementGrantedForServices":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Fair Value Adjustment of Share-based Compensation Agreement Granted for Services",
                            "label":  "Fair Value Adjustment of Share-based Compensation Agreement Granted for Services",
                            "terseLabel":  "Remeasurement of customer equity appreciation rights"
                            }
                        }
                    },
                "localname":  "FairValueAdjustmentOfShareBasedCompensationAgreementGrantedForServices",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "sgfy_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/IntangibleAssetsScheduleofExpectedAmortizationExpenseDetails":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_FiniteLivedIntangibleAssetsNet",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Finite-Lived Intangible Asset, Expected Amortization, after Year Four",
                            "label":  "Finite-Lived Intangible Asset, Expected Amortization, after Year Four",
                            "terseLabel":  "thereafter"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/IntangibleAssetsScheduleofExpectedAmortizationExpenseDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "sgfy_FormerDirectorMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Former Director",
                            "label":  "Former Director [Member]",
                            "terseLabel":  "Former Director"
                            }
                        }
                    },
                "localname":  "FormerDirectorMember",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/RelatedPartyTransactionsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "sgfy_HoldingPoolMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Holding Pool",
                            "label":  "Holding Pool [Member]",
                            "terseLabel":  "Holding Pool"
                            }
                        }
                    },
                "localname":  "HoldingPoolMember",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "sgfy_HomeCommunityServicesSegmentMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Home & Community Services, Segment",
                            "label":  "Home & Community Services, Segment [Member]",
                            "terseLabel":  "Home & Community Services"
                            }
                        }
                    },
                "localname":  "HomeCommunityServicesSegmentMember",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/RevenueRecognitionDisaggregationofRevenueDetails",
                    "http://signifyhealth.com/role/RevenueRecognitionScheduleofRelatedBalanceSheetsAccountDetails",
                    "http://signifyhealth.com/role/SegmentReportingScheduleofOperatingSegmentResultsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "sgfy_IncentiveUnitsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Incentive Units",
                            "label":  "Incentive Units [Member]",
                            "terseLabel":  "Incentive Units"
                            }
                        }
                    },
                "localname":  "IncentiveUnitsMember",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/EquityBasedCompensationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "sgfy_IncentiveUnitsPerformanceBasedMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Incentive Units, Performance-based",
                            "label":  "Incentive Units, Performance-based [Member]",
                            "terseLabel":  "Incentive Units, Performance-based"
                            }
                        }
                    },
                "localname":  "IncentiveUnitsPerformanceBasedMember",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/EquityBasedCompensationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "sgfy_IncentiveUnitsTimeBasedMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Incentive Units, Time-based",
                            "label":  "Incentive Units, Time-based [Member]",
                            "terseLabel":  "Incentive Units, Time-based"
                            }
                        }
                    },
                "localname":  "IncentiveUnitsTimeBasedMember",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/EquityBasedCompensationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "sgfy_IncreaseDecreaseInMembersEquityRollForward":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Increase (Decrease) in Members' Equity",
                            "label":  "Increase (Decrease) in Members' Equity [Roll Forward]",
                            "terseLabel":  "Increase (Decrease) in Members' Equity [Roll Forward]"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInMembersEquityRollForward",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "stringItemType"
                },
            "sgfy_LetterAgreementMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Letter Agreement",
                            "label":  "Letter Agreement [Member]",
                            "terseLabel":  "Letter Agreement"
                            }
                        }
                    },
                "localname":  "LetterAgreementMember",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/RelatedPartyTransactionsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "sgfy_MasterAgreementReleaseOfRestrictedCashAndCashEquivalents":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Master Agreement, Release of Restricted Cash and Cash Equivalents",
                            "label":  "Master Agreement, Release of Restricted Cash and Cash Equivalents",
                            "terseLabel":  "Release of restricted cash"
                            }
                        }
                    },
                "localname":  "MasterAgreementReleaseOfRestrictedCashAndCashEquivalents",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "sgfy_MembersEquityTaxRefundsReceivedValue":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Members' Equity, Tax Refunds Received, Value",
                            "label":  "Members' Equity, Tax Refunds Received, Value",
                            "terseLabel":  "Tax refunds received on behalf of New Remedy Corp"
                            }
                        }
                    },
                "localname":  "MembersEquityTaxRefundsReceivedValue",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "sgfy_NonAllocatedCostsAndExpenses":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/SegmentReportingScheduleofOperatingSegmentResultsDetails":  {
                        "order":  4.0,
                        "parentTag":  "sgfy_UnallocatedCostsAndExpenses",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Non-Allocated Costs and Expenses",
                            "label":  "Non-Allocated Costs and Expenses",
                            "terseLabel":  "Non-allocated costs"
                            }
                        }
                    },
                "localname":  "NonAllocatedCostsAndExpenses",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/SegmentReportingScheduleofOperatingSegmentResultsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "sgfy_NoncontrollingInterestOwnershipPercentage":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/NoncontrollingInterestDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Noncontrolling Interest, Ownership Percentage",
                            "label":  "Noncontrolling Interest, Ownership Percentage",
                            "totalLabel":  "Total LLC Units outstanding (as a percent)"
                            }
                        }
                    },
                "localname":  "NoncontrollingInterestOwnershipPercentage",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/NoncontrollingInterestDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "sgfy_NoncontrollingInterestOwnershipPercentageAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Noncontrolling Interest, Ownership Percentage",
                            "label":  "Noncontrolling Interest, Ownership Percentage [Abstract]",
                            "terseLabel":  "Ownership Percentage"
                            }
                        }
                    },
                "localname":  "NoncontrollingInterestOwnershipPercentageAbstract",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/NoncontrollingInterestDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "sgfy_NumberOfClassesOfCommonStock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of Classes of Common Stock",
                            "label":  "Number of Classes of Common Stock",
                            "terseLabel":  "Number of classes of common stock"
                            }
                        }
                    },
                "localname":  "NumberOfClassesOfCommonStock",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/NatureofOperationsDetails",
                    "http://signifyhealth.com/role/ShareholdersEquityDetails"
                    ],
                "xbrltype":  "integerItemType"
                },
            "sgfy_NumberOfClassesOfNonVotingCommonUnits":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of Classes of Non-Voting Common Units",
                            "label":  "Number of Classes of Non-Voting Common Units",
                            "terseLabel":  "Number of classes of non-voting common units"
                            }
                        }
                    },
                "localname":  "NumberOfClassesOfNonVotingCommonUnits",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/NatureofOperationsDetails"
                    ],
                "xbrltype":  "integerItemType"
                },
            "sgfy_NumberOfPhysicianPractices":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of Physician Practices",
                            "label":  "Number of Physician Practices",
                            "terseLabel":  "Number of physician practices"
                            }
                        }
                    },
                "localname":  "NumberOfPhysicianPractices",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/VariableInterestEntitiesNarrativeDetails"
                    ],
                "xbrltype":  "integerItemType"
                },
            "sgfy_NumberOfRelatedLettersOfCredit":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of Related Letters of Credit",
                            "label":  "Number of Related Letters of Credit",
                            "terseLabel":  "Number of related letters of credit"
                            }
                        }
                    },
                "localname":  "NumberOfRelatedLettersOfCredit",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/CommitmentandContingenciesNarrativeDetails"
                    ],
                "xbrltype":  "integerItemType"
                },
            "sgfy_OperatingLossCarryforwardsMaximumReductionOfTaxableIncomePercent":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Operating Loss Carryforwards, Maximum Reduction of Taxable Income, Percent",
                            "label":  "Operating Loss Carryforwards, Maximum Reduction of Taxable Income, Percent",
                            "terseLabel":  "Maximum reduction of taxable income (as a percent)"
                            }
                        }
                    },
                "localname":  "OperatingLossCarryforwardsMaximumReductionOfTaxableIncomePercent",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/IncomeTaxesDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "sgfy_PatientBloxMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "PatientBlox",
                            "label":  "PatientBlox [Member]",
                            "terseLabel":  "PatientBlox"
                            }
                        }
                    },
                "localname":  "PatientBloxMember",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "sgfy_ProceedsFromIncomeTaxRefundsFromAffiliate":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Proceeds from Income Tax Refunds from Affiliate",
                            "label":  "Proceeds from Income Tax Refunds from Affiliate",
                            "terseLabel":  "Refunds of taxes on behalf of New Remedy Corp"
                            }
                        }
                    },
                "localname":  "ProceedsFromIncomeTaxRefundsFromAffiliate",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "sgfy_RelatedPartyTransactionCashTransactionFeePercent":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Related Party Transaction, Cash Transaction Fee, Percent",
                            "label":  "Related Party Transaction, Cash Transaction Fee, Percent",
                            "terseLabel":  "Cash transaction fee (as a percent)"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionCashTransactionFeePercent",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/RelatedPartyTransactionsDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "sgfy_RelatedReciprocalLetterOfCreditProvidedMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Related Reciprocal Letter of Credit Provided",
                            "label":  "Related Reciprocal Letter of Credit Provided [Member]",
                            "terseLabel":  "Related Reciprocal Letter of Credit Provided"
                            }
                        }
                    },
                "localname":  "RelatedReciprocalLetterOfCreditProvidedMember",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/CommitmentandContingenciesNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "sgfy_RestrictedCashAgreementReturnOfFundsFollowingConclusionOfEffectivePeriodPeriod":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Restricted Cash Agreement, Return of Funds Following Conclusion of Effective Period, Period",
                            "label":  "Restricted Cash Agreement, Return of Funds Following Conclusion of Effective Period, Period",
                            "terseLabel":  "Return of funds following conclusion of effective period of CMS master agreement, period"
                            }
                        }
                    },
                "localname":  "RestrictedCashAgreementReturnOfFundsFollowingConclusionOfEffectivePeriodPeriod",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "sgfy_RevenueFromContractWithCustomerExcludingAssessedTaxMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Revenue from Contract with Customer, Excluding Assessed Tax",
                            "label":  "Revenue from Contract with Customer, Excluding Assessed Tax [Member]",
                            "terseLabel":  "Revenue from Contract with Customer, Excluding Assessed Tax"
                            }
                        }
                    },
                "localname":  "RevenueFromContractWithCustomerExcludingAssessedTaxMember",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/FairValueMeasurementsChangesinContingentConsiderationandCustomerEquityAppreciationRightsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "sgfy_SaleOfStockGrossConsiderationReceivedOnTransaction":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Sale of Stock, Gross Consideration Received on Transaction",
                            "label":  "Sale of Stock, Gross Consideration Received on Transaction",
                            "terseLabel":  "Gross proceeds from IPO"
                            }
                        }
                    },
                "localname":  "SaleOfStockGrossConsiderationReceivedOnTransaction",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/NatureofOperationsDetails",
                    "http://signifyhealth.com/role/ShareholdersEquityDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "sgfy_SecondaryRepaymentSourceMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Secondary Repayment Source",
                            "label":  "Secondary Repayment Source [Member]",
                            "terseLabel":  "Secondary Repayment Source"
                            }
                        }
                    },
                "localname":  "SecondaryRepaymentSourceMember",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "sgfy_SegmentAdjustedEBITDA":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/SegmentReportingScheduleofOperatingSegmentResultsDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Segment Adjusted EBITDA",
                            "label":  "Segment Adjusted EBITDA",
                            "terseLabel":  "Segment Adjusted EBITDA"
                            }
                        }
                    },
                "localname":  "SegmentAdjustedEBITDA",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/SegmentReportingScheduleofOperatingSegmentResultsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "sgfy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodGrantDateFairValue":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Grant Date Fair Value",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Grant Date Fair Value",
                            "terseLabel":  "Grant date fair value of award"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodGrantDateFairValue",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/EquityBasedCompensationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "sgfy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedGrantDateFairValue":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share Based Compensation Arrangement by Share Based Payment Award, Equity Instruments Other than Options, Nonvested Grant Date Fair Value",
                            "label":  "Share Based Compensation Arrangement by Share Based Payment Award, Equity Instruments Other than Options, Nonvested Grant Date Fair Value",
                            "terseLabel":  "Grant date fair value"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedGrantDateFairValue",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/CommitmentandContingenciesNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "sgfy_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInSharesAuthorizedPercent":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share-based Compensation Arrangement by Share-based Payment Award, Increase in Shares Authorized, Percent",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Increase in Shares Authorized, Percent",
                            "terseLabel":  "Increase in shares authorized (as a percent)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInSharesAuthorizedPercent",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/EquityBasedCompensationDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "sgfy_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Fair Value",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Fair Value",
                            "terseLabel":  "Total grant date fair value"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/EquityBasedCompensationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "sgfy_ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedAmountRollForward":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
                            "label":  "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount [Roll Forward]",
                            "terseLabel":  "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount [Roll Forward]"
                            }
                        }
                    },
                "localname":  "ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedAmountRollForward",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/CommitmentandContingenciesSummaryofSEUActivityDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "sgfy_ShareBasedPaymentArrangementNonvestedAwardPayments":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share-based Payment Arrangement, Nonvested Award, Payments",
                            "label":  "Share-based Payment Arrangement, Nonvested Award, Payments",
                            "negatedTerseLabel":  "Cash payments"
                            }
                        }
                    },
                "localname":  "ShareBasedPaymentArrangementNonvestedAwardPayments",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/CommitmentandContingenciesSummaryofSEUActivityDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "sgfy_ShareBasedPaymentArrangementPerformanceBasedOptionsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share-based Payment Arrangement, Performance Based Options",
                            "label":  "Share-based Payment Arrangement, Performance Based Options [Member]",
                            "terseLabel":  "Share-based Payment Arrangement, Performance Based Options"
                            }
                        }
                    },
                "localname":  "ShareBasedPaymentArrangementPerformanceBasedOptionsMember",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/EquityBasedCompensationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "sgfy_ShareBasedPaymentArrangementTimeBasedOptionsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share-based Payment Arrangement, Time-based Options",
                            "label":  "Share-based Payment Arrangement, Time-based Options [Member]",
                            "terseLabel":  "Share-based Payment Arrangement, Time-based Options"
                            }
                        }
                    },
                "localname":  "ShareBasedPaymentArrangementTimeBasedOptionsMember",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/EquityBasedCompensationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "sgfy_ShareBasedPaymentArrangementWeightedAveragePriceVolumePeriod":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share-based Payment Arrangement, Weighted Average Price Volume, Period",
                            "label":  "Share-based Payment Arrangement, Weighted Average Price Volume, Period",
                            "terseLabel":  "Weighted average price volume period"
                            }
                        }
                    },
                "localname":  "ShareBasedPaymentArrangementWeightedAveragePriceVolumePeriod",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/CommitmentandContingenciesNarrativeDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "sgfy_SharedSavingsPayable":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/AccountsPayableandAccruedExpensesDetails":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Shared Savings Payable",
                            "label":  "Shared Savings Payable",
                            "periodEndLabel":  "Ending balance",
                            "periodStartLabel":  "Beginning balance",
                            "terseLabel":  "Shared savings payable"
                            }
                        }
                    },
                "localname":  "SharedSavingsPayable",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/AccountsPayableandAccruedExpensesDetails",
                    "http://signifyhealth.com/role/RevenueRecognitionScheduleofRelatedBalanceSheetsAccountDetails",
                    "http://signifyhealth.com/role/RevenueRecognitionSharedSavingsPayableDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "sgfy_SharedSavingsPayableAxis":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Shared Savings Payable",
                            "label":  "Shared Savings Payable [Axis]",
                            "terseLabel":  "Shared Savings Payable [Axis]"
                            }
                        }
                    },
                "localname":  "SharedSavingsPayableAxis",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/RevenueRecognitionScheduleofRelatedBalanceSheetsAccountDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "sgfy_SharedSavingsPayableDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Shared Savings Payable",
                            "label":  "Shared Savings Payable [Domain]",
                            "terseLabel":  "Shared Savings Payable [Domain]"
                            }
                        }
                    },
                "localname":  "SharedSavingsPayableDomain",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/RevenueRecognitionScheduleofRelatedBalanceSheetsAccountDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "sgfy_SharedSavingsPayableDueToCustomerPerformanceObligationSatisfied":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Shared Savings Payable, Due to Customer, Performance Obligation Satisfied",
                            "label":  "Shared Savings Payable, Due to Customer, Performance Obligation Satisfied",
                            "terseLabel":  "Amounts due to customer upon completion of performance obligation"
                            }
                        }
                    },
                "localname":  "SharedSavingsPayableDueToCustomerPerformanceObligationSatisfied",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/RevenueRecognitionSharedSavingsPayableDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "sgfy_SharedSavingsPayablePaymentsToCustomer":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Shared Savings Payable, Payments to Customer",
                            "label":  "Shared Savings Payable, Payments to Customer",
                            "negatedTerseLabel":  "Amounts paid to customer and/or CMS"
                            }
                        }
                    },
                "localname":  "SharedSavingsPayablePaymentsToCustomer",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/RevenueRecognitionSharedSavingsPayableDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "sgfy_SharedSavingsPayableRollForward":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Shared Savings Payable",
                            "label":  "Shared Savings Payable [Roll Forward]",
                            "terseLabel":  "Shared Savings Payable [Roll Forward]"
                            }
                        }
                    },
                "localname":  "SharedSavingsPayableRollForward",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/RevenueRecognitionSharedSavingsPayableDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "sgfy_StockAppreciationRightsLiability":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_Liabilities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Stock Appreciation Rights, Liability",
                            "label":  "Stock Appreciation Rights, Liability",
                            "terseLabel":  "Customer EAR liability",
                            "verboseLabel":  "Customer equity appreciation rights, fair value"
                            }
                        }
                    },
                "localname":  "StockAppreciationRightsLiability",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets",
                    "http://signifyhealth.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
                    "http://signifyhealth.com/role/FairValueMeasurementsScheduleofValuationTechniquesandSignificantUnobservableInputsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "sgfy_StockAppreciationRightsLiabilityMeasurementInput":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Stock Appreciation Rights, Liability, Measurement Input",
                            "label":  "Stock Appreciation Rights, Liability, Measurement Input",
                            "terseLabel":  "Customer equity appreciation rights, measurement input"
                            }
                        }
                    },
                "localname":  "StockAppreciationRightsLiabilityMeasurementInput",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/FairValueMeasurementsScheduleofValuationTechniquesandSignificantUnobservableInputsDetails"
                    ],
                "xbrltype":  "decimalItemType"
                },
            "sgfy_StockAppreciationRightsLiabilityTerm":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Stock Appreciation Rights, Liability, Term",
                            "label":  "Stock Appreciation Rights, Liability, Term",
                            "terseLabel":  "Customer equity appreciation rights, term"
                            }
                        }
                    },
                "localname":  "StockAppreciationRightsLiabilityTerm",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/FairValueMeasurementsScheduleofValuationTechniquesandSignificantUnobservableInputsDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "sgfy_StockIssuedAndGrantedDuringPeriodValue":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Stock Issued and Granted During Period, Value",
                            "label":  "Stock Issued and Granted During Period, Value",
                            "terseLabel":  "Equity-based compensation subsequent to Reorganization Transactions"
                            }
                        }
                    },
                "localname":  "StockIssuedAndGrantedDuringPeriodValue",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "sgfy_StockIssuedDuringPeriodSharesEffectOfReorganizationTransactions":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Stock Issued During Period, Shares, Effect of Reorganization Transactions",
                            "label":  "Stock Issued During Period, Shares, Effect of Reorganization Transactions",
                            "terseLabel":  "Initial effect of the Reorganization Transactions and IPO on noncontrolling interests (in shares)"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesEffectOfReorganizationTransactions",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "sgfy_StockIssuedDuringPeriodValueEffectOfReorganizationTransactions":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Stock Issued During Period, Value, Effect of Reorganization Transactions",
                            "label":  "Stock Issued During Period, Value, Effect of Reorganization Transactions",
                            "terseLabel":  "Initial effect of the Reorganization Transactions and IPO on noncontrolling interests"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodValueEffectOfReorganizationTransactions",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "sgfy_SynethicEquityUnitsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Synethic Equity Units",
                            "label":  "Synethic Equity Units [Member]",
                            "terseLabel":  "Synethic Equity Units"
                            }
                        }
                    },
                "localname":  "SynethicEquityUnitsMember",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/SegmentReportingScheduleofOperatingSegmentResultsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "sgfy_SyntheticEquityUnitsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Synthetic Equity Units",
                            "label":  "Synthetic Equity Units [Member]",
                            "terseLabel":  "Synthetic Equity Units"
                            }
                        }
                    },
                "localname":  "SyntheticEquityUnitsMember",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/CommitmentandContingenciesNarrativeDetails",
                    "http://signifyhealth.com/role/CommitmentandContingenciesSummaryofSEUActivityDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "sgfy_SyntheticEquityUnitsPerformanceBasedVestingMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Synthetic Equity Units, Performance-Based Vesting",
                            "label":  "Synthetic Equity Units, Performance-Based Vesting [Member]",
                            "terseLabel":  "Synthetic Equity Units, Performance-Based Vesting"
                            }
                        }
                    },
                "localname":  "SyntheticEquityUnitsPerformanceBasedVestingMember",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/CommitmentandContingenciesNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "sgfy_SyntheticEquityUnitsTimeBasedVestingMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Synthetic Equity Units, Time-Based Vesting",
                            "label":  "Synthetic Equity Units, Time-Based Vesting [Member]",
                            "terseLabel":  "Synthetic Equity Units, Time-Based Vesting"
                            }
                        }
                    },
                "localname":  "SyntheticEquityUnitsTimeBasedVestingMember",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/CommitmentandContingenciesNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "sgfy_TaxReceivableAgreementApplicableCashSavingsPayablePercent":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tax Receivable Agreement, Applicable Cash Savings, Payable, Percent",
                            "label":  "Tax Receivable Agreement, Applicable Cash Savings, Payable, Percent",
                            "terseLabel":  "Applicable cash savings payable (as a percent)"
                            }
                        }
                    },
                "localname":  "TaxReceivableAgreementApplicableCashSavingsPayablePercent",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/IncomeTaxesDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "sgfy_TaxReceivableAgreementApplicableCashSavingsRetainablePercent":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tax Receivable Agreement, Applicable Cash Savings, Retainable, Percent",
                            "label":  "Tax Receivable Agreement, Applicable Cash Savings, Retainable, Percent",
                            "terseLabel":  "Applicable cash savings retainable (as a percent)"
                            }
                        }
                    },
                "localname":  "TaxReceivableAgreementApplicableCashSavingsRetainablePercent",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/IncomeTaxesDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "sgfy_TaxReceivableAgreementLiabilityMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tax Receivable Agreement, Liability",
                            "label":  "Tax Receivable Agreement, Liability [Member]",
                            "terseLabel":  "Tax Receivable Agreement, Liability"
                            }
                        }
                    },
                "localname":  "TaxReceivableAgreementLiabilityMember",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/IncomeTaxesDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "sgfy_ThirdReconciliationPeriodOfBPCIAProgramMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Third Reconciliation Period of BPCI-A Program",
                            "label":  "Third Reconciliation Period of BPCI-A Program [Member]",
                            "terseLabel":  "Third Reconciliation Period of BPCI-A Program"
                            }
                        }
                    },
                "localname":  "ThirdReconciliationPeriodOfBPCIAProgramMember",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/RevenueRecognitionScheduleofRelatedBalanceSheetsAccountDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "sgfy_TopTenCustomersMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Top Ten Customers",
                            "label":  "Top Ten Customers [Member]",
                            "terseLabel":  "Top Ten Customers"
                            }
                        }
                    },
                "localname":  "TopTenCustomersMember",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/ConcentrationsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "sgfy_TransactionRelatedExpenses":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofOperations":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_CostsAndExpenses",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Transaction Related Expenses",
                            "label":  "Transaction Related Expenses",
                            "terseLabel":  "Transaction related expenses"
                            }
                        }
                    },
                "localname":  "TransactionRelatedExpenses",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofOperations",
                    "http://signifyhealth.com/role/TransactionrelatedExpensesNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "sgfy_UnallocatedCostsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Unallocated Costs",
                            "label":  "Unallocated Costs [Abstract]",
                            "terseLabel":  "Unallocated costs as follows:"
                            }
                        }
                    },
                "localname":  "UnallocatedCostsAbstract",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/SegmentReportingScheduleofOperatingSegmentResultsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "sgfy_UnallocatedCostsAndExpenses":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/SegmentReportingScheduleofOperatingSegmentResultsDetails":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Unallocated Costs and Expenses",
                            "label":  "Unallocated Costs and Expenses",
                            "terseLabel":  "Unallocated costs",
                            "totalLabel":  "Total unallocated costs"
                            }
                        }
                    },
                "localname":  "UnallocatedCostsAndExpenses",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/SegmentReportingScheduleofOperatingSegmentResultsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "sgfy_ValuationTechniqueMonteCarloMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Valuation Technique, Monte Carlo",
                            "label":  "Valuation Technique, Monte Carlo [Member]",
                            "terseLabel":  "Monte Carlo"
                            }
                        }
                    },
                "localname":  "ValuationTechniqueMonteCarloMember",
                "nsuri":  "http://signifyhealth.com/20210331",
                "presentation":  [
                    "http://signifyhealth.com/role/FairValueMeasurementsScheduleofValuationTechniquesandSignificantUnobservableInputsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_ConsolidatedEntitiesAxis":  {
                "auth_ref":  [
                    "r100",
                    "r234",
                    "r239",
                    "r247",
                    "r418",
                    "r419",
                    "r425",
                    "r426",
                    "r478",
                    "r561"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Consolidated Entities [Axis]",
                            "terseLabel":  "Consolidated Entities [Axis]"
                            }
                        }
                    },
                "localname":  "ConsolidatedEntitiesAxis",
                "nsuri":  "http://fasb.org/srt/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/VariableInterestEntitiesNarrativeDetails",
                    "http://signifyhealth.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "srt_ConsolidatedEntitiesDomain":  {
                "auth_ref":  [
                    "r100",
                    "r234",
                    "r239",
                    "r247",
                    "r418",
                    "r419",
                    "r425",
                    "r426",
                    "r478",
                    "r561"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Consolidated Entities [Domain]",
                            "terseLabel":  "Consolidated Entities [Domain]"
                            }
                        }
                    },
                "localname":  "ConsolidatedEntitiesDomain",
                "nsuri":  "http://fasb.org/srt/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/VariableInterestEntitiesNarrativeDetails",
                    "http://signifyhealth.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_ConsolidationItemsAxis":  {
                "auth_ref":  [
                    "r100",
                    "r153",
                    "r166",
                    "r167",
                    "r168",
                    "r169",
                    "r171",
                    "r173",
                    "r177",
                    "r234",
                    "r235",
                    "r236",
                    "r237",
                    "r238",
                    "r239",
                    "r241",
                    "r242",
                    "r244",
                    "r246",
                    "r247"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Consolidation Items [Axis]",
                            "terseLabel":  "Consolidation Items [Axis]"
                            }
                        }
                    },
                "localname":  "ConsolidationItemsAxis",
                "nsuri":  "http://fasb.org/srt/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/SegmentReportingScheduleofOperatingSegmentResultsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "srt_ConsolidationItemsDomain":  {
                "auth_ref":  [
                    "r100",
                    "r153",
                    "r166",
                    "r167",
                    "r168",
                    "r169",
                    "r171",
                    "r173",
                    "r177",
                    "r234",
                    "r235",
                    "r236",
                    "r237",
                    "r238",
                    "r239",
                    "r241",
                    "r242",
                    "r244",
                    "r246",
                    "r247"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Consolidation Items [Domain]",
                            "terseLabel":  "Consolidation Items [Domain]"
                            }
                        }
                    },
                "localname":  "ConsolidationItemsDomain",
                "nsuri":  "http://fasb.org/srt/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/SegmentReportingScheduleofOperatingSegmentResultsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_DirectorMember":  {
                "auth_ref":  [
                    "r184"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Director [Member]",
                            "terseLabel":  "Director"
                            }
                        }
                    },
                "localname":  "DirectorMember",
                "nsuri":  "http://fasb.org/srt/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/RelatedPartyTransactionsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_MajorCustomersAxis":  {
                "auth_ref":  [
                    "r182",
                    "r323",
                    "r329",
                    "r548"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Customer [Axis]",
                            "terseLabel":  "Customer [Axis]"
                            }
                        }
                    },
                "localname":  "MajorCustomersAxis",
                "nsuri":  "http://fasb.org/srt/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/ConcentrationsDetails",
                    "http://signifyhealth.com/role/RevenueRecognitionScheduleofRelatedBalanceSheetsAccountDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "srt_ManagementMember":  {
                "auth_ref":  [
                    "r184",
                    "r474"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Management [Member]",
                            "terseLabel":  "Management"
                            }
                        }
                    },
                "localname":  "ManagementMember",
                "nsuri":  "http://fasb.org/srt/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/EquityBasedCompensationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_MaximumMember":  {
                "auth_ref":  [
                    "r252",
                    "r280",
                    "r346",
                    "r348",
                    "r485",
                    "r486",
                    "r487",
                    "r488",
                    "r489",
                    "r490",
                    "r491",
                    "r546",
                    "r549",
                    "r562",
                    "r563"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Maximum [Member]",
                            "terseLabel":  "Maximum"
                            }
                        }
                    },
                "localname":  "MaximumMember",
                "nsuri":  "http://fasb.org/srt/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/EquityBasedCompensationDetails",
                    "http://signifyhealth.com/role/IntangibleAssetsScheduleofIntangibleAssetsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_MinimumMember":  {
                "auth_ref":  [
                    "r252",
                    "r280",
                    "r346",
                    "r348",
                    "r485",
                    "r486",
                    "r487",
                    "r488",
                    "r489",
                    "r490",
                    "r491",
                    "r546",
                    "r549",
                    "r562",
                    "r563"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Minimum [Member]",
                            "terseLabel":  "Minimum"
                            }
                        }
                    },
                "localname":  "MinimumMember",
                "nsuri":  "http://fasb.org/srt/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/EquityBasedCompensationDetails",
                    "http://signifyhealth.com/role/IntangibleAssetsScheduleofIntangibleAssetsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_NameOfMajorCustomerDomain":  {
                "auth_ref":  [
                    "r182",
                    "r323",
                    "r329",
                    "r548"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Customer [Domain]",
                            "terseLabel":  "Customer [Domain]"
                            }
                        }
                    },
                "localname":  "NameOfMajorCustomerDomain",
                "nsuri":  "http://fasb.org/srt/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/ConcentrationsDetails",
                    "http://signifyhealth.com/role/RevenueRecognitionScheduleofRelatedBalanceSheetsAccountDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_OwnershipAxis":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Ownership [Axis]",
                            "terseLabel":  "Ownership [Axis]"
                            }
                        }
                    },
                "localname":  "OwnershipAxis",
                "nsuri":  "http://fasb.org/srt/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/NatureofOperationsDetails",
                    "http://signifyhealth.com/role/NoncontrollingInterestDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "srt_OwnershipDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Ownership [Domain]",
                            "terseLabel":  "Ownership [Domain]"
                            }
                        }
                    },
                "localname":  "OwnershipDomain",
                "nsuri":  "http://fasb.org/srt/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/NatureofOperationsDetails",
                    "http://signifyhealth.com/role/NoncontrollingInterestDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_ProductOrServiceAxis":  {
                "auth_ref":  [
                    "r179",
                    "r323",
                    "r327",
                    "r493",
                    "r545",
                    "r547"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Product and Service [Axis]",
                            "terseLabel":  "Product and Service [Axis]"
                            }
                        }
                    },
                "localname":  "ProductOrServiceAxis",
                "nsuri":  "http://fasb.org/srt/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/RevenueRecognitionDisaggregationofRevenueDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "srt_ProductsAndServicesDomain":  {
                "auth_ref":  [
                    "r179",
                    "r323",
                    "r327",
                    "r493",
                    "r545",
                    "r547"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Product and Service [Domain]",
                            "terseLabel":  "Product and Service [Domain]"
                            }
                        }
                    },
                "localname":  "ProductsAndServicesDomain",
                "nsuri":  "http://fasb.org/srt/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/RevenueRecognitionDisaggregationofRevenueDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_RangeAxis":  {
                "auth_ref":  [
                    "r252",
                    "r280",
                    "r335",
                    "r346",
                    "r348",
                    "r485",
                    "r486",
                    "r487",
                    "r488",
                    "r489",
                    "r490",
                    "r491",
                    "r546",
                    "r549",
                    "r562",
                    "r563"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Statistical Measurement [Axis]",
                            "terseLabel":  "Statistical Measurement [Axis]"
                            }
                        }
                    },
                "localname":  "RangeAxis",
                "nsuri":  "http://fasb.org/srt/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/EquityBasedCompensationDetails",
                    "http://signifyhealth.com/role/IntangibleAssetsScheduleofIntangibleAssetsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "srt_RangeMember":  {
                "auth_ref":  [
                    "r252",
                    "r280",
                    "r335",
                    "r346",
                    "r348",
                    "r485",
                    "r486",
                    "r487",
                    "r488",
                    "r489",
                    "r490",
                    "r491",
                    "r546",
                    "r549",
                    "r562",
                    "r563"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Statistical Measurement [Domain]",
                            "terseLabel":  "Statistical Measurement [Domain]"
                            }
                        }
                    },
                "localname":  "RangeMember",
                "nsuri":  "http://fasb.org/srt/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/EquityBasedCompensationDetails",
                    "http://signifyhealth.com/role/IntangibleAssetsScheduleofIntangibleAssetsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_TitleOfIndividualAxis":  {
                "auth_ref":  [
                    "r184",
                    "r474"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Title of Individual [Axis]",
                            "terseLabel":  "Title of Individual [Axis]"
                            }
                        }
                    },
                "localname":  "TitleOfIndividualAxis",
                "nsuri":  "http://fasb.org/srt/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/EquityBasedCompensationDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "srt_TitleOfIndividualWithRelationshipToEntityDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Title of Individual [Domain]",
                            "terseLabel":  "Title of Individual [Domain]"
                            }
                        }
                    },
                "localname":  "TitleOfIndividualWithRelationshipToEntityDomain",
                "nsuri":  "http://fasb.org/srt/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/EquityBasedCompensationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_AccountingPoliciesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Accounting Policies [Abstract]"
                            }
                        }
                    },
                "localname":  "AccountingPoliciesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent":  {
                "auth_ref":  [
                    "r37"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
                            "label":  "Accounts Payable and Accrued Liabilities, Current",
                            "terseLabel":  "Accounts payable and accrued expenses"
                            }
                        }
                    },
                "localname":  "AccountsPayableAndAccruedLiabilitiesCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets",
                    "http://signifyhealth.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent":  {
                "auth_ref":  [
                    "r517",
                    "r539"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/AccountsPayableandAccruedExpensesDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.",
                            "label":  "Accounts Payable and Accrued Liabilities",
                            "totalLabel":  "Total accounts payable and accrued liabilities"
                            }
                        }
                    },
                "localname":  "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/AccountsPayableandAccruedExpensesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock":  {
                "auth_ref":  [
                    "r35"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
                            "label":  "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
                            "terseLabel":  "Accounts Payable and Accrued Expenses"
                            }
                        }
                    },
                "localname":  "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/AccountsPayableandAccruedExpenses"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_AccountsPayableCurrentAndNoncurrent":  {
                "auth_ref":  [
                    "r519",
                    "r538"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/AccountsPayableandAccruedExpensesDetails":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
                            "label":  "Accounts Payable",
                            "terseLabel":  "Accounts payable"
                            }
                        }
                    },
                "localname":  "AccountsPayableCurrentAndNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/AccountsPayableandAccruedExpensesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccountsReceivableMember":  {
                "auth_ref":  [
                    "r556"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Due from customers or clients for goods or services that have been delivered or sold.",
                            "label":  "Accounts Receivable [Member]",
                            "terseLabel":  "Accounts Receivable"
                            }
                        }
                    },
                "localname":  "AccountsReceivableMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/ConcentrationsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_AccountsReceivableNetCurrent":  {
                "auth_ref":  [
                    "r6",
                    "r22",
                    "r185",
                    "r186"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
                            "label":  "Accounts Receivable, after Allowance for Credit Loss, Current",
                            "terseLabel":  "Accounts receivable, net"
                            }
                        }
                    },
                "localname":  "AccountsReceivableNetCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets",
                    "http://signifyhealth.com/role/RevenueRecognitionScheduleofRelatedBalanceSheetsAccountDetails",
                    "http://signifyhealth.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccruedIncomeTaxes":  {
                "auth_ref":  [
                    "r16",
                    "r18",
                    "r384",
                    "r513",
                    "r530"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/AccountsPayableandAccruedExpensesDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due.  This amount is the total of current and noncurrent accrued income taxes.",
                            "label":  "Accrued Income Taxes",
                            "terseLabel":  "Accrued income taxes"
                            }
                        }
                    },
                "localname":  "AccruedIncomeTaxes",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/AccountsPayableandAccruedExpensesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment":  {
                "auth_ref":  [
                    "r32",
                    "r218"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/PropertyandEquipmentPropertyandEquipmentnetDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_PropertyPlantAndEquipmentNet",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
                            "label":  "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
                            "negatedTerseLabel":  "Less:  Accumulated depreciation and amortization"
                            }
                        }
                    },
                "localname":  "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/PropertyandEquipmentPropertyandEquipmentnetDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AdditionalPaidInCapital":  {
                "auth_ref":  [
                    "r23",
                    "r373",
                    "r481"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                        "weight":  1.0
                        },
                    "http://signifyhealth.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder.  Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
                            "label":  "Additional Paid in Capital",
                            "terseLabel":  "Company capital",
                            "verboseLabel":  "Additional paid-in capital"
                            }
                        }
                    },
                "localname":  "AdditionalPaidInCapital",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets",
                    "http://signifyhealth.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AdditionalPaidInCapitalMember":  {
                "auth_ref":  [
                    "r102",
                    "r103",
                    "r104",
                    "r370",
                    "r371",
                    "r372",
                    "r438"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
                            "label":  "Additional Paid-in Capital [Member]",
                            "terseLabel":  "Additional paid-in capital"
                            }
                        }
                    },
                "localname":  "AdditionalPaidInCapitalMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
                            "terseLabel":  "Adjustments to reconcile net loss to net cash provided by operating activities:"
                            }
                        }
                    },
                "localname":  "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AdvertisingCostsPolicyTextBlock":  {
                "auth_ref":  [
                    "r376"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for advertising cost.",
                            "label":  "Advertising Cost [Policy Text Block]",
                            "terseLabel":  "Advertising and Marketing Cost"
                            }
                        }
                    },
                "localname":  "AdvertisingCostsPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/SignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_AllocatedShareBasedCompensationExpense":  {
                "auth_ref":  [
                    "r352",
                    "r367",
                    "r374"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/SegmentReportingScheduleofOperatingSegmentResultsDetails":  {
                        "order":  1.0,
                        "parentTag":  "sgfy_UnallocatedCostsAndExpenses",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of expense for award under share-based payment arrangement.  Excludes amount capitalized.",
                            "label":  "Share-based Payment Arrangement, Expense",
                            "terseLabel":  "Equity-based compensation",
                            "verboseLabel":  "SEU expense"
                            }
                        }
                    },
                "localname":  "AllocatedShareBasedCompensationExpense",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CommitmentandContingenciesSummaryofSEUActivityDetails",
                    "http://signifyhealth.com/role/EquityBasedCompensationDetails",
                    "http://signifyhealth.com/role/SegmentReportingScheduleofOperatingSegmentResultsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AllowanceForDoubtfulAccountsReceivable":  {
                "auth_ref":  [
                    "r191",
                    "r197",
                    "r198",
                    "r199"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of allowance for credit loss on accounts receivable.",
                            "label":  "Accounts Receivable, Allowance for Credit Loss",
                            "terseLabel":  "Allowance for doubtful accounts"
                            }
                        }
                    },
                "localname":  "AllowanceForDoubtfulAccountsReceivable",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AmortizationOfFinancingCosts":  {
                "auth_ref":  [
                    "r62",
                    "r80",
                    "r265",
                    "r466"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of amortization expense attributable to debt issuance costs.",
                            "label":  "Amortization of Debt Issuance Costs",
                            "terseLabel":  "Amortization of deferred financing fees"
                            }
                        }
                    },
                "localname":  "AmortizationOfFinancingCosts",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AmortizationOfIntangibleAssets":  {
                "auth_ref":  [
                    "r80",
                    "r204",
                    "r210"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets.  As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
                            "label":  "Amortization of Intangible Assets",
                            "terseLabel":  "Amortization of intangible assets"
                            }
                        }
                    },
                "localname":  "AmortizationOfIntangibleAssets",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/IntangibleAssetsNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount":  {
                "auth_ref":  [
                    "r124"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
                            "label":  "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
                            "terseLabel":  "Antidilutive securities excluded from computation of earnings per share (in shares)"
                            }
                        }
                    },
                "localname":  "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/LossPerShareNarrativeDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis":  {
                "auth_ref":  [
                    "r124"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of antidilutive security.",
                            "label":  "Antidilutive Securities [Axis]",
                            "terseLabel":  "Antidilutive Securities [Axis]"
                            }
                        }
                    },
                "localname":  "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/LossPerShareNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
                            "terseLabel":  "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
                            }
                        }
                    },
                "localname":  "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/LossPerShareNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AntidilutiveSecuritiesNameDomain":  {
                "auth_ref":  [
                    "r124"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
                            "label":  "Antidilutive Securities, Name [Domain]",
                            "terseLabel":  "Antidilutive Securities, Name [Domain]"
                            }
                        }
                    },
                "localname":  "AntidilutiveSecuritiesNameDomain",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/LossPerShareNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_Assets":  {
                "auth_ref":  [
                    "r95",
                    "r161",
                    "r168",
                    "r175",
                    "r195",
                    "r234",
                    "r235",
                    "r236",
                    "r238",
                    "r239",
                    "r240",
                    "r241",
                    "r243",
                    "r245",
                    "r247",
                    "r248",
                    "r418",
                    "r425",
                    "r455",
                    "r479",
                    "r481",
                    "r511",
                    "r529"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized.  Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
                            "label":  "Assets",
                            "terseLabel":  "Assets",
                            "totalLabel":  "Total assets"
                            }
                        }
                    },
                "localname":  "Assets",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets",
                    "http://signifyhealth.com/role/VariableInterestEntitiesNarrativeDetails",
                    "http://signifyhealth.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AssetsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Assets [Abstract]",
                            "terseLabel":  "ASSETS"
                            }
                        }
                    },
                "localname":  "AssetsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets",
                    "http://signifyhealth.com/role/RevenueRecognitionScheduleofRelatedBalanceSheetsAccountDetails",
                    "http://signifyhealth.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AssetsCurrent":  {
                "auth_ref":  [
                    "r7",
                    "r8",
                    "r49",
                    "r95",
                    "r195",
                    "r234",
                    "r235",
                    "r236",
                    "r238",
                    "r239",
                    "r240",
                    "r241",
                    "r243",
                    "r245",
                    "r247",
                    "r248",
                    "r418",
                    "r425",
                    "r455",
                    "r479",
                    "r481"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer).  Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
                            "label":  "Assets, Current",
                            "totalLabel":  "Total current assets"
                            }
                        }
                    },
                "localname":  "AssetsCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets",
                    "http://signifyhealth.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AssetsCurrentAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Assets, Current [Abstract]",
                            "terseLabel":  "Current assets"
                            }
                        }
                    },
                "localname":  "AssetsCurrentAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets",
                    "http://signifyhealth.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AwardTypeAxis":  {
                "auth_ref":  [
                    "r353",
                    "r369"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of award under share-based payment arrangement.",
                            "label":  "Award Type [Axis]",
                            "terseLabel":  "Award Type [Axis]"
                            }
                        }
                    },
                "localname":  "AwardTypeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CommitmentandContingenciesNarrativeDetails",
                    "http://signifyhealth.com/role/CommitmentandContingenciesSummaryofSEUActivityDetails",
                    "http://signifyhealth.com/role/EquityBasedCompensationDetails",
                    "http://signifyhealth.com/role/SegmentReportingScheduleofOperatingSegmentResultsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_BasisOfAccountingPolicyPolicyTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
                            "label":  "Basis of Accounting, Policy [Policy Text Block]",
                            "terseLabel":  "Basis of Presentation"
                            }
                        }
                    },
                "localname":  "BasisOfAccountingPolicyPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/SignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_BusinessAcquisitionAcquireeDomain":  {
                "auth_ref":  [
                    "r345",
                    "r347"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
                            "label":  "Business Acquisition, Acquiree [Domain]",
                            "terseLabel":  "Business Acquisition, Acquiree [Domain]"
                            }
                        }
                    },
                "localname":  "BusinessAcquisitionAcquireeDomain",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_BusinessAcquisitionAxis":  {
                "auth_ref":  [
                    "r345",
                    "r347",
                    "r405",
                    "r406"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by business combination or series of individually immaterial business combinations.",
                            "label":  "Business Acquisition [Axis]",
                            "terseLabel":  "Business Acquisition [Axis]"
                            }
                        }
                    },
                "localname":  "BusinessAcquisitionAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock":  {
                "auth_ref":  [
                    "r414"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire description for costs incurred to effect a business combination that have been expensed during the period.  Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.",
                            "label":  "Business Acquisition, Integration, Restructuring and Other Related Costs [Text Block]",
                            "terseLabel":  "Transaction-related Expenses"
                            }
                        }
                    },
                "localname":  "BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/TransactionrelatedExpenses"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_BusinessCombinationAcquisitionRelatedCosts":  {
                "auth_ref":  [
                    "r404"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period.  Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
                            "label":  "Business Combination, Acquisition Related Costs",
                            "terseLabel":  "Transaction-related expenses, corporate development activities"
                            }
                        }
                    },
                "localname":  "BusinessCombinationAcquisitionRelatedCosts",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/TransactionrelatedExpensesNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1":  {
                "auth_ref":  [
                    "r79",
                    "r413"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows":  {
                        "order":  11.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
                            "label":  "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
                            "terseLabel":  "Remeasurement of contingent consideration"
                            }
                        }
                    },
                "localname":  "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_BusinessCombinationContingentConsiderationLiability":  {
                "auth_ref":  [
                    "r409",
                    "r410",
                    "r412"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of liability recognized arising from contingent consideration in a business combination.",
                            "label":  "Business Combination, Contingent Consideration, Liability",
                            "terseLabel":  "Contingent consideration",
                            "verboseLabel":  "Consideration due to sellers, fair value"
                            }
                        }
                    },
                "localname":  "BusinessCombinationContingentConsiderationLiability",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
                    "http://signifyhealth.com/role/FairValueMeasurementsScheduleofValuationTechniquesandSignificantUnobservableInputsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent":  {
                "auth_ref":  [
                    "r409",
                    "r411"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.",
                            "label":  "Business Combination, Contingent Consideration, Liability, Current",
                            "terseLabel":  "Contingent consideration",
                            "verboseLabel":  "Contingent consideration, current"
                            }
                        }
                    },
                "localname":  "BusinessCombinationContingentConsiderationLiabilityCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CommitmentandContingenciesNarrativeDetails",
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput":  {
                "auth_ref":  [
                    "r446"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Value of input used to measure contingent consideration liability from business combination.",
                            "label":  "Business Combination, Contingent Consideration, Liability, Measurement Input",
                            "terseLabel":  "Consideration due to sellers, measurement input"
                            }
                        }
                    },
                "localname":  "BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/FairValueMeasurementsScheduleofValuationTechniquesandSignificantUnobservableInputsDetails"
                    ],
                "xbrltype":  "decimalItemType"
                },
            "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent":  {
                "auth_ref":  [
                    "r409",
                    "r411"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_Liabilities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.",
                            "label":  "Business Combination, Contingent Consideration, Liability, Noncurrent",
                            "terseLabel":  "Contingent consideration",
                            "verboseLabel":  "Contingent consideration, noncurrent"
                            }
                        }
                    },
                "localname":  "BusinessCombinationContingentConsiderationLiabilityNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CommitmentandContingenciesNarrativeDetails",
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_BusinessCombinationIntegrationRelatedCosts":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/SegmentReportingScheduleofOperatingSegmentResultsDetails":  {
                        "order":  3.0,
                        "parentTag":  "sgfy_UnallocatedCostsAndExpenses",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Costs incurred to effect a business combination which have been expensed during the period.  Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.",
                            "label":  "Business Combination, Integration Related Costs",
                            "terseLabel":  "Transaction-related expenses"
                            }
                        }
                    },
                "localname":  "BusinessCombinationIntegrationRelatedCosts",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/SegmentReportingScheduleofOperatingSegmentResultsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CapitalExpendituresIncurredButNotYetPaid":  {
                "auth_ref":  [
                    "r85",
                    "r86",
                    "r87"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Future cash outflow to pay for purchases of fixed assets that have occurred.",
                            "label":  "Capital Expenditures Incurred but Not yet Paid",
                            "terseLabel":  "Capital expenditures not yet paid"
                            }
                        }
                    },
                "localname":  "CapitalExpendituresIncurredButNotYetPaid",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CapitalizedComputerSoftwareAdditions":  {
                "auth_ref":  [
                    "r205"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Additions made to capitalized computer software costs during the period.",
                            "label":  "Capitalized Computer Software, Additions",
                            "terseLabel":  "Capitalization of internally-developed software costs"
                            }
                        }
                    },
                "localname":  "CapitalizedComputerSoftwareAdditions",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/IntangibleAssetsNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CashAndCashEquivalentsAtCarryingValue":  {
                "auth_ref":  [
                    "r5",
                    "r30",
                    "r82"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0
                        },
                    "http://signifyhealth.com/role/SignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of currency on hand as well as demand deposits with banks or financial institutions.  Includes other kinds of accounts that have the general characteristics of demand deposits.  Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.  Excludes cash and cash equivalents within disposal group and discontinued operation.",
                            "label":  "Cash and Cash Equivalents, at Carrying Value",
                            "terseLabel":  "Cash and cash equivalents"
                            }
                        }
                    },
                "localname":  "CashAndCashEquivalentsAtCarryingValue",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets",
                    "http://signifyhealth.com/role/SignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails",
                    "http://signifyhealth.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CashAndCashEquivalentsAxis":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of cash and cash equivalent balance.",
                            "label":  "Cash and Cash Equivalents [Axis]",
                            "terseLabel":  "Cash and Cash Equivalents [Axis]"
                            }
                        }
                    },
                "localname":  "CashAndCashEquivalentsAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_CashAndCashEquivalentsFairValueDisclosure":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions.  Includes other kinds of accounts that have the general characteristics of demand deposits.  Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
                            "label":  "Cash and Cash Equivalents, Fair Value Disclosure",
                            "terseLabel":  "Cash equivalents"
                            }
                        }
                    },
                "localname":  "CashAndCashEquivalentsFairValueDisclosure",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CashAndCashEquivalentsLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Cash and Cash Equivalents [Line Items]",
                            "terseLabel":  "Cash and Cash Equivalents [Line Items]"
                            }
                        }
                    },
                "localname":  "CashAndCashEquivalentsLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy":  {
                "auth_ref":  [
                    "r12",
                    "r83",
                    "r509"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
                            "label":  "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
                            "terseLabel":  "Restricted Cash"
                            }
                        }
                    },
                "localname":  "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/SignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents":  {
                "auth_ref":  [
                    "r76",
                    "r82",
                    "r88"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/SignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage.  Excludes amount for disposal group and discontinued operations.  Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.  Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
                            "label":  "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
                            "periodEndLabel":  "Cash, cash equivalents and restricted cash - end of period",
                            "periodStartLabel":  "Cash, cash equivalents and restricted cash - beginning of period",
                            "totalLabel":  "Total cash, cash equivalents, and restricted cash"
                            }
                        }
                    },
                "localname":  "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows",
                    "http://signifyhealth.com/role/SignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect":  {
                "auth_ref":  [
                    "r76",
                    "r456"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change.  Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.  Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
                            "label":  "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
                            "totalLabel":  "Increase in cash, cash equivalents and restricted cash"
                            }
                        }
                    },
                "localname":  "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ClassOfStockDomain":  {
                "auth_ref":  [
                    "r92",
                    "r95",
                    "r117",
                    "r118",
                    "r119",
                    "r121",
                    "r123",
                    "r131",
                    "r133",
                    "r134",
                    "r195",
                    "r234",
                    "r239",
                    "r240",
                    "r241",
                    "r247",
                    "r248",
                    "r278",
                    "r279",
                    "r283",
                    "r287",
                    "r455",
                    "r569"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share of stock differentiated by the voting rights the holder receives.  Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
                            "label":  "Class of Stock [Domain]",
                            "terseLabel":  "Class of Stock [Domain]"
                            }
                        }
                    },
                "localname":  "ClassOfStockDomain",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets",
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquity",
                    "http://signifyhealth.com/role/ConsolidatedBalanceSheetsParenthetical",
                    "http://signifyhealth.com/role/EquityBasedCompensationDetails",
                    "http://signifyhealth.com/role/NatureofOperationsDetails",
                    "http://signifyhealth.com/role/ShareholdersEquityDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ClassOfStockLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Class of Stock [Line Items]",
                            "terseLabel":  "Class of Stock [Line Items]"
                            }
                        }
                    },
                "localname":  "ClassOfStockLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/ShareholdersEquityDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_CommitmentsAndContingencies":  {
                "auth_ref":  [
                    "r45",
                    "r230",
                    "r520",
                    "r537"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_LiabilitiesAndStockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
                            "label":  "Commitments and Contingencies",
                            "terseLabel":  "Commitments and Contingencies"
                            }
                        }
                    },
                "localname":  "CommitmentsAndContingencies",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CommitmentsAndContingenciesDisclosureAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Commitments and Contingencies Disclosure [Abstract]"
                            }
                        }
                    },
                "localname":  "CommitmentsAndContingenciesDisclosureAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock":  {
                "auth_ref":  [
                    "r227",
                    "r228",
                    "r229",
                    "r231",
                    "r557"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for commitments and contingencies.",
                            "label":  "Commitments and Contingencies Disclosure [Text Block]",
                            "terseLabel":  "Commitments and Contingencies"
                            }
                        }
                    },
                "localname":  "CommitmentsAndContingenciesDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CommitmentandContingencies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_CommonClassAMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Classification of common stock representing ownership interest in a corporation.",
                            "label":  "Common Class A [Member]",
                            "terseLabel":  "Class A Common Stock"
                            }
                        }
                    },
                "localname":  "CommonClassAMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets",
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquity",
                    "http://signifyhealth.com/role/ConsolidatedBalanceSheetsParenthetical",
                    "http://signifyhealth.com/role/EquityBasedCompensationDetails",
                    "http://signifyhealth.com/role/NatureofOperationsDetails",
                    "http://signifyhealth.com/role/ShareholdersEquityDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_CommonClassBMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.",
                            "label":  "Common Class B [Member]",
                            "terseLabel":  "Common Class B"
                            }
                        }
                    },
                "localname":  "CommonClassBMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets",
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquity",
                    "http://signifyhealth.com/role/ConsolidatedBalanceSheetsParenthetical",
                    "http://signifyhealth.com/role/LossPerShareNarrativeDetails",
                    "http://signifyhealth.com/role/ShareholdersEquityDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_CommonStockMember":  {
                "auth_ref":  [
                    "r102",
                    "r103",
                    "r438"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Stock that is subordinate to all other stock of the issuer.",
                            "label":  "Common Stock [Member]",
                            "terseLabel":  "Common Stock"
                            }
                        }
                    },
                "localname":  "CommonStockMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_CommonStockParOrStatedValuePerShare":  {
                "auth_ref":  [
                    "r21"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Face amount or stated value per share of common stock.",
                            "label":  "Common Stock, Par or Stated Value Per Share",
                            "terseLabel":  "Common stock par value (in dollars per share)"
                            }
                        }
                    },
                "localname":  "CommonStockParOrStatedValuePerShare",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/ConsolidatedBalanceSheetsParenthetical"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_CommonStockSharesIssued":  {
                "auth_ref":  [
                    "r21"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury).  These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized.  Shares issued include shares outstanding and shares held in the treasury.",
                            "label":  "Common Stock, Shares, Issued",
                            "terseLabel":  "Common stock issued (in shares)"
                            }
                        }
                    },
                "localname":  "CommonStockSharesIssued",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/ConsolidatedBalanceSheetsParenthetical"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_CommonStockSharesOutstanding":  {
                "auth_ref":  [
                    "r21",
                    "r294"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares of common stock outstanding.  Common stock represent the ownership interest in a corporation.",
                            "label":  "Common Stock, Shares, Outstanding",
                            "periodEndLabel":  "Ending balance (in shares)",
                            "periodStartLabel":  "Beginning balance (in shares)",
                            "terseLabel":  "Common stock outstanding (in shares)"
                            }
                        }
                    },
                "localname":  "CommonStockSharesOutstanding",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquity",
                    "http://signifyhealth.com/role/ConsolidatedBalanceSheetsParenthetical"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_CommonStockValue":  {
                "auth_ref":  [
                    "r21",
                    "r481"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer).  This item includes treasury stock repurchased by the entity.  Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
                            "label":  "Common Stock, Value, Issued",
                            "terseLabel":  "Common stock"
                            }
                        }
                    },
                "localname":  "CommonStockValue",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for comprehensive income.",
                            "label":  "Comprehensive Income, Policy [Policy Text Block]",
                            "terseLabel":  "Comprehensive Income (Loss)"
                            }
                        }
                    },
                "localname":  "ComprehensiveIncomePolicyPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/SignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ComputerEquipmentMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.",
                            "label":  "Computer Equipment [Member]",
                            "terseLabel":  "Computer equipment"
                            }
                        }
                    },
                "localname":  "ComputerEquipmentMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/PropertyandEquipmentPropertyandEquipmentnetDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ConcentrationRiskBenchmarkDomain":  {
                "auth_ref":  [
                    "r141",
                    "r142",
                    "r182",
                    "r452",
                    "r453",
                    "r556"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The denominator in a calculation of a disclosed concentration risk percentage.",
                            "label":  "Concentration Risk Benchmark [Domain]",
                            "terseLabel":  "Concentration Risk Benchmark [Domain]"
                            }
                        }
                    },
                "localname":  "ConcentrationRiskBenchmarkDomain",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/ConcentrationsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ConcentrationRiskByBenchmarkAxis":  {
                "auth_ref":  [
                    "r141",
                    "r142",
                    "r182",
                    "r452",
                    "r453",
                    "r555",
                    "r556"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by benchmark of concentration risk.",
                            "label":  "Concentration Risk Benchmark [Axis]",
                            "terseLabel":  "Concentration Risk Benchmark [Axis]"
                            }
                        }
                    },
                "localname":  "ConcentrationRiskByBenchmarkAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/ConcentrationsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ConcentrationRiskByTypeAxis":  {
                "auth_ref":  [
                    "r141",
                    "r142",
                    "r182",
                    "r452",
                    "r453",
                    "r555",
                    "r556"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
                            "label":  "Concentration Risk Type [Axis]",
                            "terseLabel":  "Concentration Risk Type [Axis]"
                            }
                        }
                    },
                "localname":  "ConcentrationRiskByTypeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/ConcentrationsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ConcentrationRiskDisclosureTextBlock":  {
                "auth_ref":  [
                    "r147"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact.  This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.",
                            "label":  "Concentration Risk Disclosure [Text Block]",
                            "terseLabel":  "Concentrations"
                            }
                        }
                    },
                "localname":  "ConcentrationRiskDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/Concentrations"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ConcentrationRiskLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Concentration Risk [Line Items]",
                            "terseLabel":  "Concentration Risk [Line Items]"
                            }
                        }
                    },
                "localname":  "ConcentrationRiskLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/ConcentrationsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ConcentrationRiskPercentage1":  {
                "auth_ref":  [
                    "r141",
                    "r142",
                    "r182",
                    "r452",
                    "r453"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
                            "label":  "Concentration Risk, Percentage",
                            "terseLabel":  "Concentration risk (as a percent)"
                            }
                        }
                    },
                "localname":  "ConcentrationRiskPercentage1",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/ConcentrationsDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_ConcentrationRiskTable":  {
                "auth_ref":  [
                    "r139",
                    "r141",
                    "r142",
                    "r143",
                    "r452",
                    "r454",
                    "r556"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
                            "label":  "Concentration Risk [Table]",
                            "terseLabel":  "Concentration Risk [Table]"
                            }
                        }
                    },
                "localname":  "ConcentrationRiskTable",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/ConcentrationsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ConcentrationRiskTypeDomain":  {
                "auth_ref":  [
                    "r141",
                    "r142",
                    "r182",
                    "r452",
                    "r453",
                    "r556"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
                            "label":  "Concentration Risk Type [Domain]",
                            "terseLabel":  "Concentration Risk Type [Domain]"
                            }
                        }
                    },
                "localname":  "ConcentrationRiskTypeDomain",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/ConcentrationsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]",
                            "terseLabel":  "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]"
                            }
                        }
                    },
                "localname":  "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/NoncontrollingInterestDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable":  {
                "auth_ref":  [
                    "r424",
                    "r435"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Summarization of information required and determined to be disclosed concerning the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent which may have occurred during the period.  The changes represented by this element did not result in the deconsolidation of the subsidiary.",
                            "label":  "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]",
                            "terseLabel":  "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]"
                            }
                        }
                    },
                "localname":  "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/NoncontrollingInterestDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock":  {
                "auth_ref":  [
                    "r424",
                    "r435"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The tabular disclosure of the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent if the ownership interests in a subsidiary changes during the period.  The changes represented by this element did not result in the deconsolidation of the subsidiary.",
                            "label":  "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table Text Block]",
                            "terseLabel":  "Summary of Ownership Interests in Cure TopCo"
                            }
                        }
                    },
                "localname":  "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/NoncontrollingInterestTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ConsolidationPolicyTextBlock":  {
                "auth_ref":  [
                    "r90",
                    "r420"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
                            "label":  "Consolidation, Policy [Policy Text Block]",
                            "terseLabel":  "Consolidation"
                            }
                        }
                    },
                "localname":  "ConsolidationPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/SignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ConstructionInProgressMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Structure or a modification to a structure under construction.  Includes recently completed structures or modifications to structures that have not been placed into service.",
                            "label":  "Construction in Progress [Member]",
                            "terseLabel":  "Projects in progress"
                            }
                        }
                    },
                "localname":  "ConstructionInProgressMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/PropertyandEquipmentPropertyandEquipmentnetDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock":  {
                "auth_ref":  [
                    "r306"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer.  Includes, but is not limited to, change in contract asset and contract liability.",
                            "label":  "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
                            "terseLabel":  "Schedule of Contract Assets and Contract Liabilities"
                            }
                        }
                    },
                "localname":  "ContractWithCustomerAssetAndLiabilityTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/RevenueRecognitionTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ContractWithCustomerAssetNetCurrent":  {
                "auth_ref":  [
                    "r303",
                    "r305",
                    "r324"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.",
                            "label":  "Contract with Customer, Asset, after Allowance for Credit Loss, Current",
                            "periodEndLabel":  "Ending balance",
                            "periodStartLabel":  "Beginning balance",
                            "terseLabel":  "Contract assets"
                            }
                        }
                    },
                "localname":  "ContractWithCustomerAssetNetCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets",
                    "http://signifyhealth.com/role/RevenueRecognitionContractAssetsDetails",
                    "http://signifyhealth.com/role/RevenueRecognitionScheduleofRelatedBalanceSheetsAccountDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ContractWithCustomerLiabilityCurrent":  {
                "auth_ref":  [
                    "r303",
                    "r304",
                    "r324"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
                            "label":  "Contract with Customer, Liability, Current",
                            "periodEndLabel":  "Ending balance",
                            "periodStartLabel":  "Beginning balance",
                            "terseLabel":  "Deferred revenue"
                            }
                        }
                    },
                "localname":  "ContractWithCustomerLiabilityCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/RevenueRecognitionDeferredRevenueDetails",
                    "http://signifyhealth.com/role/RevenueRecognitionScheduleofRelatedBalanceSheetsAccountDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ContractWithCustomerRefundLiabilityCurrent":  {
                "auth_ref":  [
                    "r326"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of liability for consideration received or receivable from customer which is not included in transaction price, when consideration is expected to be refunded to customer, classified as current.",
                            "label":  "Contract with Customer, Refund Liability, Current",
                            "periodEndLabel":  "Ending balance",
                            "periodStartLabel":  "Beginning balance",
                            "terseLabel":  "Contract liabilities",
                            "verboseLabel":  "Contract liabilities"
                            }
                        }
                    },
                "localname":  "ContractWithCustomerRefundLiabilityCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets",
                    "http://signifyhealth.com/role/RevenueRecognitionContractLiabilitiesDetails",
                    "http://signifyhealth.com/role/RevenueRecognitionScheduleofRelatedBalanceSheetsAccountDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization":  {
                "auth_ref":  [
                    "r58",
                    "r59"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofOperations":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_CostsAndExpenses",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Cost of product sold and service rendered, excluding depreciation, depletion, and amortization.",
                            "label":  "Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization",
                            "terseLabel":  "Service expense (exclusive of depreciation and amortization shown below)"
                            }
                        }
                    },
                "localname":  "CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization":  {
                "auth_ref":  [
                    "r63"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofOperations":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_CostsAndExpenses",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of expense for allocation of cost of tangible and intangible assets over their useful lives directly used in production of good and rendering of service.",
                            "label":  "Cost, Depreciation and Amortization",
                            "terseLabel":  "Depreciation and amortization"
                            }
                        }
                    },
                "localname":  "CostOfGoodsAndServicesSoldDepreciationAndAmortization",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CostsAndExpenses":  {
                "auth_ref":  [
                    "r64"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofOperations":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_OperatingIncomeLoss",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Total costs of sales and operating expenses for the period.",
                            "label":  "Costs and Expenses",
                            "totalLabel":  "Total operating expenses"
                            }
                        }
                    },
                "localname":  "CostsAndExpenses",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CreditFacilityAxis":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of credit facility.  Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
                            "label":  "Credit Facility [Axis]",
                            "terseLabel":  "Credit Facility [Axis]"
                            }
                        }
                    },
                "localname":  "CreditFacilityAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/LongTermDebtNarrativeDetails",
                    "http://signifyhealth.com/role/LongTermDebtScheduleofLongTermDebtDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_CreditFacilityDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Type of credit facility.  Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
                            "label":  "Credit Facility [Domain]",
                            "terseLabel":  "Credit Facility [Domain]"
                            }
                        }
                    },
                "localname":  "CreditFacilityDomain",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/LongTermDebtNarrativeDetails",
                    "http://signifyhealth.com/role/LongTermDebtScheduleofLongTermDebtDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_CustomerConcentrationRiskMember":  {
                "auth_ref":  [
                    "r140",
                    "r182"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues.  The risk is the materially adverse effects of loss of a significant customer.",
                            "label":  "Customer Concentration Risk [Member]",
                            "terseLabel":  "Customer Concentration Risk"
                            }
                        }
                    },
                "localname":  "CustomerConcentrationRiskMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/ConcentrationsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_CustomerRelationshipsMember":  {
                "auth_ref":  [
                    "r408"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
                            "label":  "Customer Relationships [Member]",
                            "terseLabel":  "Customer relationships"
                            }
                        }
                    },
                "localname":  "CustomerRelationshipsMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/IntangibleAssetsScheduleofIntangibleAssetsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_DebtDisclosureAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Debt Disclosure [Abstract]"
                            }
                        }
                    },
                "localname":  "DebtDisclosureAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DebtInstrumentAxis":  {
                "auth_ref":  [
                    "r15",
                    "r16",
                    "r17",
                    "r94",
                    "r100",
                    "r249",
                    "r250",
                    "r251",
                    "r252",
                    "r253",
                    "r254",
                    "r255",
                    "r256",
                    "r257",
                    "r258",
                    "r259",
                    "r260",
                    "r261",
                    "r262",
                    "r263",
                    "r264",
                    "r265",
                    "r270",
                    "r271",
                    "r272",
                    "r273",
                    "r467",
                    "r512",
                    "r514",
                    "r528"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
                            "label":  "Debt Instrument [Axis]",
                            "terseLabel":  "Debt Instrument [Axis]"
                            }
                        }
                    },
                "localname":  "DebtInstrumentAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/LongTermDebtNarrativeDetails",
                    "http://signifyhealth.com/role/LongTermDebtScheduleofLongTermDebtDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DebtInstrumentCarryingAmount":  {
                "auth_ref":  [
                    "r17",
                    "r267",
                    "r514",
                    "r528"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/LongTermDebtFuturePrincipalMaturitiesofLongTermDebtDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        },
                    "http://signifyhealth.com/role/LongTermDebtScheduleofLongTermDebtDetails_1":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_LongTermDebt",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt.  Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
                            "label":  "Long-term Debt, Gross",
                            "terseLabel":  "Total debt",
                            "totalLabel":  "Total debt"
                            }
                        }
                    },
                "localname":  "DebtInstrumentCarryingAmount",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/LongTermDebtFuturePrincipalMaturitiesofLongTermDebtDetails",
                    "http://signifyhealth.com/role/LongTermDebtScheduleofLongTermDebtDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DebtInstrumentInterestRateEffectivePercentage":  {
                "auth_ref":  [
                    "r41",
                    "r269",
                    "r465",
                    "r467"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
                            "label":  "Debt Instrument, Interest Rate, Effective Percentage",
                            "terseLabel":  "Effective interest rate (as a percent)"
                            }
                        }
                    },
                "localname":  "DebtInstrumentInterestRateEffectivePercentage",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_DebtInstrumentLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Debt Instrument [Line Items]",
                            "terseLabel":  "Debt Instrument [Line Items]"
                            }
                        }
                    },
                "localname":  "DebtInstrumentLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/LongTermDebtNarrativeDetails",
                    "http://signifyhealth.com/role/LongTermDebtScheduleofLongTermDebtDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DebtInstrumentNameDomain":  {
                "auth_ref":  [
                    "r42",
                    "r94",
                    "r100",
                    "r249",
                    "r250",
                    "r251",
                    "r252",
                    "r253",
                    "r254",
                    "r255",
                    "r256",
                    "r257",
                    "r258",
                    "r259",
                    "r260",
                    "r261",
                    "r262",
                    "r263",
                    "r264",
                    "r265",
                    "r270",
                    "r271",
                    "r272",
                    "r273",
                    "r467"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
                            "label":  "Debt Instrument, Name [Domain]",
                            "terseLabel":  "Debt Instrument, Name [Domain]"
                            }
                        }
                    },
                "localname":  "DebtInstrumentNameDomain",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/LongTermDebtNarrativeDetails",
                    "http://signifyhealth.com/role/LongTermDebtScheduleofLongTermDebtDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_DebtInstrumentTable":  {
                "auth_ref":  [
                    "r42",
                    "r94",
                    "r100",
                    "r249",
                    "r250",
                    "r251",
                    "r252",
                    "r253",
                    "r254",
                    "r255",
                    "r256",
                    "r257",
                    "r258",
                    "r259",
                    "r260",
                    "r261",
                    "r262",
                    "r263",
                    "r264",
                    "r265",
                    "r266",
                    "r270",
                    "r271",
                    "r272",
                    "r273",
                    "r295",
                    "r298",
                    "r299",
                    "r300",
                    "r464",
                    "r465",
                    "r467",
                    "r468",
                    "r527"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation.  These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
                            "label":  "Schedule of Long-term Debt Instruments [Table]",
                            "terseLabel":  "Schedule of Long-term Debt Instruments [Table]"
                            }
                        }
                    },
                "localname":  "DebtInstrumentTable",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/LongTermDebtNarrativeDetails",
                    "http://signifyhealth.com/role/LongTermDebtScheduleofLongTermDebtDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DebtInstrumentUnamortizedDiscount":  {
                "auth_ref":  [
                    "r256",
                    "r464",
                    "r468"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/LongTermDebtScheduleofLongTermDebtDetails_1":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_LongTermDebt",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, after accumulated amortization, of debt discount.",
                            "label":  "Debt Instrument, Unamortized Discount",
                            "negatedTerseLabel":  "Unamortized discount on debt"
                            }
                        }
                    },
                "localname":  "DebtInstrumentUnamortizedDiscount",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/LongTermDebtScheduleofLongTermDebtDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredFinanceCostsNet":  {
                "auth_ref":  [
                    "r33",
                    "r256",
                    "r466"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/LongTermDebtScheduleofLongTermDebtDetails_1":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_LongTermDebt",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, after accumulated amortization, of debt issuance costs.  Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
                            "label":  "Debt Issuance Costs, Net",
                            "negatedTerseLabel":  "Unamortized debt issuance costs"
                            }
                        }
                    },
                "localname":  "DeferredFinanceCostsNet",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/LongTermDebtScheduleofLongTermDebtDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredIncomeTaxAssetsNet":  {
                "auth_ref":  [
                    "r379",
                    "r380"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
                            "label":  "Deferred Income Tax Assets, Net",
                            "terseLabel":  "Deferred tax assets"
                            }
                        }
                    },
                "localname":  "DeferredIncomeTaxAssetsNet",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredIncomeTaxExpenseBenefit":  {
                "auth_ref":  [
                    "r80",
                    "r96",
                    "r390",
                    "r396",
                    "r397",
                    "r398"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows":  {
                        "order":  15.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
                            "label":  "Deferred Income Tax Expense (Benefit)",
                            "terseLabel":  "Deferred income taxes"
                            }
                        }
                    },
                "localname":  "DeferredIncomeTaxExpenseBenefit",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_Depreciation":  {
                "auth_ref":  [
                    "r80",
                    "r216"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives.  Includes production and non-production related depreciation.",
                            "label":  "Depreciation",
                            "terseLabel":  "Depreciation"
                            }
                        }
                    },
                "localname":  "Depreciation",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/PropertyandEquipmentNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DepreciationDepletionAndAmortization":  {
                "auth_ref":  [
                    "r80",
                    "r156"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows":  {
                        "order":  14.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        },
                    "http://signifyhealth.com/role/SegmentReportingScheduleofOperatingSegmentResultsDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
                            "label":  "Depreciation, Depletion and Amortization",
                            "verboseLabel":  "Depreciation and amortization"
                            }
                        }
                    },
                "localname":  "DepreciationDepletionAndAmortization",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows",
                    "http://signifyhealth.com/role/SegmentReportingScheduleofOperatingSegmentResultsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DisaggregationOfRevenueLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Disaggregation of Revenue [Line Items]",
                            "terseLabel":  "Disaggregation of Revenue [Line Items]"
                            }
                        }
                    },
                "localname":  "DisaggregationOfRevenueLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/RevenueRecognitionDisaggregationofRevenueDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DisaggregationOfRevenueTable":  {
                "auth_ref":  [
                    "r323",
                    "r327",
                    "r328",
                    "r329",
                    "r330",
                    "r331",
                    "r332",
                    "r333"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
                            "label":  "Disaggregation of Revenue [Table]",
                            "terseLabel":  "Disaggregation of Revenue [Table]"
                            }
                        }
                    },
                "localname":  "DisaggregationOfRevenueTable",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/RevenueRecognitionDisaggregationofRevenueDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DisaggregationOfRevenueTableTextBlock":  {
                "auth_ref":  [
                    "r323"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
                            "label":  "Disaggregation of Revenue [Table Text Block]",
                            "terseLabel":  "Disaggregation of Revenue"
                            }
                        }
                    },
                "localname":  "DisaggregationOfRevenueTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/RevenueRecognitionTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock":  {
                "auth_ref":  [
                    "r375"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for share-based payment arrangement.",
                            "label":  "Share-based Payment Arrangement [Text Block]",
                            "terseLabel":  "Equity-Based Compensation"
                            }
                        }
                    },
                "localname":  "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/EquityBasedCompensation"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-based Payment Arrangement [Abstract]"
                            }
                        }
                    },
                "localname":  "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DueToRelatedPartiesCurrentAndNoncurrent":  {
                "auth_ref":  [
                    "r99",
                    "r237",
                    "r239",
                    "r240",
                    "r246",
                    "r247",
                    "r248",
                    "r472",
                    "r518",
                    "r540"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying amount as of the balance sheet date of obligations due all related parties.",
                            "label":  "Due to Related Parties",
                            "terseLabel":  "Tax receivable agreement liability"
                            }
                        }
                    },
                "localname":  "DueToRelatedPartiesCurrentAndNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/IncomeTaxesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DueToRelatedPartiesNoncurrent":  {
                "auth_ref":  [
                    "r43",
                    "r99",
                    "r237",
                    "r239",
                    "r240",
                    "r246",
                    "r247",
                    "r248",
                    "r472"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_Liabilities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Portion of the carrying amount as of the balance sheet date of obligations due all related parties that is payable after one year or beyond the normal operating cycle if longer.",
                            "label":  "Due to Related Parties, Noncurrent",
                            "terseLabel":  "Tax receivable agreement liability"
                            }
                        }
                    },
                "localname":  "DueToRelatedPartiesNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_EarningsPerShareAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Earnings Per Share [Abstract]"
                            }
                        }
                    },
                "localname":  "EarningsPerShareAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_EarningsPerShareBasic":  {
                "auth_ref":  [
                    "r61",
                    "r107",
                    "r108",
                    "r109",
                    "r110",
                    "r111",
                    "r115",
                    "r117",
                    "r121",
                    "r122",
                    "r123",
                    "r127",
                    "r128",
                    "r439",
                    "r440",
                    "r523",
                    "r542"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
                            "label":  "Earnings Per Share, Basic",
                            "terseLabel":  "Earnings (loss) per share of Class A common stock - Basic (in dollars per share)",
                            "verboseLabel":  "Basic (in dollars per share)"
                            }
                        }
                    },
                "localname":  "EarningsPerShareBasic",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofOperations",
                    "http://signifyhealth.com/role/LossPerShareScheduleofEarningsLossPerShareDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_EarningsPerShareBasicAndDilutedAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Earnings Per Share, Basic and Diluted [Abstract]",
                            "terseLabel":  "Loss per share of Class A common stock"
                            }
                        }
                    },
                "localname":  "EarningsPerShareBasicAndDilutedAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofOperations"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_EarningsPerShareDiluted":  {
                "auth_ref":  [
                    "r61",
                    "r107",
                    "r108",
                    "r109",
                    "r110",
                    "r111",
                    "r117",
                    "r121",
                    "r122",
                    "r123",
                    "r127",
                    "r128",
                    "r439",
                    "r440",
                    "r523",
                    "r542"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
                            "label":  "Earnings Per Share, Diluted",
                            "terseLabel":  "Earnings (loss) per share of Class A common stock - Diluted (in dollars per share)",
                            "verboseLabel":  "Diluted (in dollars per share)"
                            }
                        }
                    },
                "localname":  "EarningsPerShareDiluted",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofOperations",
                    "http://signifyhealth.com/role/LossPerShareScheduleofEarningsLossPerShareDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_EarningsPerShareTextBlock":  {
                "auth_ref":  [
                    "r124",
                    "r125",
                    "r126",
                    "r129"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for earnings per share.",
                            "label":  "Earnings Per Share [Text Block]",
                            "terseLabel":  "Loss Per Share"
                            }
                        }
                    },
                "localname":  "EarningsPerShareTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/LossPerShare"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_EffectiveIncomeTaxRateContinuingOperations":  {
                "auth_ref":  [
                    "r382"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
                            "label":  "Effective Income Tax Rate Reconciliation, Percent",
                            "terseLabel":  "Effective tax rate (as a percent)"
                            }
                        }
                    },
                "localname":  "EffectiveIncomeTaxRateContinuingOperations",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/IncomeTaxesDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent":  {
                "auth_ref":  [
                    "r519",
                    "r538"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/AccountsPayableandAccruedExpensesDetails":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.",
                            "label":  "Employee-related Liabilities",
                            "terseLabel":  "Accrued payroll and payroll-related expenses"
                            }
                        }
                    },
                "localname":  "EmployeeRelatedLiabilitiesCurrentAndNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/AccountsPayableandAccruedExpensesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized":  {
                "auth_ref":  [
                    "r368"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
                            "label":  "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
                            "periodEndLabel":  "Ending balance",
                            "periodStartLabel":  "Beginning balance",
                            "terseLabel":  "Original grant date fair value unrecognized",
                            "verboseLabel":  "Total unrecognized compensation expense"
                            }
                        }
                    },
                "localname":  "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CommitmentandContingenciesNarrativeDetails",
                    "http://signifyhealth.com/role/CommitmentandContingenciesSummaryofSEUActivityDetails",
                    "http://signifyhealth.com/role/EquityBasedCompensationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1":  {
                "auth_ref":  [
                    "r368"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
                            "label":  "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
                            "terseLabel":  "Performance period of award",
                            "verboseLabel":  "Weighted average recognition period"
                            }
                        }
                    },
                "localname":  "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CommitmentandContingenciesNarrativeDetails",
                    "http://signifyhealth.com/role/EquityBasedCompensationDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_EmployeeStockOptionMember":  {
                "auth_ref":  [
                    "r366"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
                            "label":  "Share-based Payment Arrangement, Option [Member]",
                            "terseLabel":  "Stock Options"
                            }
                        }
                    },
                "localname":  "EmployeeStockOptionMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/EquityBasedCompensationDetails",
                    "http://signifyhealth.com/role/LossPerShareNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_EquityAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Equity [Abstract]"
                            }
                        }
                    },
                "localname":  "EquityAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_EquityComponentDomain":  {
                "auth_ref":  [
                    "r0",
                    "r53",
                    "r54",
                    "r55",
                    "r102",
                    "r103",
                    "r104",
                    "r106",
                    "r112",
                    "r114",
                    "r130",
                    "r196",
                    "r294",
                    "r301",
                    "r370",
                    "r371",
                    "r372",
                    "r392",
                    "r393",
                    "r438",
                    "r457",
                    "r458",
                    "r459",
                    "r460",
                    "r461",
                    "r462",
                    "r550",
                    "r551",
                    "r552",
                    "r572"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
                            "label":  "Equity Component [Domain]",
                            "terseLabel":  "Equity Component [Domain]"
                            }
                        }
                    },
                "localname":  "EquityComponentDomain",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquity",
                    "http://signifyhealth.com/role/NoncontrollingInterestDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ExtraordinaryAndUnusualItemsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Unusual or Infrequent Items, or Both [Abstract]"
                            }
                        }
                    },
                "localname":  "ExtraordinaryAndUnusualItemsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
                            "terseLabel":  "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
                            }
                        }
                    },
                "localname":  "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/FairValueMeasurementsChangesinContingentConsiderationandCustomerEquityAppreciationRightsDetails",
                    "http://signifyhealth.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
                    "http://signifyhealth.com/role/FairValueMeasurementsScheduleofValuationTechniquesandSignificantUnobservableInputsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable":  {
                "auth_ref":  [
                    "r441",
                    "r442",
                    "r443",
                    "r450"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
                            "label":  "Fair Value, Recurring and Nonrecurring [Table]",
                            "terseLabel":  "Fair Value, Recurring and Nonrecurring [Table]"
                            }
                        }
                    },
                "localname":  "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/FairValueMeasurementsChangesinContingentConsiderationandCustomerEquityAppreciationRightsDetails",
                    "http://signifyhealth.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
                    "http://signifyhealth.com/role/FairValueMeasurementsScheduleofValuationTechniquesandSignificantUnobservableInputsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock":  {
                "auth_ref":  [
                    "r444"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
                            "label":  "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
                            "terseLabel":  "Schedule of Valuation Techniques and Significant Unobservable Inputs"
                            }
                        }
                    },
                "localname":  "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/FairValueMeasurementsTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_FairValueByFairValueHierarchyLevelAxis":  {
                "auth_ref":  [
                    "r258",
                    "r270",
                    "r271",
                    "r336",
                    "r337",
                    "r338",
                    "r339",
                    "r340",
                    "r341",
                    "r342",
                    "r344",
                    "r442",
                    "r482",
                    "r483",
                    "r484"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
                            "label":  "Fair Value Hierarchy and NAV [Axis]",
                            "terseLabel":  "Fair Value Hierarchy and NAV [Axis]"
                            }
                        }
                    },
                "localname":  "FairValueByFairValueHierarchyLevelAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/FairValueMeasurementsChangesinContingentConsiderationandCustomerEquityAppreciationRightsDetails",
                    "http://signifyhealth.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
                    "http://signifyhealth.com/role/FairValueMeasurementsScheduleofValuationTechniquesandSignificantUnobservableInputsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FairValueByLiabilityClassAxis":  {
                "auth_ref":  [
                    "r449",
                    "r450"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by class of liability.",
                            "label":  "Liability Class [Axis]",
                            "terseLabel":  "Liability Class [Axis]"
                            }
                        }
                    },
                "localname":  "FairValueByLiabilityClassAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/FairValueMeasurementsChangesinContingentConsiderationandCustomerEquityAppreciationRightsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FairValueByMeasurementFrequencyAxis":  {
                "auth_ref":  [
                    "r441",
                    "r442",
                    "r445",
                    "r446",
                    "r451"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by measurement frequency.",
                            "label":  "Measurement Frequency [Axis]",
                            "terseLabel":  "Measurement Frequency [Axis]"
                            }
                        }
                    },
                "localname":  "FairValueByMeasurementFrequencyAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/FairValueMeasurementsChangesinContingentConsiderationandCustomerEquityAppreciationRightsDetails",
                    "http://signifyhealth.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
                    "http://signifyhealth.com/role/FairValueMeasurementsScheduleofValuationTechniquesandSignificantUnobservableInputsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FairValueDisclosuresAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Fair Value Disclosures [Abstract]"
                            }
                        }
                    },
                "localname":  "FairValueDisclosuresAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FairValueDisclosuresTextBlock":  {
                "auth_ref":  [
                    "r449"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities.  Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
                            "label":  "Fair Value Disclosures [Text Block]",
                            "terseLabel":  "Fair Value Measurements"
                            }
                        }
                    },
                "localname":  "FairValueDisclosuresTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/FairValueMeasurements"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_FairValueInputsLevel1Member":  {
                "auth_ref":  [
                    "r258",
                    "r336",
                    "r337",
                    "r342",
                    "r344",
                    "r442",
                    "r482"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
                            "label":  "Fair Value, Inputs, Level 1 [Member]",
                            "terseLabel":  "Level 1"
                            }
                        }
                    },
                "localname":  "FairValueInputsLevel1Member",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_FairValueInputsLevel2Member":  {
                "auth_ref":  [
                    "r258",
                    "r270",
                    "r271",
                    "r336",
                    "r337",
                    "r342",
                    "r344",
                    "r442",
                    "r483"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
                            "label":  "Fair Value, Inputs, Level 2 [Member]",
                            "terseLabel":  "Level 2"
                            }
                        }
                    },
                "localname":  "FairValueInputsLevel2Member",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_FairValueInputsLevel3Member":  {
                "auth_ref":  [
                    "r258",
                    "r270",
                    "r271",
                    "r336",
                    "r337",
                    "r338",
                    "r339",
                    "r340",
                    "r341",
                    "r342",
                    "r344",
                    "r442",
                    "r484"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
                            "label":  "Fair Value, Inputs, Level 3 [Member]",
                            "terseLabel":  "Level 3"
                            }
                        }
                    },
                "localname":  "FairValueInputsLevel3Member",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/FairValueMeasurementsChangesinContingentConsiderationandCustomerEquityAppreciationRightsDetails",
                    "http://signifyhealth.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
                    "http://signifyhealth.com/role/FairValueMeasurementsScheduleofValuationTechniquesandSignificantUnobservableInputsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain":  {
                "auth_ref":  [
                    "r447"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Represents classes of liabilities measured and disclosed at fair value.",
                            "label":  "Fair Value by Liability Class [Domain]",
                            "terseLabel":  "Fair Value by Liability Class [Domain]"
                            }
                        }
                    },
                "localname":  "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/FairValueMeasurementsChangesinContingentConsiderationandCustomerEquityAppreciationRightsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
                            "label":  "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
                            "terseLabel":  "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"
                            }
                        }
                    },
                "localname":  "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/FairValueMeasurementsChangesinContingentConsiderationandCustomerEquityAppreciationRightsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock":  {
                "auth_ref":  [
                    "r447",
                    "r450"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
                            "label":  "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
                            "terseLabel":  "Changes in Level 3 Liabilities Measured at Fair Value on a Recurring Basis"
                            }
                        }
                    },
                "localname":  "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/FairValueMeasurementsTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_FairValueMeasurementFrequencyDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Measurement frequency.",
                            "label":  "Measurement Frequency [Domain]",
                            "terseLabel":  "Measurement Frequency [Domain]"
                            }
                        }
                    },
                "localname":  "FairValueMeasurementFrequencyDomain",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/FairValueMeasurementsChangesinContingentConsiderationandCustomerEquityAppreciationRightsDetails",
                    "http://signifyhealth.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
                    "http://signifyhealth.com/role/FairValueMeasurementsScheduleofValuationTechniquesandSignificantUnobservableInputsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings":  {
                "auth_ref":  [
                    "r448"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
                            "label":  "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
                            "negatedTerseLabel":  "Remeasurement of fair value"
                            }
                        }
                    },
                "localname":  "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/FairValueMeasurementsChangesinContingentConsiderationandCustomerEquityAppreciationRightsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue":  {
                "auth_ref":  [
                    "r447"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
                            "label":  "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
                            "periodEndLabel":  "Ending balance",
                            "periodStartLabel":  "Beginning balance"
                            }
                        }
                    },
                "localname":  "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/FairValueMeasurementsChangesinContingentConsiderationandCustomerEquityAppreciationRightsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FairValueMeasurementsFairValueHierarchyDomain":  {
                "auth_ref":  [
                    "r258",
                    "r270",
                    "r271",
                    "r336",
                    "r337",
                    "r338",
                    "r339",
                    "r340",
                    "r341",
                    "r342",
                    "r344",
                    "r482",
                    "r483",
                    "r484"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
                            "label":  "Fair Value Hierarchy and NAV [Domain]",
                            "terseLabel":  "Fair Value Hierarchy and NAV [Domain]"
                            }
                        }
                    },
                "localname":  "FairValueMeasurementsFairValueHierarchyDomain",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/FairValueMeasurementsChangesinContingentConsiderationandCustomerEquityAppreciationRightsDetails",
                    "http://signifyhealth.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
                    "http://signifyhealth.com/role/FairValueMeasurementsScheduleofValuationTechniquesandSignificantUnobservableInputsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_FairValueMeasurementsRecurringMember":  {
                "auth_ref":  [
                    "r449",
                    "r451"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Frequent fair value measurement.  Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
                            "label":  "Fair Value, Recurring [Member]",
                            "terseLabel":  "Fair Value, Recurring"
                            }
                        }
                    },
                "localname":  "FairValueMeasurementsRecurringMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/FairValueMeasurementsChangesinContingentConsiderationandCustomerEquityAppreciationRightsDetails",
                    "http://signifyhealth.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
                    "http://signifyhealth.com/role/FairValueMeasurementsScheduleofValuationTechniquesandSignificantUnobservableInputsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetUsefulLife":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
                            "label":  "Finite-Lived Intangible Asset, Useful Life",
                            "terseLabel":  "Estimated Useful Life (years)"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetUsefulLife",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/IntangibleAssetsScheduleofIntangibleAssetsDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization":  {
                "auth_ref":  [
                    "r209"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/IntangibleAssetsScheduleofIntangibleAssetsDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_FiniteLivedIntangibleAssetsNet",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
                            "label":  "Finite-Lived Intangible Assets, Accumulated Amortization",
                            "negatedTerseLabel":  "Accumulated amortization"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsAccumulatedAmortization",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/IntangibleAssetsScheduleofIntangibleAssetsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths":  {
                "auth_ref":  [
                    "r211"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/IntangibleAssetsScheduleofExpectedAmortizationExpenseDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_FiniteLivedIntangibleAssetsNet",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Finite-Lived Intangible Asset, Expected Amortization, Year One",
                            "terseLabel":  "2022"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/IntangibleAssetsScheduleofExpectedAmortizationExpenseDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/IntangibleAssetsScheduleofExpectedAmortizationExpenseDetails":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_FiniteLivedIntangibleAssetsNet",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
                            "label":  "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
                            "terseLabel":  "Remainder of 2021"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/IntangibleAssetsScheduleofExpectedAmortizationExpenseDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour":  {
                "auth_ref":  [
                    "r211"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/IntangibleAssetsScheduleofExpectedAmortizationExpenseDetails":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_FiniteLivedIntangibleAssetsNet",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
                            "terseLabel":  "2025"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/IntangibleAssetsScheduleofExpectedAmortizationExpenseDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree":  {
                "auth_ref":  [
                    "r211"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/IntangibleAssetsScheduleofExpectedAmortizationExpenseDetails":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_FiniteLivedIntangibleAssetsNet",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
                            "terseLabel":  "2024"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/IntangibleAssetsScheduleofExpectedAmortizationExpenseDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo":  {
                "auth_ref":  [
                    "r211"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/IntangibleAssetsScheduleofExpectedAmortizationExpenseDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_FiniteLivedIntangibleAssetsNet",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
                            "terseLabel":  "2023"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/IntangibleAssetsScheduleofExpectedAmortizationExpenseDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis":  {
                "auth_ref":  [
                    "r205",
                    "r206",
                    "r209",
                    "r212",
                    "r494",
                    "r495"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by major type or class of finite-lived intangible assets.",
                            "label":  "Finite-Lived Intangible Assets by Major Class [Axis]",
                            "terseLabel":  "Finite-Lived Intangible Assets by Major Class [Axis]"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsByMajorClassAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/IntangibleAssetsScheduleofIntangibleAssetsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsGross":  {
                "auth_ref":  [
                    "r209",
                    "r495"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/IntangibleAssetsScheduleofIntangibleAssetsDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_FiniteLivedIntangibleAssetsNet",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
                            "label":  "Finite-Lived Intangible Assets, Gross",
                            "terseLabel":  "Gross Carrying Amount"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsGross",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/IntangibleAssetsScheduleofIntangibleAssetsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Finite-Lived Intangible Assets [Line Items]",
                            "terseLabel":  "Finite-Lived Intangible Assets [Line Items]"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/IntangibleAssetsScheduleofIntangibleAssetsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain":  {
                "auth_ref":  [
                    "r205",
                    "r208"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
                            "label":  "Finite-Lived Intangible Assets, Major Class Name [Domain]",
                            "terseLabel":  "Finite-Lived Intangible Assets, Major Class Name [Domain]"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsMajorClassNameDomain",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/IntangibleAssetsScheduleofIntangibleAssetsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsNet":  {
                "auth_ref":  [
                    "r209",
                    "r494"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/IntangibleAssetsScheduleofExpectedAmortizationExpenseDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        },
                    "http://signifyhealth.com/role/IntangibleAssetsScheduleofIntangibleAssetsDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
                            "label":  "Finite-Lived Intangible Assets, Net",
                            "totalLabel":  "Net Carrying Value"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsNet",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/IntangibleAssetsScheduleofExpectedAmortizationExpenseDetails",
                    "http://signifyhealth.com/role/IntangibleAssetsScheduleofIntangibleAssetsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FurnitureAndFixturesMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities.  Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
                            "label":  "Furniture and Fixtures [Member]",
                            "terseLabel":  "Furniture and fixtures"
                            }
                        }
                    },
                "localname":  "FurnitureAndFixturesMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/PropertyandEquipmentPropertyandEquipmentnetDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_Goodwill":  {
                "auth_ref":  [
                    "r200",
                    "r201",
                    "r481",
                    "r510"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
                            "label":  "Goodwill",
                            "terseLabel":  "Goodwill"
                            }
                        }
                    },
                "localname":  "Goodwill",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Goodwill and Intangible Assets Disclosure [Abstract]"
                            }
                        }
                    },
                "localname":  "GoodwillAndIntangibleAssetsDisclosureAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_GranteeStatusAxis":  {
                "auth_ref":  [
                    "r349",
                    "r350",
                    "r366"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by status of recipient to whom award is granted.",
                            "label":  "Grantee Status [Axis]",
                            "terseLabel":  "Grantee Status [Axis]"
                            }
                        }
                    },
                "localname":  "GranteeStatusAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CommitmentandContingenciesNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_GranteeStatusDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Status of recipient to whom award is granted.",
                            "label":  "Grantee Status [Domain]",
                            "terseLabel":  "Grantee Status [Domain]"
                            }
                        }
                    },
                "localname":  "GranteeStatusDomain",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CommitmentandContingenciesNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_IPOMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "First sale of stock by a private company to the public.",
                            "label":  "IPO [Member]",
                            "terseLabel":  "IPO"
                            }
                        }
                    },
                "localname":  "IPOMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/NatureofOperationsDetails",
                    "http://signifyhealth.com/role/ShareholdersEquityDetails",
                    "http://signifyhealth.com/role/TransactionrelatedExpensesNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ImpairmentOfIntangibleAssetsFinitelived":  {
                "auth_ref":  [
                    "r80",
                    "r213"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.",
                            "label":  "Impairment of Intangible Assets, Finite-lived",
                            "terseLabel":  "Impairment of finite-lived intangible assets"
                            }
                        }
                    },
                "localname":  "ImpairmentOfIntangibleAssetsFinitelived",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/IntangibleAssetsNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse":  {
                "auth_ref":  [
                    "r80",
                    "r215",
                    "r220"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).",
                            "label":  "Impairment, Long-Lived Asset, Held-for-Use",
                            "terseLabel":  "Impairment of property and equipment"
                            }
                        }
                    },
                "localname":  "ImpairmentOfLongLivedAssetsHeldForUse",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/PropertyandEquipmentNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest":  {
                "auth_ref":  [
                    "r57",
                    "r161",
                    "r167",
                    "r171",
                    "r174",
                    "r177",
                    "r508",
                    "r521",
                    "r525",
                    "r543"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofOperations":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_ProfitLoss",
                        "weight":  1.0
                        },
                    "http://signifyhealth.com/role/SegmentReportingScheduleofOperatingSegmentResultsDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
                            "label":  "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
                            "totalLabel":  "Loss before income taxes"
                            }
                        }
                    },
                "localname":  "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofOperations",
                    "http://signifyhealth.com/role/SegmentReportingScheduleofOperatingSegmentResultsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncomeStatementAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Income Statement [Abstract]"
                            }
                        }
                    },
                "localname":  "IncomeStatementAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IncomeStatementLocationAxis":  {
                "auth_ref":  [
                    "r221",
                    "r224"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by location in the income statement.",
                            "label":  "Income Statement Location [Axis]",
                            "terseLabel":  "Income Statement Location [Axis]"
                            }
                        }
                    },
                "localname":  "IncomeStatementLocationAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CommitmentandContingenciesSummaryofSEUActivityDetails",
                    "http://signifyhealth.com/role/FairValueMeasurementsChangesinContingentConsiderationandCustomerEquityAppreciationRightsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IncomeStatementLocationDomain":  {
                "auth_ref":  [
                    "r224"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Location in the income statement.",
                            "label":  "Income Statement Location [Domain]",
                            "terseLabel":  "Income Statement Location [Domain]"
                            }
                        }
                    },
                "localname":  "IncomeStatementLocationDomain",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CommitmentandContingenciesSummaryofSEUActivityDetails",
                    "http://signifyhealth.com/role/FairValueMeasurementsChangesinContingentConsiderationandCustomerEquityAppreciationRightsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_IncomeTaxDisclosureAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Income Tax Disclosure [Abstract]"
                            }
                        }
                    },
                "localname":  "IncomeTaxDisclosureAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IncomeTaxDisclosureTextBlock":  {
                "auth_ref":  [
                    "r97",
                    "r383",
                    "r385",
                    "r388",
                    "r394",
                    "r399",
                    "r401",
                    "r402",
                    "r403"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for income taxes.  Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
                            "label":  "Income Tax Disclosure [Text Block]",
                            "terseLabel":  "Income Taxes"
                            }
                        }
                    },
                "localname":  "IncomeTaxDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/IncomeTaxes"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_IncomeTaxExpenseBenefit":  {
                "auth_ref":  [
                    "r98",
                    "r113",
                    "r114",
                    "r159",
                    "r381",
                    "r395",
                    "r400",
                    "r544"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofOperations":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_ProfitLoss",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
                            "label":  "Income Tax Expense (Benefit)",
                            "terseLabel":  "Income tax (benefit) expense"
                            }
                        }
                    },
                "localname":  "IncomeTaxExpenseBenefit",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofOperations",
                    "http://signifyhealth.com/role/IncomeTaxesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncomeTaxPolicyTextBlock":  {
                "auth_ref":  [
                    "r52",
                    "r377",
                    "r378",
                    "r385",
                    "r386",
                    "r387",
                    "r391"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
                            "label":  "Income Tax, Policy [Policy Text Block]",
                            "terseLabel":  "Income Taxes"
                            }
                        }
                    },
                "localname":  "IncomeTaxPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/SignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_IncomeTaxesPaidNet":  {
                "auth_ref":  [
                    "r84"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
                            "label":  "Income Taxes Paid, Net",
                            "terseLabel":  "Cash payments, net of refunds, for taxes"
                            }
                        }
                    },
                "localname":  "IncomeTaxesPaidNet",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities":  {
                "auth_ref":  [
                    "r79"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows":  {
                        "order":  7.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
                            "label":  "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
                            "terseLabel":  "Accounts payable and accrued expenses"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInAccountsReceivable":  {
                "auth_ref":  [
                    "r79"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
                            "label":  "Increase (Decrease) in Accounts Receivable",
                            "negatedTerseLabel":  "Accounts receivable"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInAccountsReceivable",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInContractWithCustomerAsset":  {
                "auth_ref":  [
                    "r79"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows":  {
                        "order":  12.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
                            "label":  "Increase (Decrease) in Contract with Customer, Asset",
                            "negatedTerseLabel":  "Contract assets"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInContractWithCustomerAsset",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInContractWithCustomerLiability":  {
                "auth_ref":  [
                    "r79",
                    "r492"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows":  {
                        "order":  10.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
                            "label":  "Increase (Decrease) in Contract with Customer, Liability",
                            "terseLabel":  "Contract liabilities"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInContractWithCustomerLiability",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes":  {
                "auth_ref":  [
                    "r79"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.",
                            "label":  "Increase (Decrease) in Deferred Income Taxes",
                            "terseLabel":  "Increase in deferred tax asset position"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInDeferredIncomeTaxes",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/IncomeTaxesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Increase (Decrease) in Operating Capital [Abstract]",
                            "terseLabel":  "Changes in operating assets and liabilities:"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInOperatingCapitalAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IncreaseDecreaseInOtherCurrentLiabilities":  {
                "auth_ref":  [
                    "r79"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows":  {
                        "order":  13.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of increase (decrease) in current liabilities classified as other.",
                            "label":  "Increase (Decrease) in Other Current Liabilities",
                            "terseLabel":  "Other current liabilities"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInOtherCurrentLiabilities",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows":  {
                        "order":  16.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of increase (decrease) in noncurrent operating liabilities classified as other.",
                            "label":  "Increase (Decrease) in Other Noncurrent Liabilities",
                            "terseLabel":  "Other noncurrent liabilities"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInOtherNoncurrentLiabilities",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInOtherOperatingAssets":  {
                "auth_ref":  [
                    "r79"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows":  {
                        "order":  9.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of increase (decrease) in operating assets classified as other.",
                            "label":  "Increase (Decrease) in Other Operating Assets",
                            "negatedTerseLabel":  "Other assets"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInOtherOperatingAssets",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets":  {
                "auth_ref":  [
                    "r79"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
                            "label":  "Increase (Decrease) in Prepaid Expense and Other Assets",
                            "negatedTerseLabel":  "Prepaid expenses and other current assets"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
                            "label":  "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
                            "terseLabel":  "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInStockholdersEquityRollForward",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IntangibleAssetsDisclosureTextBlock":  {
                "auth_ref":  [
                    "r214"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for all or part of the information related to intangible assets.",
                            "label":  "Intangible Assets Disclosure [Text Block]",
                            "terseLabel":  "Intangible Assets"
                            }
                        }
                    },
                "localname":  "IntangibleAssetsDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/IntangibleAssets"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_IntangibleAssetsNetExcludingGoodwill":  {
                "auth_ref":  [
                    "r203",
                    "r207"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
                            "label":  "Intangible Assets, Net (Excluding Goodwill)",
                            "terseLabel":  "Intangible assets, net"
                            }
                        }
                    },
                "localname":  "IntangibleAssetsNetExcludingGoodwill",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_InterestExpense":  {
                "auth_ref":  [
                    "r56",
                    "r155",
                    "r463",
                    "r466",
                    "r524"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofOperations":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_NonoperatingIncomeExpense",
                        "weight":  -1.0
                        },
                    "http://signifyhealth.com/role/SegmentReportingScheduleofOperatingSegmentResultsDetails":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of the cost of borrowed funds accounted for as interest expense.",
                            "label":  "Interest Expense",
                            "terseLabel":  "Interest expense"
                            }
                        }
                    },
                "localname":  "InterestExpense",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofOperations",
                    "http://signifyhealth.com/role/SegmentReportingScheduleofOperatingSegmentResultsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_InterestPaidNet":  {
                "auth_ref":  [
                    "r74",
                    "r77",
                    "r84"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity.  Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
                            "label":  "Interest Paid, Excluding Capitalized Interest, Operating Activities",
                            "terseLabel":  "Cash paid for interest"
                            }
                        }
                    },
                "localname":  "InterestPaidNet",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims":  {
                "auth_ref":  [
                    "r80"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows":  {
                        "order":  17.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.",
                            "label":  "Issuance of Stock and Warrants for Services or Claims",
                            "terseLabel":  "Customer equity appreciation rights"
                            }
                        }
                    },
                "localname":  "IssuanceOfStockAndWarrantsForServicesOrClaims",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LeaseholdImprovementsMember":  {
                "auth_ref":  [
                    "r217"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Additions or improvements to assets held under a lease arrangement.",
                            "label":  "Leasehold Improvements [Member]",
                            "terseLabel":  "Leasehold Improvements"
                            }
                        }
                    },
                "localname":  "LeaseholdImprovementsMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/PropertyandEquipmentPropertyandEquipmentnetDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_LettersOfCreditOutstandingAmount":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
                            "label":  "Letters of Credit Outstanding, Amount",
                            "terseLabel":  "Outstanding letters of credit"
                            }
                        }
                    },
                "localname":  "LettersOfCreditOutstandingAmount",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CommitmentandContingenciesNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_Liabilities":  {
                "auth_ref":  [
                    "r38",
                    "r95",
                    "r169",
                    "r195",
                    "r234",
                    "r235",
                    "r236",
                    "r239",
                    "r240",
                    "r241",
                    "r243",
                    "r245",
                    "r247",
                    "r248",
                    "r419",
                    "r425",
                    "r426",
                    "r455",
                    "r479",
                    "r480"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_LiabilitiesAndStockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized.  Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
                            "label":  "Liabilities",
                            "totalLabel":  "Total liabilities"
                            }
                        }
                    },
                "localname":  "Liabilities",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets",
                    "http://signifyhealth.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LiabilitiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Liabilities [Abstract]",
                            "terseLabel":  "Liabilities"
                            }
                        }
                    },
                "localname":  "LiabilitiesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/RevenueRecognitionScheduleofRelatedBalanceSheetsAccountDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LiabilitiesAndStockholdersEquity":  {
                "auth_ref":  [
                    "r27",
                    "r95",
                    "r195",
                    "r455",
                    "r481",
                    "r516",
                    "r535"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
                            "label":  "Liabilities and Equity",
                            "totalLabel":  "Total liabilities and stockholders' / members' equity"
                            }
                        }
                    },
                "localname":  "LiabilitiesAndStockholdersEquity",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets",
                    "http://signifyhealth.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LiabilitiesAndStockholdersEquityAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Liabilities and Equity [Abstract]",
                            "terseLabel":  "LIABILITIES AND STOCKHOLDERS' / MEMBERS' EQUITY"
                            }
                        }
                    },
                "localname":  "LiabilitiesAndStockholdersEquityAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets",
                    "http://signifyhealth.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LiabilitiesAssumed1":  {
                "auth_ref":  [
                    "r85",
                    "r86",
                    "r87"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The fair value of liabilities assumed in noncash investing or financing activities.",
                            "label":  "Liabilities Assumed",
                            "terseLabel":  "Assumption of liabilities from New Remedy Corp"
                            }
                        }
                    },
                "localname":  "LiabilitiesAssumed1",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LiabilitiesCurrent":  {
                "auth_ref":  [
                    "r40",
                    "r95",
                    "r195",
                    "r234",
                    "r235",
                    "r236",
                    "r239",
                    "r240",
                    "r241",
                    "r243",
                    "r245",
                    "r247",
                    "r248",
                    "r419",
                    "r425",
                    "r426",
                    "r455",
                    "r479",
                    "r480",
                    "r481"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_Liabilities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
                            "label":  "Liabilities, Current",
                            "totalLabel":  "Total current liabilities"
                            }
                        }
                    },
                "localname":  "LiabilitiesCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets",
                    "http://signifyhealth.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LiabilitiesCurrentAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Liabilities, Current [Abstract]",
                            "terseLabel":  "Current liabilities"
                            }
                        }
                    },
                "localname":  "LiabilitiesCurrentAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets",
                    "http://signifyhealth.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LimitedLiabilityCompanyLLCMembersEquityAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Limited Liability Company (LLC) Members' Equity [Abstract]",
                            "terseLabel":  "LLC Units"
                            }
                        }
                    },
                "localname":  "LimitedLiabilityCompanyLLCMembersEquityAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/NoncontrollingInterestDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LimitedLiabilityCompanyLLCMembersEquityUnitBasedCompensation":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of increase (decrease) in members' equity for unit-based payment arrangement issued by limited liability company (LLC).",
                            "label":  "Limited Liability Company (LLC) Members' Equity, Unit-based Payment Arrangement",
                            "terseLabel":  "Equity-based compensation"
                            }
                        }
                    },
                "localname":  "LimitedLiabilityCompanyLLCMembersEquityUnitBasedCompensation",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LimitedLiabilityCompanyLLCPreferredUnitOutstanding":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of preferred units of ownership outstanding of a limited liability company (LLC).",
                            "label":  "Limited Liability Company (LLC) Preferred Unit, Outstanding",
                            "terseLabel":  "Total LLC Units outstanding"
                            }
                        }
                    },
                "localname":  "LimitedLiabilityCompanyLLCPreferredUnitOutstanding",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/LossPerShareNarrativeDetails",
                    "http://signifyhealth.com/role/NoncontrollingInterestDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity":  {
                "auth_ref":  [
                    "r36"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
                            "label":  "Line of Credit Facility, Remaining Borrowing Capacity",
                            "terseLabel":  "Remaining borrowing capacity"
                            }
                        }
                    },
                "localname":  "LineOfCreditFacilityRemainingBorrowingCapacity",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LineOfCreditMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
                            "label":  "Line of Credit [Member]",
                            "terseLabel":  "Line of Credit"
                            }
                        }
                    },
                "localname":  "LineOfCreditMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/LongTermDebtNarrativeDetails",
                    "http://signifyhealth.com/role/LongTermDebtScheduleofLongTermDebtDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_LongTermDebt":  {
                "auth_ref":  [
                    "r17",
                    "r257",
                    "r268",
                    "r270",
                    "r271",
                    "r514",
                    "r531"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/LongTermDebtScheduleofLongTermDebtDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        },
                    "http://signifyhealth.com/role/LongTermDebtScheduleofLongTermDebtDetails_1":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt.  Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper.  Excludes capital lease obligations.",
                            "label":  "Long-term Debt",
                            "totalLabel":  "Total debt, net"
                            }
                        }
                    },
                "localname":  "LongTermDebt",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/LongTermDebtScheduleofLongTermDebtDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LongTermDebtCurrent":  {
                "auth_ref":  [
                    "r37"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        },
                    "http://signifyhealth.com/role/LongTermDebtScheduleofLongTermDebtDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_LongTermDebt",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current.  Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper.  Excludes capital lease obligations.",
                            "label":  "Long-term Debt, Current Maturities",
                            "negatedTerseLabel":  "Less current maturities",
                            "verboseLabel":  "Current maturities of long-term debt"
                            }
                        }
                    },
                "localname":  "LongTermDebtCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets",
                    "http://signifyhealth.com/role/LongTermDebtScheduleofLongTermDebtDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths":  {
                "auth_ref":  [
                    "r100",
                    "r232",
                    "r261"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/LongTermDebtFuturePrincipalMaturitiesofLongTermDebtDetails":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_DebtInstrumentCarryingAmount",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Long-Term Debt, Maturity, Year One",
                            "terseLabel":  "2022"
                            }
                        }
                    },
                "localname":  "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/LongTermDebtFuturePrincipalMaturitiesofLongTermDebtDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree":  {
                "auth_ref":  [
                    "r100",
                    "r232",
                    "r261"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/LongTermDebtFuturePrincipalMaturitiesofLongTermDebtDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_DebtInstrumentCarryingAmount",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Long-Term Debt, Maturity, Year Three",
                            "terseLabel":  "2024"
                            }
                        }
                    },
                "localname":  "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/LongTermDebtFuturePrincipalMaturitiesofLongTermDebtDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo":  {
                "auth_ref":  [
                    "r100",
                    "r232",
                    "r261"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/LongTermDebtFuturePrincipalMaturitiesofLongTermDebtDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_DebtInstrumentCarryingAmount",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Long-Term Debt, Maturity, Year Two",
                            "terseLabel":  "2023"
                            }
                        }
                    },
                "localname":  "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/LongTermDebtFuturePrincipalMaturitiesofLongTermDebtDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear":  {
                "auth_ref":  [
                    "r100"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/LongTermDebtFuturePrincipalMaturitiesofLongTermDebtDetails":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_DebtInstrumentCarryingAmount",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.",
                            "label":  "Long-Term Debt, Maturity, Remainder of Fiscal Year",
                            "terseLabel":  "Remainder of 2021"
                            }
                        }
                    },
                "localname":  "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/LongTermDebtFuturePrincipalMaturitiesofLongTermDebtDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LongTermDebtNoncurrent":  {
                "auth_ref":  [
                    "r42"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_Liabilities",
                        "weight":  1.0
                        },
                    "http://signifyhealth.com/role/LongTermDebtScheduleofLongTermDebtDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_LongTermDebt",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer.  Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper.  Excludes capital lease obligations.",
                            "label":  "Long-term Debt, Excluding Current Maturities",
                            "terseLabel":  "Total long-term debt",
                            "verboseLabel":  "Long-term debt"
                            }
                        }
                    },
                "localname":  "LongTermDebtNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets",
                    "http://signifyhealth.com/role/LongTermDebtScheduleofLongTermDebtDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LongTermDebtTextBlock":  {
                "auth_ref":  [
                    "r274"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for long-term debt.",
                            "label":  "Long-term Debt [Text Block]",
                            "terseLabel":  "Long-term Debt"
                            }
                        }
                    },
                "localname":  "LongTermDebtTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/LongTermDebt"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_LongtermDebtTypeAxis":  {
                "auth_ref":  [
                    "r42"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of long-term debt.",
                            "label":  "Long-term Debt, Type [Axis]",
                            "terseLabel":  "Long-term Debt, Type [Axis]"
                            }
                        }
                    },
                "localname":  "LongtermDebtTypeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/LongTermDebtNarrativeDetails",
                    "http://signifyhealth.com/role/LongTermDebtScheduleofLongTermDebtDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LongtermDebtTypeDomain":  {
                "auth_ref":  [
                    "r42",
                    "r233"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.  These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
                            "label":  "Long-term Debt, Type [Domain]",
                            "terseLabel":  "Long-term Debt, Type [Domain]"
                            }
                        }
                    },
                "localname":  "LongtermDebtTypeDomain",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/LongTermDebtNarrativeDetails",
                    "http://signifyhealth.com/role/LongTermDebtScheduleofLongTermDebtDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_MarketingAndAdvertisingExpense":  {
                "auth_ref":  [
                    "r65"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The total expense recognized in the period for promotion, public relations, and brand or product advertising.",
                            "label":  "Marketing and Advertising Expense",
                            "terseLabel":  "Advertising and marketing costs"
                            }
                        }
                    },
                "localname":  "MarketingAndAdvertisingExpense",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_MeasurementInputDiscountRateMember":  {
                "auth_ref":  [
                    "r444"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Measurement input using interest rate to determine present value of future cash flows.",
                            "label":  "Measurement Input, Discount Rate [Member]",
                            "terseLabel":  "Discount Rate"
                            }
                        }
                    },
                "localname":  "MeasurementInputDiscountRateMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/FairValueMeasurementsScheduleofValuationTechniquesandSignificantUnobservableInputsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_MeasurementInputExpectedDividendRateMember":  {
                "auth_ref":  [
                    "r444"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Measurement input using expected dividend rate to be paid to holder of share per year.",
                            "label":  "Measurement Input, Expected Dividend Rate [Member]",
                            "terseLabel":  "Dividend yield"
                            }
                        }
                    },
                "localname":  "MeasurementInputExpectedDividendRateMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/FairValueMeasurementsScheduleofValuationTechniquesandSignificantUnobservableInputsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_MeasurementInputExpectedTermMember":  {
                "auth_ref":  [
                    "r444"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Measurement input using period financial instrument is expected to be outstanding.  Excludes maturity date.",
                            "label":  "Measurement Input, Expected Term [Member]",
                            "terseLabel":  "Expected term (years)"
                            }
                        }
                    },
                "localname":  "MeasurementInputExpectedTermMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/FairValueMeasurementsScheduleofValuationTechniquesandSignificantUnobservableInputsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_MeasurementInputPriceVolatilityMember":  {
                "auth_ref":  [
                    "r444"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Measurement input using rate at which price of security will increase (decrease) for given set of returns.",
                            "label":  "Measurement Input, Price Volatility [Member]",
                            "terseLabel":  "Volatility"
                            }
                        }
                    },
                "localname":  "MeasurementInputPriceVolatilityMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/FairValueMeasurementsScheduleofValuationTechniquesandSignificantUnobservableInputsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_MeasurementInputRiskFreeInterestRateMember":  {
                "auth_ref":  [
                    "r444"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Measurement input using interest rate on instrument with zero risk of financial loss.",
                            "label":  "Measurement Input, Risk Free Interest Rate [Member]",
                            "terseLabel":  "Risk-free rate"
                            }
                        }
                    },
                "localname":  "MeasurementInputRiskFreeInterestRateMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/FairValueMeasurementsScheduleofValuationTechniquesandSignificantUnobservableInputsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_MeasurementInputTypeAxis":  {
                "auth_ref":  [
                    "r444"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of measurement input used to determine value of asset and liability.",
                            "label":  "Measurement Input Type [Axis]",
                            "terseLabel":  "Measurement Input Type [Axis]"
                            }
                        }
                    },
                "localname":  "MeasurementInputTypeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/FairValueMeasurementsScheduleofValuationTechniquesandSignificantUnobservableInputsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_MeasurementInputTypeDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Measurement input used to determine value of asset and liability.",
                            "label":  "Measurement Input Type [Domain]",
                            "terseLabel":  "Measurement Input Type [Domain]"
                            }
                        }
                    },
                "localname":  "MeasurementInputTypeDomain",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/FairValueMeasurementsScheduleofValuationTechniquesandSignificantUnobservableInputsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_MemberUnitsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Ownership interest in limited liability company (LLC).",
                            "label":  "Member Units [Member]",
                            "terseLabel":  "Member Units"
                            }
                        }
                    },
                "localname":  "MemberUnitsMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_MembersCapital":  {
                "auth_ref":  [
                    "r301"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_MembersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of member capital in limited liability company (LLC).",
                            "label":  "Members' Capital",
                            "terseLabel":  "Members' equity"
                            }
                        }
                    },
                "localname":  "MembersCapital",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_MembersEquity":  {
                "auth_ref":  [
                    "r131",
                    "r132",
                    "r133",
                    "r134",
                    "r301"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of ownership interest in limited liability company (LLC), attributable to the parent entity.",
                            "label":  "Members' Equity",
                            "periodEndLabel":  "Ending balance",
                            "periodStartLabel":  "Beginning balance",
                            "totalLabel":  "Total members' equity"
                            }
                        }
                    },
                "localname":  "MembersEquity",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets",
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_MinorityInterest":  {
                "auth_ref":  [
                    "r48",
                    "r95",
                    "r195",
                    "r234",
                    "r239",
                    "r240",
                    "r241",
                    "r247",
                    "r248",
                    "r455",
                    "r515",
                    "r534"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_MembersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
                            "label":  "Stockholders' Equity Attributable to Noncontrolling Interest",
                            "terseLabel":  "Contingently redeemable noncontrolling interest"
                            }
                        }
                    },
                "localname":  "MinorityInterest",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_MinorityInterestDisclosureTextBlock":  {
                "auth_ref":  [
                    "r436"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
                            "label":  "Noncontrolling Interest Disclosure [Text Block]",
                            "terseLabel":  "Noncontrolling Interest"
                            }
                        }
                    },
                "localname":  "MinorityInterestDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/NoncontrollingInterest"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/NoncontrollingInterestDetails":  {
                        "order":  1.0,
                        "parentTag":  "sgfy_NoncontrollingInterestOwnershipPercentage",
                        "weight":  1.0
                        }
                    },
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.",
                            "label":  "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners",
                            "terseLabel":  "Economic ownership interest by noncontrolling interest (as a percent)",
                            "verboseLabel":  "Number of LLC Units held by non-controlling interests (as a percent)"
                            }
                        }
                    },
                "localname":  "MinorityInterestOwnershipPercentageByNoncontrollingOwners",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/NatureofOperationsDetails",
                    "http://signifyhealth.com/role/NoncontrollingInterestDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_MinorityInterestOwnershipPercentageByParent":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/NoncontrollingInterestDetails":  {
                        "order":  2.0,
                        "parentTag":  "sgfy_NoncontrollingInterestOwnershipPercentage",
                        "weight":  1.0
                        }
                    },
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.",
                            "label":  "Noncontrolling Interest, Ownership Percentage by Parent",
                            "terseLabel":  "Economic ownership interest by parent (as a percent)",
                            "verboseLabel":  "Number of LLC Units held by Signify Health, Inc. (as a percent)"
                            }
                        }
                    },
                "localname":  "MinorityInterestOwnershipPercentageByParent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/NatureofOperationsDetails",
                    "http://signifyhealth.com/role/NoncontrollingInterestDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_MoneyMarketFundsMember":  {
                "auth_ref":  [
                    "r336"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
                            "label":  "Money Market Funds [Member]",
                            "terseLabel":  "Money market funds"
                            }
                        }
                    },
                "localname":  "MoneyMarketFundsMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_NetCashProvidedByUsedInFinancingActivities":  {
                "auth_ref":  [
                    "r76"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash inflow (outflow) from financing activities, including discontinued operations.  Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
                            "label":  "Net Cash Provided by (Used in) Financing Activities",
                            "totalLabel":  "Net cash provided by financing activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInFinancingActivities",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Net Cash Provided by (Used in) Financing Activities [Abstract]",
                            "terseLabel":  "Financing activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInFinancingActivitiesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_NetCashProvidedByUsedInInvestingActivities":  {
                "auth_ref":  [
                    "r76"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash inflow (outflow) from investing activities, including discontinued operations.  Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
                            "label":  "Net Cash Provided by (Used in) Investing Activities",
                            "totalLabel":  "Net cash used in investing activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInInvestingActivities",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Net Cash Provided by (Used in) Investing Activities [Abstract]",
                            "terseLabel":  "Investing activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInInvestingActivitiesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_NetCashProvidedByUsedInOperatingActivities":  {
                "auth_ref":  [
                    "r76",
                    "r78",
                    "r81"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                        "weight":  1.0
                        }
                    },
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash inflow (outflow) from operating activities, including discontinued operations.  Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
                            "label":  "Net Cash Provided by (Used in) Operating Activities",
                            "totalLabel":  "Net cash provided by operating activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInOperatingActivities",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Net Cash Provided by (Used in) Operating Activities [Abstract]",
                            "terseLabel":  "Operating activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInOperatingActivitiesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_NetIncomeLoss":  {
                "auth_ref":  [
                    "r3",
                    "r50",
                    "r51",
                    "r55",
                    "r60",
                    "r81",
                    "r95",
                    "r105",
                    "r107",
                    "r108",
                    "r109",
                    "r110",
                    "r113",
                    "r114",
                    "r120",
                    "r161",
                    "r167",
                    "r171",
                    "r174",
                    "r177",
                    "r195",
                    "r234",
                    "r235",
                    "r236",
                    "r239",
                    "r240",
                    "r241",
                    "r243",
                    "r245",
                    "r247",
                    "r248",
                    "r440",
                    "r455",
                    "r522",
                    "r541"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofOperations":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
                            "label":  "Net Income (Loss) Attributable to Parent",
                            "totalLabel":  "Net loss attributable to parent"
                            }
                        }
                    },
                "localname":  "NetIncomeLoss",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofOperations",
                    "http://signifyhealth.com/role/LossPerShareScheduleofEarningsLossPerShareDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest":  {
                "auth_ref":  [
                    "r50",
                    "r51",
                    "r55",
                    "r113",
                    "r114",
                    "r422",
                    "r433"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofOperations":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_NetIncomeLoss",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of Net Income (Loss) attributable to noncontrolling interest.",
                            "label":  "Net Income (Loss) Attributable to Noncontrolling Interest",
                            "terseLabel":  "Less:  Net (loss) income attributable to the noncontrolling interest",
                            "verboseLabel":  "Net loss attributable to noncontrolling interest"
                            }
                        }
                    },
                "localname":  "NetIncomeLossAttributableToNoncontrollingInterest",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofOperations",
                    "http://signifyhealth.com/role/LossPerShareScheduleofEarningsLossPerShareDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting.  Includes, but is not limited to, quantification of the expected or actual impact.",
                            "label":  "New Accounting Pronouncements, Policy [Policy Text Block]",
                            "terseLabel":  "Recent Accounting Pronouncements"
                            }
                        }
                    },
                "localname":  "NewAccountingPronouncementsPolicyPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/SignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_NoncontrollingInterestAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Noncontrolling Interest [Abstract]"
                            }
                        }
                    },
                "localname":  "NoncontrollingInterestAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_NoncontrollingInterestMember":  {
                "auth_ref":  [
                    "r102",
                    "r103",
                    "r104",
                    "r301",
                    "r415"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent.  A noncontrolling interest is sometimes called a minority interest.",
                            "label":  "Noncontrolling Interest [Member]",
                            "terseLabel":  "Non-controlling interest"
                            }
                        }
                    },
                "localname":  "NoncontrollingInterestMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquity",
                    "http://signifyhealth.com/role/NoncontrollingInterestDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_NonoperatingIncomeExpense":  {
                "auth_ref":  [
                    "r66"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofOperations":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
                            "label":  "Nonoperating Income (Expense)",
                            "negatedTotalLabel":  "Other expense, net"
                            }
                        }
                    },
                "localname":  "NonoperatingIncomeExpense",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NumberOfOperatingSegments":  {
                "auth_ref":  [
                    "r149"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of operating segments.  An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available.  An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
                            "label":  "Number of Operating Segments",
                            "terseLabel":  "Number of operating segments"
                            }
                        }
                    },
                "localname":  "NumberOfOperatingSegments",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/NatureofOperationsDetails",
                    "http://signifyhealth.com/role/RevenueRecognitionNarrativeDetails",
                    "http://signifyhealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "integerItemType"
                },
            "us-gaap_NumberOfReportableSegments":  {
                "auth_ref":  [
                    "r149"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of segments reported by the entity.  A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
                            "label":  "Number of Reportable Segments",
                            "terseLabel":  "Number of reportable segments"
                            }
                        }
                    },
                "localname":  "NumberOfReportableSegments",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/SegmentReportingNarrativeDetails"
                    ],
                "xbrltype":  "integerItemType"
                },
            "us-gaap_OperatingExpenseMember":  {
                "auth_ref":  [
                    "r437"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Primary financial statement caption encompassing expenses associated with normal operations.",
                            "label":  "Operating Expense [Member]",
                            "terseLabel":  "Operating Expense"
                            }
                        }
                    },
                "localname":  "OperatingExpenseMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CommitmentandContingenciesSummaryofSEUActivityDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_OperatingExpensesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Operating Expenses [Abstract]",
                            "terseLabel":  "Operating expenses:"
                            }
                        }
                    },
                "localname":  "OperatingExpensesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofOperations"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_OperatingIncomeLoss":  {
                "auth_ref":  [
                    "r161",
                    "r167",
                    "r171",
                    "r174",
                    "r177"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofOperations":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The net result for the period of deducting operating expenses from operating revenues.",
                            "label":  "Operating Income (Loss)",
                            "totalLabel":  "Income (loss) from operations"
                            }
                        }
                    },
                "localname":  "OperatingIncomeLoss",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLossCarryforwards":  {
                "auth_ref":  [
                    "r389"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
                            "label":  "Operating Loss Carryforwards",
                            "terseLabel":  "Net operating loss carryforwards"
                            }
                        }
                    },
                "localname":  "OperatingLossCarryforwards",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/IncomeTaxesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingSegmentsMember":  {
                "auth_ref":  [
                    "r166",
                    "r167",
                    "r168",
                    "r169",
                    "r171",
                    "r177"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
                            "label":  "Operating Segments [Member]",
                            "terseLabel":  "Operating Segments"
                            }
                        }
                    },
                "localname":  "OperatingSegmentsMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/SegmentReportingScheduleofOperatingSegmentResultsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
                            }
                        }
                    },
                "localname":  "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock":  {
                "auth_ref":  [
                    "r4",
                    "r436"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
                            "label":  "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
                            "terseLabel":  "Nature of Operations"
                            }
                        }
                    },
                "localname":  "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/NatureofOperations"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent":  {
                "auth_ref":  [
                    "r519",
                    "r538"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/AccountsPayableandAccruedExpensesDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of expenses incurred but not yet paid classified as other.",
                            "label":  "Other Accrued Liabilities",
                            "terseLabel":  "Other accrued expenses"
                            }
                        }
                    },
                "localname":  "OtherAccruedLiabilitiesCurrentAndNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/AccountsPayableandAccruedExpensesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OtherAssetsNoncurrent":  {
                "auth_ref":  [
                    "r33"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of noncurrent assets classified as other.",
                            "label":  "Other Assets, Noncurrent",
                            "terseLabel":  "Other assets"
                            }
                        }
                    },
                "localname":  "OtherAssetsNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OtherIncomeAndExpensesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Other Income and Expenses [Abstract]"
                            }
                        }
                    },
                "localname":  "OtherIncomeAndExpensesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_OtherLiabilitiesCurrent":  {
                "auth_ref":  [
                    "r9",
                    "r10",
                    "r39",
                    "r481"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
                            "label":  "Other Liabilities, Current",
                            "terseLabel":  "Other current liabilities"
                            }
                        }
                    },
                "localname":  "OtherLiabilitiesCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OtherLiabilitiesNoncurrent":  {
                "auth_ref":  [
                    "r44"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_Liabilities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
                            "label":  "Other Liabilities, Noncurrent",
                            "terseLabel":  "Other noncurrent liabilities"
                            }
                        }
                    },
                "localname":  "OtherLiabilitiesNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OtherNoncashIncomeExpense":  {
                "auth_ref":  [
                    "r81"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
                            "label":  "Other Noncash Income (Expense)",
                            "negatedTerseLabel":  "Other"
                            }
                        }
                    },
                "localname":  "OtherNoncashIncomeExpense",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Other Noncash Investing and Financing Items [Abstract]",
                            "terseLabel":  "Noncash transactions"
                            }
                        }
                    },
                "localname":  "OtherNoncashInvestingAndFinancingItemsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_OtherNonoperatingIncomeExpense":  {
                "auth_ref":  [
                    "r67"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofOperations":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_NonoperatingIncomeExpense",
                        "weight":  1.0
                        },
                    "http://signifyhealth.com/role/SegmentReportingScheduleofOperatingSegmentResultsDetails":  {
                        "order":  2.0,
                        "parentTag":  "sgfy_UnallocatedCostsAndExpenses",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of income (expense) related to nonoperating activities, classified as other.",
                            "label":  "Other Nonoperating Income (Expense)",
                            "negatedTerseLabel":  "Other expense (income), net"
                            }
                        }
                    },
                "localname":  "OtherNonoperatingIncomeExpense",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofOperations",
                    "http://signifyhealth.com/role/SegmentReportingScheduleofOperatingSegmentResultsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OtherNonoperatingIncomeExpenseMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Primary financial statement caption encompassing other nonoperating income (expense).",
                            "label":  "Other Nonoperating Income (Expense) [Member]",
                            "terseLabel":  "Other Nonoperating Income (Expense)"
                            }
                        }
                    },
                "localname":  "OtherNonoperatingIncomeExpenseMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/FairValueMeasurementsChangesinContingentConsiderationandCustomerEquityAppreciationRightsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_OverAllotmentOptionMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Right given to the underwriter to sell additional shares over the initial allotment.",
                            "label":  "Over-Allotment Option [Member]",
                            "terseLabel":  "Over-Allotment Option"
                            }
                        }
                    },
                "localname":  "OverAllotmentOptionMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/NatureofOperationsDetails",
                    "http://signifyhealth.com/role/ShareholdersEquityDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ParentMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent.  Excludes noncontrolling interests.",
                            "label":  "Parent [Member]",
                            "terseLabel":  "Parent"
                            }
                        }
                    },
                "localname":  "ParentMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/NoncontrollingInterestDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_PartnersCapitalAccountTreasuryUnitsPurchases":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Value of units that were previously issued and have been repurchased during the year.",
                            "label":  "Partners' Capital Account, Treasury Units, Purchased",
                            "negatedTerseLabel":  "Repurchase of member units"
                            }
                        }
                    },
                "localname":  "PartnersCapitalAccountTreasuryUnitsPurchases",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PayablesAndAccrualsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Payables and Accruals [Abstract]"
                            }
                        }
                    },
                "localname":  "PayablesAndAccrualsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_PaymentsForSoftware":  {
                "auth_ref":  [
                    "r69"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInInvestingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash outflow associated with the development, modification or acquisition of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.",
                            "label":  "Payments for Software",
                            "negatedTerseLabel":  "Capital expenditures - internal-use software development"
                            }
                        }
                    },
                "localname":  "PaymentsForSoftware",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PaymentsOfStockIssuanceCosts":  {
                "auth_ref":  [
                    "r73"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows":  {
                        "order":  8.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash outflow for cost incurred directly with the issuance of an equity security.",
                            "label":  "Payments of Stock Issuance Costs",
                            "negatedLabel":  "Payments related to the issuance of common stock under stock plans",
                            "terseLabel":  "Underwriting discounts and commissions"
                            }
                        }
                    },
                "localname":  "PaymentsOfStockIssuanceCosts",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows",
                    "http://signifyhealth.com/role/NatureofOperationsDetails",
                    "http://signifyhealth.com/role/ShareholdersEquityDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment":  {
                "auth_ref":  [
                    "r69"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInInvestingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
                            "label":  "Payments to Acquire Property, Plant, and Equipment",
                            "negatedTerseLabel":  "Capital expenditures - property and equipment"
                            }
                        }
                    },
                "localname":  "PaymentsToAcquirePropertyPlantAndEquipment",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PlanNameAxis":  {
                "auth_ref":  [
                    "r353",
                    "r369"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by plan name for share-based payment arrangement.",
                            "label":  "Plan Name [Axis]",
                            "terseLabel":  "Plan Name [Axis]"
                            }
                        }
                    },
                "localname":  "PlanNameAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/EquityBasedCompensationDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_PlanNameDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Plan name for share-based payment arrangement.",
                            "label":  "Plan Name [Domain]",
                            "terseLabel":  "Plan Name [Domain]"
                            }
                        }
                    },
                "localname":  "PlanNameDomain",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/EquityBasedCompensationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_PrepaidExpenseAndOtherAssetsCurrent":  {
                "auth_ref":  [
                    "r7",
                    "r28",
                    "r29"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
                            "label":  "Prepaid Expense and Other Assets, Current",
                            "terseLabel":  "Prepaid expenses and other current assets"
                            }
                        }
                    },
                "localname":  "PrepaidExpenseAndOtherAssetsCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProceedsFromIssuanceInitialPublicOffering":  {
                "auth_ref":  [
                    "r70"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash inflow associated with the amount received from entity's first offering of stock to the public.",
                            "label":  "Proceeds from Issuance Initial Public Offering",
                            "terseLabel":  "Proceeds from IPO, net"
                            }
                        }
                    },
                "localname":  "ProceedsFromIssuanceInitialPublicOffering",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProceedsFromIssuanceOfCommonStock":  {
                "auth_ref":  [
                    "r70"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash inflow from the additional capital contribution to the entity.",
                            "label":  "Proceeds from Issuance of Common Stock",
                            "terseLabel":  "Proceeds related to the issuance of common stock under stock plans"
                            }
                        }
                    },
                "localname":  "ProceedsFromIssuanceOfCommonStock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProceedsFromLinesOfCredit":  {
                "auth_ref":  [
                    "r71",
                    "r94"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
                            "label":  "Proceeds from Lines of Credit",
                            "terseLabel":  "Proceeds from lines of credit"
                            }
                        }
                    },
                "localname":  "ProceedsFromLinesOfCredit",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/LongTermDebtNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProceedsFromLongTermLinesOfCredit":  {
                "auth_ref":  [
                    "r71"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
                            "label":  "Proceeds from Long-term Lines of Credit",
                            "terseLabel":  "Proceeds from borrowings under revolving credit facility"
                            }
                        }
                    },
                "localname":  "ProceedsFromLongTermLinesOfCredit",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProductAndServiceOtherMember":  {
                "auth_ref":  [
                    "r327"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Article or substance produced by nature, labor or machinery and act of providing assistance, classified as other.",
                            "label":  "Product and Service, Other [Member]",
                            "terseLabel":  "Other"
                            }
                        }
                    },
                "localname":  "ProductAndServiceOtherMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/RevenueRecognitionDisaggregationofRevenueDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ProfitLoss":  {
                "auth_ref":  [
                    "r3",
                    "r50",
                    "r51",
                    "r55",
                    "r75",
                    "r95",
                    "r105",
                    "r113",
                    "r114",
                    "r161",
                    "r167",
                    "r171",
                    "r174",
                    "r177",
                    "r195",
                    "r234",
                    "r235",
                    "r236",
                    "r239",
                    "r240",
                    "r241",
                    "r243",
                    "r245",
                    "r247",
                    "r248",
                    "r417",
                    "r421",
                    "r423",
                    "r433",
                    "r434",
                    "r440",
                    "r455",
                    "r525"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows":  {
                        "order":  8.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        },
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofOperations":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_NetIncomeLoss",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
                            "label":  "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
                            "terseLabel":  "Net loss",
                            "totalLabel":  "Net loss",
                            "verboseLabel":  "Net loss"
                            }
                        }
                    },
                "localname":  "ProfitLoss",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows",
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquity",
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofOperations",
                    "http://signifyhealth.com/role/LossPerShareScheduleofEarningsLossPerShareDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Property, Plant and Equipment [Abstract]"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentByTypeAxis":  {
                "auth_ref":  [
                    "r32",
                    "r219"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
                            "label":  "Long-Lived Tangible Asset [Axis]",
                            "terseLabel":  "Long-Lived Tangible Asset [Axis]"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentByTypeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/PropertyandEquipmentPropertyandEquipmentnetDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock":  {
                "auth_ref":  [
                    "r223",
                    "r558",
                    "r559",
                    "r560"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale.  Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
                            "label":  "Property, Plant and Equipment Disclosure [Text Block]",
                            "terseLabel":  "Property and Equipment"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/PropertyandEquipment"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentGross":  {
                "auth_ref":  [
                    "r31",
                    "r217"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/PropertyandEquipmentPropertyandEquipmentnetDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_PropertyPlantAndEquipmentNet",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale.  Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
                            "label":  "Property, Plant and Equipment, Gross",
                            "terseLabel":  "Property and equipment, gross"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentGross",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/PropertyandEquipmentPropertyandEquipmentnetDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Property, Plant and Equipment [Line Items]",
                            "terseLabel":  "Property, Plant and Equipment [Line Items]"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/PropertyandEquipmentPropertyandEquipmentnetDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentNet":  {
                "auth_ref":  [
                    "r13",
                    "r14",
                    "r219",
                    "r481",
                    "r526",
                    "r536"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0
                        },
                    "http://signifyhealth.com/role/PropertyandEquipmentPropertyandEquipmentnetDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale.  Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
                            "label":  "Property, Plant and Equipment, Net",
                            "terseLabel":  "Property and equipment, net",
                            "totalLabel":  "Property and equipment, net"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentNet",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets",
                    "http://signifyhealth.com/role/PropertyandEquipmentPropertyandEquipmentnetDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentTextBlock":  {
                "auth_ref":  [
                    "r13",
                    "r219"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale.  Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
                            "label":  "Property, Plant and Equipment [Table Text Block]",
                            "terseLabel":  "Schedule of Property and Equipment, net"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/PropertyandEquipmentTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentTypeDomain":  {
                "auth_ref":  [
                    "r13",
                    "r217"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.  Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
                            "label":  "Long-Lived Tangible Asset [Domain]",
                            "terseLabel":  "Long-Lived Tangible Asset [Domain]"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentTypeDomain",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/PropertyandEquipmentPropertyandEquipmentnetDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]",
                            "terseLabel":  "Less: reconciling items to net loss:"
                            }
                        }
                    },
                "localname":  "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/SegmentReportingScheduleofOperatingSegmentResultsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_RelatedPartyDomain":  {
                "auth_ref":  [
                    "r343",
                    "r471",
                    "r472"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families.  It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
                            "label":  "Related Party [Domain]",
                            "terseLabel":  "Related Party [Domain]"
                            }
                        }
                    },
                "localname":  "RelatedPartyDomain",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/IncomeTaxesDetails",
                    "http://signifyhealth.com/role/RelatedPartyTransactionsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_RelatedPartyTransactionAmountsOfTransaction":  {
                "auth_ref":  [
                    "r471",
                    "r475"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of transactions with related party during the financial reporting period.",
                            "label":  "Related Party Transaction, Amounts of Transaction",
                            "terseLabel":  "Related party transaction, amounts of transaction"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionAmountsOfTransaction",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/RelatedPartyTransactionsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RelatedPartyTransactionAxis":  {
                "auth_ref":  [
                    "r343",
                    "r471",
                    "r472",
                    "r475"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of related party transaction.",
                            "label":  "Related Party Transaction [Axis]",
                            "terseLabel":  "Related Party Transaction [Axis]"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/RelatedPartyTransactionsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_RelatedPartyTransactionDomain":  {
                "auth_ref":  [
                    "r343"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Transaction between related party.",
                            "label":  "Related Party Transaction [Domain]",
                            "terseLabel":  "Related Party Transaction [Domain]"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionDomain",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/RelatedPartyTransactionsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_RelatedPartyTransactionLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Related Party Transaction [Line Items]",
                            "terseLabel":  "Related Party Transaction [Line Items]"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/IncomeTaxesDetails",
                    "http://signifyhealth.com/role/RelatedPartyTransactionsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_RelatedPartyTransactionsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Related Party Transactions [Abstract]"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis":  {
                "auth_ref":  [
                    "r343",
                    "r471",
                    "r475",
                    "r496",
                    "r497",
                    "r498",
                    "r499",
                    "r500",
                    "r501",
                    "r502",
                    "r503",
                    "r504",
                    "r505",
                    "r506",
                    "r507"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of related party.  Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families.  It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
                            "label":  "Related Party [Axis]",
                            "terseLabel":  "Related Party [Axis]"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionsByRelatedPartyAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/IncomeTaxesDetails",
                    "http://signifyhealth.com/role/RelatedPartyTransactionsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_RelatedPartyTransactionsDisclosureTextBlock":  {
                "auth_ref":  [
                    "r469",
                    "r470",
                    "r472",
                    "r476",
                    "r477"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for related party transactions.  Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
                            "label":  "Related Party Transactions Disclosure [Text Block]",
                            "terseLabel":  "Related Party Transactions"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionsDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/RelatedPartyTransactions"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_RepaymentsOfLongTermLinesOfCredit":  {
                "auth_ref":  [
                    "r72"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
                            "label":  "Repayments of Long-term Lines of Credit",
                            "negatedTerseLabel":  "Repayment of borrowings under revolving credit facility"
                            }
                        }
                    },
                "localname":  "RepaymentsOfLongTermLinesOfCredit",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RepaymentsOfOtherLongTermDebt":  {
                "auth_ref":  [
                    "r72"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows":  {
                        "order":  7.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash outflow for the payment of debt classified as other, maturing after one year or the operating cycle, if longer.",
                            "label":  "Repayments of Other Long-term Debt",
                            "negatedTerseLabel":  "Repayments of borrowings under financing agreement"
                            }
                        }
                    },
                "localname":  "RepaymentsOfOtherLongTermDebt",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RepaymentsOfSecuredDebt":  {
                "auth_ref":  [
                    "r72"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash outflow to repay long-term debt that is wholly or partially secured by collateral.  Excludes repayments of tax exempt secured debt.",
                            "label":  "Repayments of Secured Debt",
                            "negatedTerseLabel":  "Repayment of long-term debt"
                            }
                        }
                    },
                "localname":  "RepaymentsOfSecuredDebt",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RestrictedCashAndCashEquivalents":  {
                "auth_ref":  [
                    "r12",
                    "r82",
                    "r88",
                    "r509",
                    "r532"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/SignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash and cash equivalents restricted as to withdrawal or usage.  Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.  Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
                            "label":  "Restricted Cash and Cash Equivalents",
                            "terseLabel":  "Restricted cash"
                            }
                        }
                    },
                "localname":  "RestrictedCashAndCashEquivalents",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/SignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails",
                    "http://signifyhealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue":  {
                "auth_ref":  [
                    "r5",
                    "r12",
                    "r82",
                    "r88"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current.  Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.  Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
                            "label":  "Restricted Cash and Cash Equivalents, Current",
                            "terseLabel":  "Restricted cash"
                            }
                        }
                    },
                "localname":  "RestrictedCashAndCashEquivalentsAtCarryingValue",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis":  {
                "auth_ref":  [
                    "r30"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by category of cash or cash equivalent items which are restricted as to withdrawal or usage.",
                            "label":  "Restricted Cash and Cash Equivalents [Axis]",
                            "terseLabel":  "Restricted Cash and Cash Equivalents [Axis]"
                            }
                        }
                    },
                "localname":  "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Type of cash and cash equivalent.  Cash is currency on hand as well as demand deposits with banks or financial institutions.  Includes other kinds of accounts that have the general characteristics of demand deposits.  Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
                            "label":  "Cash and Cash Equivalents [Domain]",
                            "terseLabel":  "Cash and Cash Equivalents [Domain]"
                            }
                        }
                    },
                "localname":  "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
                    "http://signifyhealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_RestrictedStockUnitsRSUMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
                            "label":  "Restricted Stock Units (RSUs) [Member]",
                            "terseLabel":  "Restricted Stock Units (RSUs)"
                            }
                        }
                    },
                "localname":  "RestrictedStockUnitsRSUMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/EquityBasedCompensationDetails",
                    "http://signifyhealth.com/role/LossPerShareNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_RetainedEarningsAccumulatedDeficit":  {
                "auth_ref":  [
                    "r24",
                    "r301",
                    "r373",
                    "r481",
                    "r533",
                    "r553",
                    "r554"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_MembersEquity",
                        "weight":  1.0
                        },
                    "http://signifyhealth.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
                            "label":  "Retained Earnings (Accumulated Deficit)",
                            "terseLabel":  "Retained earnings",
                            "verboseLabel":  "Accumulated deficit"
                            }
                        }
                    },
                "localname":  "RetainedEarningsAccumulatedDeficit",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets",
                    "http://signifyhealth.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RetainedEarningsMember":  {
                "auth_ref":  [
                    "r0",
                    "r102",
                    "r103",
                    "r104",
                    "r106",
                    "r112",
                    "r114",
                    "r196",
                    "r370",
                    "r371",
                    "r372",
                    "r392",
                    "r393",
                    "r438",
                    "r550",
                    "r552"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
                            "label":  "Retained Earnings [Member]",
                            "terseLabel":  "Retained earnings (Accumulated deficit)"
                            }
                        }
                    },
                "localname":  "RetainedEarningsMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_RevenueFromContractWithCustomerAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Revenue from Contract with Customer [Abstract]"
                            }
                        }
                    },
                "localname":  "RevenueFromContractWithCustomerAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax":  {
                "auth_ref":  [
                    "r152",
                    "r153",
                    "r166",
                    "r172",
                    "r173",
                    "r179",
                    "r180",
                    "r182",
                    "r322",
                    "r323",
                    "r493"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofOperations":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_OperatingIncomeLoss",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer.  Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
                            "label":  "Revenue from Contract with Customer, Excluding Assessed Tax",
                            "terseLabel":  "Revenue"
                            }
                        }
                    },
                "localname":  "RevenueFromContractWithCustomerExcludingAssessedTax",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofOperations",
                    "http://signifyhealth.com/role/RevenueRecognitionDisaggregationofRevenueDetails",
                    "http://signifyhealth.com/role/SegmentReportingScheduleofOperatingSegmentResultsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock":  {
                "auth_ref":  [
                    "r91",
                    "r314",
                    "r315",
                    "r316",
                    "r317",
                    "r318",
                    "r319",
                    "r320",
                    "r321",
                    "r334"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for revenue from contract with customer.",
                            "label":  "Revenue from Contract with Customer [Policy Text Block]",
                            "terseLabel":  "Revenue from Contract with Customer"
                            }
                        }
                    },
                "localname":  "RevenueFromContractWithCustomerPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/SignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_RevenueFromContractWithCustomerTextBlock":  {
                "auth_ref":  [
                    "r306",
                    "r307",
                    "r308",
                    "r309",
                    "r310",
                    "r311",
                    "r312",
                    "r313",
                    "r325",
                    "r334"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset.  Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer.  Excludes insurance and lease contracts.",
                            "label":  "Revenue from Contract with Customer [Text Block]",
                            "terseLabel":  "Revenue Recognition"
                            }
                        }
                    },
                "localname":  "RevenueFromContractWithCustomerTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/RevenueRecognition"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_RevolvingCreditFacilityMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
                            "label":  "Revolving Credit Facility [Member]",
                            "terseLabel":  "Revolving Credit Facility"
                            }
                        }
                    },
                "localname":  "RevolvingCreditFacilityMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/LongTermDebtNarrativeDetails",
                    "http://signifyhealth.com/role/LongTermDebtScheduleofLongTermDebtDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_RisksAndUncertaintiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Risks and Uncertainties [Abstract]"
                            }
                        }
                    },
                "localname":  "RisksAndUncertaintiesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_SaleOfStockConsiderationReceivedOnTransaction":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Cash received on stock transaction after deduction of issuance costs.",
                            "label":  "Sale of Stock, Consideration Received on Transaction",
                            "terseLabel":  "Net proceeds from IPO"
                            }
                        }
                    },
                "localname":  "SaleOfStockConsiderationReceivedOnTransaction",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/NatureofOperationsDetails",
                    "http://signifyhealth.com/role/ShareholdersEquityDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_SaleOfStockNameOfTransactionDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
                            "label":  "Sale of Stock [Domain]",
                            "terseLabel":  "Sale of Stock [Domain]"
                            }
                        }
                    },
                "localname":  "SaleOfStockNameOfTransactionDomain",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/NatureofOperationsDetails",
                    "http://signifyhealth.com/role/ShareholdersEquityDetails",
                    "http://signifyhealth.com/role/TransactionrelatedExpensesNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
                            "label":  "Sale of Stock, Number of Shares Issued in Transaction",
                            "terseLabel":  "Sale of stock, number of shares issued in transaction (in shares)"
                            }
                        }
                    },
                "localname":  "SaleOfStockNumberOfSharesIssuedInTransaction",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/NatureofOperationsDetails",
                    "http://signifyhealth.com/role/ShareholdersEquityDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_SaleOfStockPricePerShare":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
                            "label":  "Sale of Stock, Price Per Share",
                            "terseLabel":  "Sale of stock, price per share (in dollars per share)"
                            }
                        }
                    },
                "localname":  "SaleOfStockPricePerShare",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/NatureofOperationsDetails",
                    "http://signifyhealth.com/role/ShareholdersEquityDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_SalesAndExciseTaxPayableCurrent":  {
                "auth_ref":  [
                    "r11",
                    "r34"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                            "label":  "Sales and Excise Tax Payable, Current",
                            "terseLabel":  "Sales tax reserve liability"
                            }
                        }
                    },
                "localname":  "SalesAndExciseTaxPayableCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CommitmentandContingenciesNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_SalesRevenueNetMember":  {
                "auth_ref":  [
                    "r141",
                    "r182"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
                            "label":  "Revenue Benchmark [Member]",
                            "terseLabel":  "Revenue Benchmark"
                            }
                        }
                    },
                "localname":  "SalesRevenueNetMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/ConcentrationsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities.  Examples include taxes, interest, rent and utilities.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).  An alternative caption includes accrued expenses.",
                            "label":  "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
                            "terseLabel":  "Schedule of Accounts Payable and Accrued Expenses"
                            }
                        }
                    },
                "localname":  "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/AccountsPayableandAccruedExpensesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable":  {
                "auth_ref":  [
                    "r124"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
                            "label":  "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
                            "terseLabel":  "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/LossPerShareNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfCashAndCashEquivalentsTable":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule of cash and cash equivalent balances.  This table excludes restricted cash balances.",
                            "label":  "Schedule of Cash and Cash Equivalents [Table]",
                            "terseLabel":  "Schedule of Cash and Cash Equivalents [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfCashAndCashEquivalentsTable",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the components of cash and cash equivalents.",
                            "label":  "Schedule of Cash and Cash Equivalents [Table Text Block]",
                            "terseLabel":  "Schedule of Cash and Cash Equivalents"
                            }
                        }
                    },
                "localname":  "ScheduleOfCashAndCashEquivalentsTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/SignificantAccountingPoliciesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfDebtInstrumentsTextBlock":  {
                "auth_ref":  [
                    "r42",
                    "r100",
                    "r270",
                    "r272",
                    "r295",
                    "r298",
                    "r299",
                    "r300",
                    "r464",
                    "r465",
                    "r468",
                    "r527"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation.  These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
                            "label":  "Schedule of Long-term Debt Instruments [Table Text Block]",
                            "terseLabel":  "Schedule of Long-Term Debt"
                            }
                        }
                    },
                "localname":  "ScheduleOfDebtInstrumentsTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/LongTermDebtTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock":  {
                "auth_ref":  [
                    "r123"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
                            "label":  "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
                            "terseLabel":  "Schedule of Earnings (Loss) Per Share"
                            }
                        }
                    },
                "localname":  "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/LossPerShareTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock":  {
                "auth_ref":  [
                    "r441",
                    "r442"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis.  The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
                            "label":  "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
                            "terseLabel":  "Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis"
                            }
                        }
                    },
                "localname":  "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/FairValueMeasurementsTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable":  {
                "auth_ref":  [
                    "r205",
                    "r208",
                    "r494"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
                            "label":  "Schedule of Finite-Lived Intangible Assets [Table]",
                            "terseLabel":  "Schedule of Finite-Lived Intangible Assets [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfFiniteLivedIntangibleAssetsTable",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/IntangibleAssetsScheduleofIntangibleAssetsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock":  {
                "auth_ref":  [
                    "r205",
                    "r208"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
                            "label":  "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
                            "terseLabel":  "Schedule of Intangible Assets"
                            }
                        }
                    },
                "localname":  "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/IntangibleAssetsTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock":  {
                "auth_ref":  [
                    "r232"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
                            "label":  "Schedule of Maturities of Long-term Debt [Table Text Block]",
                            "terseLabel":  "Future Principal Maturities of Long-Term Debt"
                            }
                        }
                    },
                "localname":  "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/LongTermDebtTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock":  {
                "auth_ref":  [
                    "r362"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of activity for outstanding award under share-based payment arrangement excluding share and unit options and nonvested award.",
                            "label":  "Share-based Payment Arrangement, Outstanding Award, Activity, Excluding Option [Table Text Block]",
                            "terseLabel":  "Summary of SEU Activity"
                            }
                        }
                    },
                "localname":  "ScheduleOfOtherShareBasedCompensationActivityTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CommitmentandContingenciesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable":  {
                "auth_ref":  [
                    "r32",
                    "r219"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale.  Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
                            "label":  "Property, Plant and Equipment [Table]",
                            "terseLabel":  "Property, Plant and Equipment [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfPropertyPlantAndEquipmentTable",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/PropertyandEquipmentPropertyandEquipmentnetDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable":  {
                "auth_ref":  [
                    "r473",
                    "r475"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule of quantitative and qualitative information pertaining to related party transactions.  Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
                            "label":  "Schedule of Related Party Transactions, by Related Party [Table]",
                            "terseLabel":  "Schedule of Related Party Transactions, by Related Party [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/IncomeTaxesDetails",
                    "http://signifyhealth.com/role/RelatedPartyTransactionsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock":  {
                "auth_ref":  [
                    "r12",
                    "r88",
                    "r509",
                    "r532"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.",
                            "label":  "Restrictions on Cash and Cash Equivalents [Table Text Block]",
                            "terseLabel":  "Schedule of Restricted Cash"
                            }
                        }
                    },
                "localname":  "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/SignificantAccountingPoliciesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable":  {
                "auth_ref":  [
                    "r161",
                    "r164",
                    "r170",
                    "r202"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "A table disclosing the profit or loss and total assets for each reportable segment of the entity.  An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
                            "label":  "Schedule of Segment Reporting Information, by Segment [Table]",
                            "terseLabel":  "Schedule of Segment Reporting Information, by Segment [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfSegmentReportingInformationBySegmentTable",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/RevenueRecognitionScheduleofRelatedBalanceSheetsAccountDetails",
                    "http://signifyhealth.com/role/SegmentReportingScheduleofOperatingSegmentResultsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock":  {
                "auth_ref":  [
                    "r161",
                    "r164",
                    "r170",
                    "r202"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the profit or loss and total assets for each reportable segment.  An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
                            "label":  "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
                            "terseLabel":  "Schedule of Operating Segment Results"
                            }
                        }
                    },
                "localname":  "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/SegmentReportingTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable":  {
                "auth_ref":  [
                    "r353",
                    "r369"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of information about share-based payment arrangement.",
                            "label":  "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
                            "terseLabel":  "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CommitmentandContingenciesNarrativeDetails",
                    "http://signifyhealth.com/role/CommitmentandContingenciesSummaryofSEUActivityDetails",
                    "http://signifyhealth.com/role/EquityBasedCompensationDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfStockByClassTable":  {
                "auth_ref":  [
                    "r46",
                    "r92",
                    "r131",
                    "r133",
                    "r275",
                    "r276",
                    "r277",
                    "r278",
                    "r279",
                    "r280",
                    "r281",
                    "r283",
                    "r287",
                    "r292",
                    "r295",
                    "r296",
                    "r297",
                    "r298",
                    "r299",
                    "r300",
                    "r301"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule detailing information related to equity by class of stock.  Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer.  It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
                            "label":  "Schedule of Stock by Class [Table]",
                            "terseLabel":  "Schedule of Stock by Class [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfStockByClassTable",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/ShareholdersEquityDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfVariableInterestEntitiesTable":  {
                "auth_ref":  [
                    "r418",
                    "r419",
                    "r425",
                    "r426",
                    "r427",
                    "r428",
                    "r429",
                    "r430",
                    "r431"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of qualitative and quantitative information related to variable interests the entity holds, whether or not such variable interest entity (VIE) is included in the reporting entity's consolidated financial statements.  Includes, but is not limited to, description of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a tabular comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.",
                            "label":  "Schedule of Variable Interest Entities [Table]",
                            "terseLabel":  "Schedule of Variable Interest Entities [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfVariableInterestEntitiesTable",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/VariableInterestEntitiesNarrativeDetails",
                    "http://signifyhealth.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfVariableInterestEntitiesTextBlock":  {
                "auth_ref":  [
                    "r427",
                    "r428",
                    "r429",
                    "r430",
                    "r431"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.",
                            "label":  "Schedule of Variable Interest Entities [Table Text Block]",
                            "terseLabel":  "Schedule of Variable Interest Entities"
                            }
                        }
                    },
                "localname":  "ScheduleOfVariableInterestEntitiesTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/VariableInterestEntitiesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock":  {
                "auth_ref":  [
                    "r208"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
                            "label":  "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
                            "terseLabel":  "Schedule of Expected Amortization Expense"
                            }
                        }
                    },
                "localname":  "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/IntangibleAssetsTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_SecuredDebtMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.",
                            "label":  "Secured Debt [Member]",
                            "terseLabel":  "Secured Debt"
                            }
                        }
                    },
                "localname":  "SecuredDebtMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/LongTermDebtNarrativeDetails",
                    "http://signifyhealth.com/role/LongTermDebtScheduleofLongTermDebtDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_SegmentDomain":  {
                "auth_ref":  [
                    "r148",
                    "r152",
                    "r153",
                    "r154",
                    "r155",
                    "r156",
                    "r157",
                    "r158",
                    "r159",
                    "r160",
                    "r161",
                    "r162",
                    "r163",
                    "r166",
                    "r167",
                    "r168",
                    "r169",
                    "r171",
                    "r172",
                    "r173",
                    "r174",
                    "r175",
                    "r177",
                    "r182",
                    "r225",
                    "r226",
                    "r545"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
                            "label":  "Segments [Domain]",
                            "terseLabel":  "Segments [Domain]"
                            }
                        }
                    },
                "localname":  "SegmentDomain",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/RevenueRecognitionDisaggregationofRevenueDetails",
                    "http://signifyhealth.com/role/RevenueRecognitionScheduleofRelatedBalanceSheetsAccountDetails",
                    "http://signifyhealth.com/role/SegmentReportingScheduleofOperatingSegmentResultsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_SegmentReportingAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Segment Reporting [Abstract]"
                            }
                        }
                    },
                "localname":  "SegmentReportingAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_SegmentReportingDisclosureTextBlock":  {
                "auth_ref":  [
                    "r148",
                    "r150",
                    "r151",
                    "r161",
                    "r165",
                    "r171",
                    "r175",
                    "r176",
                    "r177",
                    "r178",
                    "r179",
                    "r181",
                    "r182",
                    "r183"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for reporting segments including data and tables.  Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
                            "label":  "Segment Reporting Disclosure [Text Block]",
                            "terseLabel":  "Segment Reporting"
                            }
                        }
                    },
                "localname":  "SegmentReportingDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/SegmentReporting"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_SegmentReportingInformationLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Segment Reporting Information [Line Items]",
                            "terseLabel":  "Segment Reporting Information [Line Items]"
                            }
                        }
                    },
                "localname":  "SegmentReportingInformationLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/RevenueRecognitionScheduleofRelatedBalanceSheetsAccountDetails",
                    "http://signifyhealth.com/role/SegmentReportingScheduleofOperatingSegmentResultsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_SellingGeneralAndAdministrativeExpense":  {
                "auth_ref":  [
                    "r65"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofOperations":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_CostsAndExpenses",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses.  Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products.  Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges.  General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
                            "label":  "Selling, General and Administrative Expense",
                            "terseLabel":  "Selling, general and administrative expense (exclusive of depreciation and amortization shown below)"
                            }
                        }
                    },
                "localname":  "SellingGeneralAndAdministrativeExpense",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_SellingGeneralAndAdministrativeExpensesMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Primary financial statement caption encompassing selling, general and administrative expense.",
                            "label":  "Selling, General and Administrative Expenses [Member]",
                            "terseLabel":  "Selling, General and Administrative Expenses"
                            }
                        }
                    },
                "localname":  "SellingGeneralAndAdministrativeExpensesMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CommitmentandContingenciesSummaryofSEUActivityDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ShareBasedCompensation":  {
                "auth_ref":  [
                    "r79"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of noncash expense for share-based payment arrangement.",
                            "label":  "Share-based Payment Arrangement, Noncash Expense",
                            "terseLabel":  "Equity-based compensation"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensation",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1":  {
                "auth_ref":  [
                    "r354"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period",
                            "terseLabel":  "Award requisite service period"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CommitmentandContingenciesNarrativeDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1":  {
                "auth_ref":  [
                    "r354"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.  Includes, but is not limited to, combination of market, performance or service condition.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
                            "terseLabel":  "Vesting period"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/EquityBasedCompensationDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod":  {
                "auth_ref":  [
                    "r364"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
                            "terseLabel":  "Grants in period (in shares)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/EquityBasedCompensationDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber":  {
                "auth_ref":  [
                    "r363"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
                            "terseLabel":  "Units outstanding (in shares)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CommitmentandContingenciesNarrativeDetails",
                    "http://signifyhealth.com/role/EquityBasedCompensationDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
                            "terseLabel":  "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CommitmentandContingenciesNarrativeDetails",
                    "http://signifyhealth.com/role/CommitmentandContingenciesSummaryofSEUActivityDetails",
                    "http://signifyhealth.com/role/EquityBasedCompensationDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber":  {
                "auth_ref":  [
                    "r358",
                    "r360"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of equity instruments other than options outstanding, including both vested and non-vested instruments.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number",
                            "terseLabel":  "Units outstanding (in shares)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/EquityBasedCompensationDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of additional shares authorized for issuance under share-based payment arrangement.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized",
                            "terseLabel":  "Number of additional shares authorized (in shares)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/EquityBasedCompensationDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized":  {
                "auth_ref":  [
                    "r356"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares authorized for issuance under share-based payment arrangement.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
                            "terseLabel":  "Number of shares available for issuance (in shares)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/EquityBasedCompensationDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Gross number of share options (or share units) granted during the period.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
                            "terseLabel":  "Options issued in period (in shares)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/EquityBasedCompensationDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue":  {
                "auth_ref":  [
                    "r365"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
                            "terseLabel":  "Weighted average exercise price (in dollars per share)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/EquityBasedCompensationDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber":  {
                "auth_ref":  [
                    "r359",
                    "r369"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of options outstanding, including both vested and non-vested options.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
                            "terseLabel":  "Options outstanding (in shares)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/EquityBasedCompensationDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice":  {
                "auth_ref":  [
                    "r358"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
                            "terseLabel":  "Weighted average exercise price (in dollars per share)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/EquityBasedCompensationDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain":  {
                "auth_ref":  [
                    "r351",
                    "r357"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Award under share-based payment arrangement.",
                            "label":  "Award Type [Domain]",
                            "terseLabel":  "Award Type [Domain]"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CommitmentandContingenciesNarrativeDetails",
                    "http://signifyhealth.com/role/CommitmentandContingenciesSummaryofSEUActivityDetails",
                    "http://signifyhealth.com/role/EquityBasedCompensationDetails",
                    "http://signifyhealth.com/role/SegmentReportingScheduleofOperatingSegmentResultsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ShareBasedPaymentArrangementNonemployeeMember":  {
                "auth_ref":  [
                    "r349",
                    "r366"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Recipient, of award granted under share-based payment arrangement, over whom grantor does not exercise nor has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction.  Excludes nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires.",
                            "label":  "Share-based Payment Arrangement, Nonemployee [Member]",
                            "terseLabel":  "Share-based Payment Arrangement, Nonemployee"
                            }
                        }
                    },
                "localname":  "ShareBasedPaymentArrangementNonemployeeMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CommitmentandContingenciesNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod":  {
                "auth_ref":  [
                    "r355"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
                            "terseLabel":  "Expiration period of award"
                            }
                        }
                    },
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CommitmentandContingenciesNarrativeDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_SignificantAccountingPoliciesTextBlock":  {
                "auth_ref":  [
                    "r89",
                    "r101"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for all significant accounting policies of the reporting entity.",
                            "label":  "Significant Accounting Policies [Text Block]",
                            "terseLabel":  "Significant Accounting Policies"
                            }
                        }
                    },
                "localname":  "SignificantAccountingPoliciesTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/SignificantAccountingPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Purchased software applications and internally developed software for sale, licensing or long-term internal use.",
                            "label":  "Software and Software Development Costs [Member]",
                            "terseLabel":  "Software"
                            }
                        }
                    },
                "localname":  "SoftwareAndSoftwareDevelopmentCostsMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/PropertyandEquipmentPropertyandEquipmentnetDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_StatementBusinessSegmentsAxis":  {
                "auth_ref":  [
                    "r2",
                    "r148",
                    "r152",
                    "r153",
                    "r154",
                    "r155",
                    "r156",
                    "r157",
                    "r158",
                    "r159",
                    "r160",
                    "r161",
                    "r162",
                    "r163",
                    "r166",
                    "r167",
                    "r168",
                    "r169",
                    "r171",
                    "r172",
                    "r173",
                    "r174",
                    "r175",
                    "r177",
                    "r182",
                    "r202",
                    "r222",
                    "r225",
                    "r226",
                    "r545"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by business segments.",
                            "label":  "Segments [Axis]",
                            "terseLabel":  "Segments [Axis]"
                            }
                        }
                    },
                "localname":  "StatementBusinessSegmentsAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/RevenueRecognitionDisaggregationofRevenueDetails",
                    "http://signifyhealth.com/role/RevenueRecognitionScheduleofRelatedBalanceSheetsAccountDetails",
                    "http://signifyhealth.com/role/SegmentReportingScheduleofOperatingSegmentResultsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementClassOfStockAxis":  {
                "auth_ref":  [
                    "r19",
                    "r20",
                    "r21",
                    "r92",
                    "r95",
                    "r117",
                    "r118",
                    "r119",
                    "r121",
                    "r123",
                    "r131",
                    "r133",
                    "r134",
                    "r195",
                    "r234",
                    "r239",
                    "r240",
                    "r241",
                    "r247",
                    "r248",
                    "r278",
                    "r279",
                    "r283",
                    "r287",
                    "r294",
                    "r455",
                    "r569"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by the different classes of stock of the entity.",
                            "label":  "Class of Stock [Axis]",
                            "terseLabel":  "Class of Stock [Axis]"
                            }
                        }
                    },
                "localname":  "StatementClassOfStockAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets",
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquity",
                    "http://signifyhealth.com/role/ConsolidatedBalanceSheetsParenthetical",
                    "http://signifyhealth.com/role/EquityBasedCompensationDetails",
                    "http://signifyhealth.com/role/NatureofOperationsDetails",
                    "http://signifyhealth.com/role/ShareholdersEquityDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementEquityComponentsAxis":  {
                "auth_ref":  [
                    "r0",
                    "r47",
                    "r53",
                    "r54",
                    "r55",
                    "r102",
                    "r103",
                    "r104",
                    "r106",
                    "r112",
                    "r114",
                    "r130",
                    "r196",
                    "r294",
                    "r301",
                    "r370",
                    "r371",
                    "r372",
                    "r392",
                    "r393",
                    "r438",
                    "r457",
                    "r458",
                    "r459",
                    "r460",
                    "r461",
                    "r462",
                    "r550",
                    "r551",
                    "r552",
                    "r572"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by component of equity.",
                            "label":  "Equity Components [Axis]",
                            "terseLabel":  "Equity Components [Axis]"
                            }
                        }
                    },
                "localname":  "StatementEquityComponentsAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquity",
                    "http://signifyhealth.com/role/NoncontrollingInterestDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Statement [Line Items]",
                            "terseLabel":  "Statement [Line Items]"
                            }
                        }
                    },
                "localname":  "StatementLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets",
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquity",
                    "http://signifyhealth.com/role/ConsolidatedBalanceSheetsParenthetical"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementOfCashFlowsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Statement of Cash Flows [Abstract]"
                            }
                        }
                    },
                "localname":  "StatementOfCashFlowsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementOfFinancialPositionAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Statement of Financial Position [Abstract]"
                            }
                        }
                    },
                "localname":  "StatementOfFinancialPositionAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementOfStockholdersEquityAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Statement of Stockholders' Equity [Abstract]"
                            }
                        }
                    },
                "localname":  "StatementOfStockholdersEquityAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementTable":  {
                "auth_ref":  [
                    "r102",
                    "r103",
                    "r104",
                    "r130",
                    "r493"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
                            "label":  "Statement [Table]",
                            "terseLabel":  "Statement [Table]"
                            }
                        }
                    },
                "localname":  "StatementTable",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets",
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquity",
                    "http://signifyhealth.com/role/ConsolidatedBalanceSheetsParenthetical"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StockAppreciationRightsSARSMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period.",
                            "label":  "Stock Appreciation Rights (SARs) [Member]",
                            "terseLabel":  "Customer equity appreciation rights"
                            }
                        }
                    },
                "localname":  "StockAppreciationRightsSARSMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CommitmentandContingenciesNarrativeDetails",
                    "http://signifyhealth.com/role/FairValueMeasurementsChangesinContingentConsiderationandCustomerEquityAppreciationRightsDetails",
                    "http://signifyhealth.com/role/SegmentReportingScheduleofOperatingSegmentResultsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_StockCompensationPlanMember":  {
                "auth_ref":  [
                    "r124"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share-based payment arrangement in which award of equity shares are granted.  Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares.",
                            "label":  "Share-based Payment Arrangement [Member]",
                            "terseLabel":  "Equity-based compensation"
                            }
                        }
                    },
                "localname":  "StockCompensationPlanMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/SegmentReportingScheduleofOperatingSegmentResultsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_StockIssuedDuringPeriodSharesNewIssues":  {
                "auth_ref":  [
                    "r20",
                    "r21",
                    "r294",
                    "r301"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of new stock issued during the period.",
                            "label":  "Stock Issued During Period, Shares, New Issues",
                            "terseLabel":  "Issuance of Class A common stock in IPO, net of issuance costs (in shares)"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesNewIssues",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation":  {
                "auth_ref":  [
                    "r20",
                    "r21",
                    "r294",
                    "r301"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number, after forfeiture, of shares or units issued under share-based payment arrangement.  Excludes shares or units issued under employee stock ownership plan (ESOP).",
                            "label":  "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
                            "terseLabel":  "Equity-based compensation subsequent to Reorganization Transactions (in shares)"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesShareBasedCompensation",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised":  {
                "auth_ref":  [
                    "r20",
                    "r21",
                    "r294",
                    "r301",
                    "r361"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of share options (or share units) exercised during the current period.",
                            "label":  "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
                            "terseLabel":  "Proceeds from exercises of stock options (in shares)"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesStockOptionsExercised",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockIssuedDuringPeriodValueNewIssues":  {
                "auth_ref":  [
                    "r20",
                    "r21",
                    "r294",
                    "r301"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Equity impact of the value of new stock issued during the period.  Includes shares issued in an initial public offering or a secondary public offering.",
                            "label":  "Stock Issued During Period, Value, New Issues",
                            "terseLabel":  "Issuance of Class A common stock in IPO, net of issuance costs"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodValueNewIssues",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised":  {
                "auth_ref":  [
                    "r47",
                    "r294",
                    "r301"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Value of stock issued as a result of the exercise of stock options.",
                            "label":  "Stock Issued During Period, Value, Stock Options Exercised",
                            "terseLabel":  "Proceeds from exercises of stock options"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodValueStockOptionsExercised",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockRepurchasedDuringPeriodValue":  {
                "auth_ref":  [
                    "r20",
                    "r21",
                    "r294",
                    "r301"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury.  Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore.  This element is used when state law does not recognize treasury stock.",
                            "label":  "Stock Repurchased During Period, Value",
                            "negatedTerseLabel":  "Repurchase of stock"
                            }
                        }
                    },
                "localname":  "StockRepurchasedDuringPeriodValue",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockholdersEquity":  {
                "auth_ref":  [
                    "r21",
                    "r25",
                    "r26",
                    "r95",
                    "r193",
                    "r195",
                    "r455",
                    "r481"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent.  The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest).  This excludes temporary equity and is sometimes called permanent equity.",
                            "label":  "Stockholders' Equity Attributable to Parent",
                            "totalLabel":  "Total equity"
                            }
                        }
                    },
                "localname":  "StockholdersEquity",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest":  {
                "auth_ref":  [
                    "r0",
                    "r1",
                    "r54",
                    "r95",
                    "r102",
                    "r103",
                    "r104",
                    "r106",
                    "r112",
                    "r195",
                    "r196",
                    "r301",
                    "r370",
                    "r371",
                    "r372",
                    "r392",
                    "r393",
                    "r415",
                    "r416",
                    "r432",
                    "r438",
                    "r455",
                    "r457",
                    "r458",
                    "r462",
                    "r551",
                    "r552",
                    "r572"
                    ],
                "calculation":  {
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_LiabilitiesAndStockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests.  Amount excludes temporary equity.  Alternate caption for the concept is permanent equity.",
                            "label":  "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
                            "periodEndLabel":  "Ending balance",
                            "periodStartLabel":  "Beginning balance",
                            "totalLabel":  "Total stockholders' equity"
                            }
                        }
                    },
                "localname":  "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets",
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockholdersEquityNoteDisclosureTextBlock":  {
                "auth_ref":  [
                    "r93",
                    "r279",
                    "r282",
                    "r283",
                    "r284",
                    "r285",
                    "r286",
                    "r287",
                    "r288",
                    "r289",
                    "r290",
                    "r291",
                    "r293",
                    "r301",
                    "r302"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income.  Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
                            "label":  "Stockholders' Equity Note Disclosure [Text Block]",
                            "terseLabel":  "Shareholders' Equity"
                            }
                        }
                    },
                "localname":  "StockholdersEquityNoteDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/ShareholdersEquity"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Different names of stock transactions and the different attributes of each transaction.",
                            "label":  "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]",
                            "terseLabel":  "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]"
                            }
                        }
                    },
                "localname":  "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/NatureofOperationsDetails",
                    "http://signifyhealth.com/role/TransactionrelatedExpensesNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_SubsidiarySaleOfStockAxis":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of sale of the entity's stock.",
                            "label":  "Sale of Stock [Axis]",
                            "terseLabel":  "Sale of Stock [Axis]"
                            }
                        }
                    },
                "localname":  "SubsidiarySaleOfStockAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/NatureofOperationsDetails",
                    "http://signifyhealth.com/role/ShareholdersEquityDetails",
                    "http://signifyhealth.com/role/TransactionrelatedExpensesNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_SubsidiarySaleOfStockLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Subsidiary, Sale of Stock [Line Items]",
                            "terseLabel":  "Subsidiary, Sale of Stock [Line Items]"
                            }
                        }
                    },
                "localname":  "SubsidiarySaleOfStockLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/NatureofOperationsDetails",
                    "http://signifyhealth.com/role/TransactionrelatedExpensesNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_SupplementalCashFlowInformationAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Supplemental Cash Flow Information [Abstract]",
                            "terseLabel":  "Supplemental disclosures of cash flow information"
                            }
                        }
                    },
                "localname":  "SupplementalCashFlowInformationAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_TechnologyBasedIntangibleAssetsMember":  {
                "auth_ref":  [
                    "r407"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
                            "label":  "Technology-Based Intangible Assets [Member]",
                            "terseLabel":  "Acquired and capitalized software"
                            }
                        }
                    },
                "localname":  "TechnologyBasedIntangibleAssetsMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/IntangibleAssetsScheduleofIntangibleAssetsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_TradeAndOtherAccountsReceivablePolicy":  {
                "auth_ref":  [
                    "r187",
                    "r188",
                    "r189",
                    "r190",
                    "r192",
                    "r194"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for accounts receivable.",
                            "label":  "Accounts Receivable [Policy Text Block]",
                            "terseLabel":  "Accounts Receivable"
                            }
                        }
                    },
                "localname":  "TradeAndOtherAccountsReceivablePolicy",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/SignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock":  {
                "auth_ref":  [
                    "r68"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for an event or transaction that is unusual in nature or infrequent in occurrence, or both.",
                            "label":  "Unusual or Infrequent Items, or Both, Disclosure [Text Block]",
                            "terseLabel":  "The COVID-19 Pandemic"
                            }
                        }
                    },
                "localname":  "UnusualOrInfrequentItemsDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/TheCOVID19Pandemic"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_UseOfEstimates":  {
                "auth_ref":  [
                    "r135",
                    "r136",
                    "r137",
                    "r138",
                    "r144",
                    "r145",
                    "r146"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
                            "label":  "Use of Estimates, Policy [Policy Text Block]",
                            "terseLabel":  "Use of Estimates"
                            }
                        }
                    },
                "localname":  "UseOfEstimates",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/SignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ValuationTechniqueAxis":  {
                "auth_ref":  [
                    "r444"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by valuation approach and technique.",
                            "label":  "Valuation Approach and Technique [Axis]",
                            "terseLabel":  "Valuation Approach and Technique [Axis]"
                            }
                        }
                    },
                "localname":  "ValuationTechniqueAxis",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/FairValueMeasurementsScheduleofValuationTechniquesandSignificantUnobservableInputsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ValuationTechniqueDiscountedCashFlowMember":  {
                "auth_ref":  [
                    "r444"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Valuation technique calculating present value of future cash flows.",
                            "label":  "Valuation Technique, Discounted Cash Flow [Member]",
                            "terseLabel":  "Discounted approach"
                            }
                        }
                    },
                "localname":  "ValuationTechniqueDiscountedCashFlowMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/FairValueMeasurementsScheduleofValuationTechniquesandSignificantUnobservableInputsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ValuationTechniqueDomain":  {
                "auth_ref":  [
                    "r444"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Valuation approach and technique.",
                            "label":  "Valuation Approach and Technique [Domain]",
                            "terseLabel":  "Valuation Approach and Technique [Domain]"
                            }
                        }
                    },
                "localname":  "ValuationTechniqueDomain",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/FairValueMeasurementsScheduleofValuationTechniquesandSignificantUnobservableInputsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_VariableInterestEntityDisclosureTextBlock":  {
                "auth_ref":  [
                    "r436"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss.",
                            "label":  "Variable Interest Entity Disclosure [Text Block]",
                            "terseLabel":  "Variable Interest Entities"
                            }
                        }
                    },
                "localname":  "VariableInterestEntityDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/VariableInterestEntities"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_VariableInterestEntityLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Variable Interest Entity [Line Items]",
                            "terseLabel":  "Variable Interest Entity [Line Items]"
                            }
                        }
                    },
                "localname":  "VariableInterestEntityLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/VariableInterestEntitiesNarrativeDetails",
                    "http://signifyhealth.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember":  {
                "auth_ref":  [
                    "r418",
                    "r419",
                    "r425",
                    "r426",
                    "r427"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary.  A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE.  VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity.",
                            "label":  "Variable Interest Entity, Primary Beneficiary [Member]",
                            "terseLabel":  "Variable Interest Entity, Primary Beneficiary"
                            }
                        }
                    },
                "localname":  "VariableInterestEntityPrimaryBeneficiaryMember",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/VariableInterestEntitiesNarrativeDetails",
                    "http://signifyhealth.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding":  {
                "auth_ref":  [
                    "r116",
                    "r123"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
                            "label":  "Weighted Average Number of Shares Outstanding, Diluted",
                            "terseLabel":  "Weighted average shares of Class A common stock outstanding, diluted (in shares)",
                            "verboseLabel":  "Diluted (in shares)"
                            }
                        }
                    },
                "localname":  "WeightedAverageNumberOfDilutedSharesOutstanding",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofOperations",
                    "http://signifyhealth.com/role/LossPerShareScheduleofEarningsLossPerShareDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic":  {
                "auth_ref":  [
                    "r115",
                    "r123"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
                            "label":  "Weighted Average Number of Shares Outstanding, Basic",
                            "terseLabel":  "Weighted average shares of Class A common stock outstanding, basic (in shares)",
                            "verboseLabel":  "Basic (in shares)"
                            }
                        }
                    },
                "localname":  "WeightedAverageNumberOfSharesOutstandingBasic",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofOperations",
                    "http://signifyhealth.com/role/LossPerShareScheduleofEarningsLossPerShareDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]",
                            "terseLabel":  "Weighted average shares of Class A common stock outstanding"
                            }
                        }
                    },
                "localname":  "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2021-01-31",
                "presentation":  [
                    "http://signifyhealth.com/role/CondensedConsolidatedStatementsofOperations"
                    ],
                "xbrltype":  "stringItemType"
                }
            },
        "unitCount":  9
        }
    },
"std_ref":  {
    "r0":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "105",
        "URI":  "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
        },
    "r1":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "105",
        "URI":  "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
        },
    "r10":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
        },
    "r100":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.12-04(a))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
        },
    "r101":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/topic&trid=2122369"
        },
    "r102":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "23",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
        },
    "r103":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "24",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
        },
    "r104":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
        },
    "r105":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)(2)",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
        },
    "r106":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)(3)",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
        },
    "r107":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
        },
    "r108":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
        },
    "r109":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
        },
    "r11":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
        },
    "r110":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
        },
    "r111":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
        },
    "r112":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
        },
    "r113":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
        },
    "r114":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
        },
    "r115":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
        },
    "r116":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "16",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
        },
    "r117":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
        },
    "r118":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
        },
    "r119":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "55",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
        },
    "r12":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(1))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r120":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "60B",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
        },
    "r121":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "60B",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
        },
    "r122":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
        },
    "r123":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
        },
    "r124":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
        },
    "r125":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
        },
    "r126":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
        },
    "r127":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
        },
    "r128":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "52",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
        },
    "r129":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/topic&trid=2144383"
        },
    "r13":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(13))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r130":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "272",
        "URI":  "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
        },
    "r131":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "272",
        "URI":  "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
        },
    "r132":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "272",
        "URI":  "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70258-108054"
        },
    "r133":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "272",
        "URI":  "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
        },
    "r134":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "272",
        "URI":  "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
        },
    "r135":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "275",
        "URI":  "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
        },
    "r136":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "275",
        "URI":  "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
        },
    "r137":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
        },
    "r138":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
        },
    "r139":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "16",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
        },
    "r14":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(14))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r140":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "275",
        "URI":  "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
        },
    "r141":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
        },
    "r142":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
        },
    "r143":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "21",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592"
        },
    "r144":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
        },
    "r145":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
        },
    "r146":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
        },
    "r147":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "275",
        "URI":  "http://asc.fasb.org/topic&trid=2134479"
        },
    "r148":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
        },
    "r149":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
        },
    "r15":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(19))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r150":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "21",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
        },
    "r151":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "21",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
        },
    "r152":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
        },
    "r153":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
        },
    "r154":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
        },
    "r155":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
        },
    "r156":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
        },
    "r157":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
        },
    "r158":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(g)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
        },
    "r159":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(h)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
        },
    "r16":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(20))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r160":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(j)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
        },
    "r161":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
        },
    "r162":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
        },
    "r163":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
        },
    "r164":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
        },
    "r165":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "26",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
        },
    "r166":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "30",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
        },
    "r167":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "30",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
        },
    "r168":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "30",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
        },
    "r169":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "30",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
        },
    "r17":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(22))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r170":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "30",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
        },
    "r171":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "31",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
        },
    "r172":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "32",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
        },
    "r173":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "32",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
        },
    "r174":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "32",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
        },
    "r175":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "32",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
        },
    "r176":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "32",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
        },
    "r177":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "32",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
        },
    "r178":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "34",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
        },
    "r179":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "40",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
        },
    "r18":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(24))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r180":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "41",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
        },
    "r181":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "41",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
        },
    "r182":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "42",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
        },
    "r183":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/topic&trid=2134510"
        },
    "r184":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "310",
        "URI":  "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522"
        },
    "r185":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "310",
        "URI":  "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
        },
    "r186":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "310",
        "URI":  "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
        },
    "r187":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "310",
        "URI":  "http://asc.fasb.org/extlink&oid=123577603&loc=d3e4975-111524"
        },
    "r188":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "310",
        "URI":  "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524"
        },
    "r189":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "310",
        "URI":  "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524"
        },
    "r19":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(27))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r190":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "310",
        "URI":  "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524"
        },
    "r191":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "310",
        "URI":  "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
        },
    "r192":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "310",
        "URI":  "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5093-111524"
        },
    "r193":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 4.E)",
        "Topic":  "310",
        "URI":  "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
        },
    "r194":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "310",
        "URI":  "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
        },
    "r195":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "323",
        "URI":  "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
        },
    "r196":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "326",
        "URI":  "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
        },
    "r197":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Topic":  "326",
        "URI":  "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
        },
    "r198":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "326",
        "URI":  "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
        },
    "r199":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(f)",
        "Topic":  "326",
        "URI":  "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
        },
    "r2":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)",
        "Topic":  "205",
        "URI":  "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
        },
    "r20":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(28))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r200":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
        },
    "r201":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
        },
    "r202":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
        },
    "r203":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
        },
    "r204":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
        },
    "r205":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(a)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
        },
    "r206":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(d)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
        },
    "r207":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "((a)(1),(b))",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
        },
    "r208":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(a)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
        },
    "r209":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(a)(1)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
        },
    "r21":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(29))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r210":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(a)(2)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
        },
    "r211":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(a)(3)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
        },
    "r212":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(d)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
        },
    "r213":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(b)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
        },
    "r214":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/topic&trid=2144416"
        },
    "r215":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "360",
        "URI":  "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2420-110228"
        },
    "r216":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "360",
        "URI":  "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
        },
    "r217":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "360",
        "URI":  "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
        },
    "r218":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "360",
        "URI":  "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
        },
    "r219":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "360",
        "URI":  "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
        },
    "r22":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(3))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r220":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "360",
        "URI":  "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230"
        },
    "r221":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "360",
        "URI":  "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
        },
    "r222":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)",
        "Topic":  "360",
        "URI":  "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
        },
    "r223":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "360",
        "URI":  "http://asc.fasb.org/topic&trid=2155823"
        },
    "r224":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "420",
        "URI":  "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
        },
    "r225":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "420",
        "URI":  "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
        },
    "r226":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 5.P.4(d))",
        "Topic":  "420",
        "URI":  "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
        },
    "r227":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "440",
        "URI":  "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
        },
    "r228":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "440",
        "URI":  "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
        },
    "r229":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "440",
        "URI":  "http://asc.fasb.org/topic&trid=2144648"
        },
    "r23":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(30)(a)(1))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r230":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "450",
        "URI":  "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
        },
    "r231":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "450",
        "URI":  "http://asc.fasb.org/topic&trid=2127136"
        },
    "r232":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601"
        },
    "r233":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
        },
    "r234":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-01(a)(4)(i))",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
        },
    "r235":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-01(a)(4)(ii))",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
        },
    "r236":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-01(a)(4)(iii)(A))",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
        },
    "r237":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-01(a)(4)(iii)(B))",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
        },
    "r238":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-01(a)(4)(iii))",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
        },
    "r239":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-01(a)(4)(iv))",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
        },
    "r24":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(30)(a)(3))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r240":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-01(a)(5))",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
        },
    "r241":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-02(a)(4)(i))",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
        },
    "r242":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-02(a)(4)(iii)(A)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
        },
    "r243":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-02(a)(4)(iii)(A))",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
        },
    "r244":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-02(a)(4)(iii)(B)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
        },
    "r245":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-02(a)(4)(iii)(B))",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
        },
    "r246":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-02(a)(4)(iii)(C))",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
        },
    "r247":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-02(a)(4)(iv))",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
        },
    "r248":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-02(a)(5))",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
        },
    "r249":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
        },
    "r25":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(30))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r250":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
        },
    "r251":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
        },
    "r252":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
        },
    "r253":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(e)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
        },
    "r254":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(f)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
        },
    "r255":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(h)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
        },
    "r256":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1D",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
        },
    "r257":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1D",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
        },
    "r258":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1D",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
        },
    "r259":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1E",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
        },
    "r26":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(31))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r260":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1E",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
        },
    "r261":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1E",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
        },
    "r262":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1F",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
        },
    "r263":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1F",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
        },
    "r264":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1F",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(1)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
        },
    "r265":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1F",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(2)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
        },
    "r266":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1I",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
        },
    "r267":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(1)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
        },
    "r268":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(3)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
        },
    "r269":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
        },
    "r27":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(32))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r270":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "69B",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
        },
    "r271":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "69C",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
        },
    "r272":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "69E",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
        },
    "r273":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "69F",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
        },
    "r274":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/topic&trid=2208564"
        },
    "r275":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(CFRR 211.02)",
        "Topic":  "480",
        "URI":  "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
        },
    "r276":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
        },
    "r277":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644"
        },
    "r278":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
        },
    "r279":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
        },
    "r28":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(7))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r280":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
        },
    "r281":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
        },
    "r282":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(g)",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
        },
    "r283":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(h)",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
        },
    "r284":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(i)",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
        },
    "r285":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
        },
    "r286":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
        },
    "r287":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
        },
    "r288":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
        },
    "r289":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "16",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
        },
    "r29":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(8))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r290":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
        },
    "r291":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
        },
    "r292":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
        },
    "r293":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
        },
    "r294":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
        },
    "r295":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
        },
    "r296":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644"
        },
    "r297":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644"
        },
    "r298":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
        },
    "r299":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
        },
    "r3":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "205",
        "URI":  "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
        },
    "r30":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.1)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r300":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
        },
    "r301":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.3-04)",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
        },
    "r302":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/topic&trid=2208762"
        },
    "r303":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
        },
    "r304":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044"
        },
    "r305":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130533-203044"
        },
    "r306":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
        },
    "r307":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
        },
    "r308":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
        },
    "r309":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
        },
    "r31":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.13)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r310":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
        },
    "r311":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
        },
    "r312":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)(2)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
        },
    "r313":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045"
        },
    "r314":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "17",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045"
        },
    "r315":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
        },
    "r316":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
        },
    "r317":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "19",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045"
        },
    "r318":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
        },
    "r319":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
        },
    "r32":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.14)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r320":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
        },
    "r321":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
        },
    "r322":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
        },
    "r323":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
        },
    "r324":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
        },
    "r325":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045"
        },
    "r326":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "27",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130611-203046-203046"
        },
    "r327":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "91",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
        },
    "r328":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "91",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
        },
    "r329":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "91",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
        },
    "r33":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.17)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r330":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "91",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
        },
    "r331":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "91",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
        },
    "r332":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "91",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Subparagraph":  "(f)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
        },
    "r333":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "91",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Subparagraph":  "(g)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
        },
    "r334":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/topic&trid=49130388"
        },
    "r335":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)(i)",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
        },
    "r336":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)(ii)",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
        },
    "r337":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)(iv)(01)",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
        },
    "r338":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)(iv)(02)",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
        },
    "r339":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)(iv)(02)(A)",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
        },
    "r34":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.19(a))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r340":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)(iv)(02)(B)",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
        },
    "r341":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)(iv)(02)(C)",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
        },
    "r342":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)(iv)(03)",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
        },
    "r343":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(n)",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
        },
    "r344":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "17",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
        },
    "r345":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "80",
        "Subparagraph":  "(a)",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
        },
    "r346":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "80",
        "Subparagraph":  "(d)",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
        },
    "r347":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "80",
        "Subparagraph":  "(a)",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
        },
    "r348":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "80",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
        },
    "r349":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1D",
        "Publisher":  "FASB",
        "Section":  "35",
        "SubTopic":  "10",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=123468992&loc=SL116886442-113899"
        },
    "r35":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.19(a),20,24)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r350":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "35",
        "SubTopic":  "10",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4549-113899"
        },
    "r351":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
        },
    "r352":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
        },
    "r353":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
        },
    "r354":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(1)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r355":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(2)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r356":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(3)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r357":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a),(g)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r358":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(i)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r359":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(i)-(ii)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r36":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.19(b),22(b))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r360":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(ii)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r361":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iv)(2)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r362":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r363":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)(i)-(ii)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r364":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)(iii)(1)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r365":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)(1)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r366":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(g)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r367":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(h)(1)(i)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r368":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(i)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r369":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
        },
    "r37":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.19,20)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r370":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
        },
    "r371":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(1)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
        },
    "r372":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
        },
    "r373":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(g)(2)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
        },
    "r374":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 14.F)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
        },
    "r375":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/topic&trid=2228938"
        },
    "r376":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "35",
        "Subparagraph":  "(a)",
        "Topic":  "720",
        "URI":  "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
        },
    "r377":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
        },
    "r378":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
        },
    "r379":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
        },
    "r38":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.19-26)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r380":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
        },
    "r381":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
        },
    "r382":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
        },
    "r383":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
        },
    "r384":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
        },
    "r385":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "17",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
        },
    "r386":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "19",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
        },
    "r387":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
        },
    "r388":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "21",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
        },
    "r389":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
        },
    "r39":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.20)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r390":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
        },
    "r391":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
        },
    "r392":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(d)(2)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
        },
    "r393":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(d)(3)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
        },
    "r394":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB TOPIC 6.I.5.Q1)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
        },
    "r395":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB TOPIC 6.I.7)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
        },
    "r396":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 6.I.7)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
        },
    "r397":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 6.I.Fact.1)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
        },
    "r398":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 6.I.Fact.2)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
        },
    "r399":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 11.C)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
        },
    "r4":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "205",
        "URI":  "http://asc.fasb.org/topic&trid=2122149"
        },
    "r40":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.21)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r400":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
        },
    "r401":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "270",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
        },
    "r402":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(a)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
        },
    "r403":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/topic&trid=2144680"
        },
    "r404":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "23",
        "Publisher":  "FASB",
        "Section":  "25",
        "SubTopic":  "10",
        "Topic":  "805",
        "URI":  "http://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460"
        },
    "r405":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "805",
        "URI":  "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
        },
    "r406":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "805",
        "URI":  "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
        },
    "r407":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "805",
        "URI":  "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473"
        },
    "r408":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Subparagraph":  "(c)",
        "Topic":  "805",
        "URI":  "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
        },
    "r409":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "25",
        "SubTopic":  "30",
        "Topic":  "805",
        "URI":  "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
        },
    "r41":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.22(a)(1))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r410":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "35",
        "SubTopic":  "30",
        "Subparagraph":  "(b)",
        "Topic":  "805",
        "URI":  "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
        },
    "r411":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "35",
        "SubTopic":  "30",
        "Subparagraph":  "b",
        "Topic":  "805",
        "URI":  "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
        },
    "r412":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(c)(1)",
        "Topic":  "805",
        "URI":  "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
        },
    "r413":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(a)(1)",
        "Topic":  "805",
        "URI":  "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479"
        },
    "r414":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "805",
        "URI":  "http://asc.fasb.org/topic&trid=2303972"
        },
    "r415":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
        },
    "r416":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "16",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
        },
    "r417":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "19",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
        },
    "r418":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
        },
    "r419":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
        },
    "r42":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.22)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r420":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
        },
    "r421":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(1)",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
        },
    "r422":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(2)",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
        },
    "r423":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
        },
    "r424":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
        },
    "r425":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(bb)",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
        },
    "r426":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
        },
    "r427":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
        },
    "r428":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685"
        },
    "r429":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685"
        },
    "r43":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.23)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r430":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5747-111685"
        },
    "r431":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=123419778&loc=SL6228884-111685"
        },
    "r432":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4I",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
        },
    "r433":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4J",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
        },
    "r434":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4K",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
        },
    "r435":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4M",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591554-111686"
        },
    "r436":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/topic&trid=2197479"
        },
    "r437":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4D",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "815",
        "URI":  "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
        },
    "r438":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(e)(3)",
        "Topic":  "815",
        "URI":  "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
        },
    "r439":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(e)(4)",
        "Topic":  "815",
        "URI":  "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
        },
    "r44":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.24)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r440":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(f)",
        "Topic":  "815",
        "URI":  "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
        },
    "r441":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "820",
        "URI":  "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
        },
    "r442":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "820",
        "URI":  "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
        },
    "r443":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(bb)",
        "Topic":  "820",
        "URI":  "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
        },
    "r444":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(bbb)",
        "Topic":  "820",
        "URI":  "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
        },
    "r445":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(bbb)(1)",
        "Topic":  "820",
        "URI":  "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
        },
    "r446":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(bbb)(2)",
        "Topic":  "820",
        "URI":  "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
        },
    "r447":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "820",
        "URI":  "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
        },
    "r448":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)",
        "Topic":  "820",
        "URI":  "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
        },
    "r449":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "820",
        "URI":  "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
        },
    "r45":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.25)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r450":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "820",
        "URI":  "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
        },
    "r451":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "820",
        "URI":  "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
        },
    "r452":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "825",
        "URI":  "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
        },
    "r453":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "21",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "825",
        "URI":  "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
        },
    "r454":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "21",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "825",
        "URI":  "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
        },
    "r455":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)",
        "Topic":  "825",
        "URI":  "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
        },
    "r456":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "230",
        "Topic":  "830",
        "URI":  "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
        },
    "r457":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "17",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Topic":  "830",
        "URI":  "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
        },
    "r458":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Subparagraph":  "(a)",
        "Topic":  "830",
        "URI":  "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
        },
    "r459":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Subparagraph":  "(b)",
        "Topic":  "830",
        "URI":  "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
        },
    "r46":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.28,29)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r460":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Subparagraph":  "(c)",
        "Topic":  "830",
        "URI":  "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
        },
    "r461":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Subparagraph":  "(d)",
        "Topic":  "830",
        "URI":  "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
        },
    "r462":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Topic":  "830",
        "URI":  "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
        },
    "r463":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "835",
        "URI":  "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
        },
    "r464":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Topic":  "835",
        "URI":  "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
        },
    "r465":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Topic":  "835",
        "URI":  "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
        },
    "r466":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Topic":  "835",
        "URI":  "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
        },
    "r467":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Topic":  "835",
        "URI":  "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
        },
    "r468":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "30",
        "Topic":  "835",
        "URI":  "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
        },
    "r469":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "850",
        "URI":  "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
        },
    "r47":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.29-31)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r470":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "850",
        "URI":  "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
        },
    "r471":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "850",
        "URI":  "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
        },
    "r472":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "850",
        "URI":  "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
        },
    "r473":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "850",
        "URI":  "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
        },
    "r474":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "850",
        "URI":  "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
        },
    "r475":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "850",
        "URI":  "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
        },
    "r476":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "850",
        "URI":  "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
        },
    "r477":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "850",
        "URI":  "http://asc.fasb.org/topic&trid=2122745"
        },
    "r478":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "852",
        "URI":  "http://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764"
        },
    "r479":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "852",
        "URI":  "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
        },
    "r48":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.31)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r480":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "852",
        "URI":  "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
        },
    "r481":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Topic":  "852",
        "URI":  "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
        },
    "r482":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(bb)(1)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
        },
    "r483":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(bb)(2)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
        },
    "r484":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(bb)(3)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
        },
    "r485":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)(1)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
        },
    "r486":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)(2)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
        },
    "r487":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)(3)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
        },
    "r488":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(1)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
        },
    "r489":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(2)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
        },
    "r49":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.9)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r490":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(3)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
        },
    "r491":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "910",
        "URI":  "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
        },
    "r492":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "310",
        "Subparagraph":  "(b)",
        "Topic":  "912",
        "URI":  "http://asc.fasb.org/extlink&oid=123371682&loc=d3e55415-109406"
        },
    "r493":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 11.L)",
        "Topic":  "924",
        "URI":  "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
        },
    "r494":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "926",
        "URI":  "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
        },
    "r495":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "340",
        "Topic":  "928",
        "URI":  "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
        },
    "r496":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(a)",
        "Topic":  "932",
        "URI":  "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
        },
    "r497":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(b)",
        "Topic":  "932",
        "URI":  "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
        },
    "r498":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(a)",
        "Topic":  "932",
        "URI":  "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
        },
    "r499":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(b)",
        "Topic":  "932",
        "URI":  "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
        },
    "r5":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
        },
    "r50":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
        },
    "r500":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(a)",
        "Topic":  "932",
        "URI":  "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
        },
    "r501":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(b)",
        "Topic":  "932",
        "URI":  "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
        },
    "r502":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "33",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(a)",
        "Topic":  "932",
        "URI":  "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
        },
    "r503":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "33",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(b)",
        "Topic":  "932",
        "URI":  "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
        },
    "r504":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "35A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(a)",
        "Topic":  "932",
        "URI":  "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
        },
    "r505":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "35A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(b)",
        "Topic":  "932",
        "URI":  "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
        },
    "r506":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(c)(1)",
        "Topic":  "932",
        "URI":  "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
        },
    "r507":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(c)(2)",
        "Topic":  "932",
        "URI":  "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
        },
    "r508":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "25",
        "SubTopic":  "20",
        "Topic":  "940",
        "URI":  "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
        },
    "r509":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(1)(a))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
        },
    "r51":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
        },
    "r510":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(10)(1))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
        },
    "r511":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(11))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
        },
    "r512":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(13))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
        },
    "r513":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(15)(1))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
        },
    "r514":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(16))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
        },
    "r515":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(22))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
        },
    "r516":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(23))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
        },
    "r517":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03.15(1),(5))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
        },
    "r518":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03.15(3),(4))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
        },
    "r519":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03.15(5))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
        },
    "r52":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
        },
    "r520":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03.17)",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
        },
    "r521":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.9-04(15))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
        },
    "r522":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.9-04(22))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
        },
    "r523":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.9-04(27))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
        },
    "r524":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.9-04.9)",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
        },
    "r525":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "235",
        "Subparagraph":  "(SX 210.9-05(b)(2))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
        },
    "r526":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "360",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
        },
    "r527":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "470",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
        },
    "r528":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(16))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
        },
    "r529":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(12))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
        },
    "r53":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
        },
    "r530":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(15)(a))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
        },
    "r531":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(16))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
        },
    "r532":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(2))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
        },
    "r533":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(23)(a)(4))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
        },
    "r534":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(24))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
        },
    "r535":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(25))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
        },
    "r536":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(8))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
        },
    "r537":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03.(a),19)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
        },
    "r538":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03.15(a))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
        },
    "r539":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03.15)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
        },
    "r54":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
        },
    "r540":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03.17)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
        },
    "r541":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.7-04(18))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
        },
    "r542":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.7-04(23))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
        },
    "r543":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.7-04(8))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
        },
    "r544":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.7-04(9))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
        },
    "r545":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4H",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "40",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
        },
    "r546":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "40",
        "Subparagraph":  "(d)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
        },
    "r547":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13H",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "40",
        "Subparagraph":  "(a)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
        },
    "r548":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13H",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "40",
        "Subparagraph":  "(c)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
        },
    "r549":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "29F",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "40",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
        },
    "r55":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
        },
    "r550":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(e)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
        },
    "r551":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(f)(1)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
        },
    "r552":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(f)(2)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
        },
    "r553":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(g)(2)(i)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
        },
    "r554":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(h)(2)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
        },
    "r555":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "825",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
        },
    "r556":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "310",
        "Topic":  "954",
        "URI":  "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594"
        },
    "r557":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "440",
        "Subparagraph":  "(a)",
        "Topic":  "954",
        "URI":  "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
        },
    "r558":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "360",
        "Subparagraph":  "(d)",
        "Topic":  "958",
        "URI":  "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
        },
    "r559":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "360",
        "Topic":  "958",
        "URI":  "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
        },
    "r56":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(210.5-03(11))",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
        },
    "r560":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "360",
        "Topic":  "958",
        "URI":  "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
        },
    "r561":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "360",
        "Subparagraph":  "(SX 210.12-28(Footnote 4))",
        "Topic":  "970",
        "URI":  "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
        },
    "r562":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "310",
        "Subparagraph":  "(c)",
        "Topic":  "976",
        "URI":  "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
        },
    "r563":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "310",
        "Subparagraph":  "(b)",
        "Topic":  "978",
        "URI":  "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
        },
    "r564":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "12",
        "Subsection":  "b"
        },
    "r565":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "12",
        "Subsection":  "d1-1"
        },
    "r566":  {
        "Name":  "Form 10-Q",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "308",
        "Subsection":  "a"
        },
    "r567":  {
        "Name":  "Forms 10-K, 10-Q, 20-F",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "13",
        "Subsection":  "a-1"
        },
    "r568":  {
        "Name":  "Regulation 12B",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "12",
        "Subsection":  "b-2"
        },
    "r569":  {
        "Name":  "Regulation S-K (SK)",
        "Number":  "229",
        "Paragraph":  "(a)",
        "Publisher":  "SEC",
        "Section":  "1402"
        },
    "r57":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(10))",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
        },
    "r570":  {
        "Name":  "Regulation S-T",
        "Number":  "232",
        "Publisher":  "SEC",
        "Section":  "405"
        },
    "r571":  {
        "Name":  "Securities Act",
        "Number":  "7A",
        "Publisher":  "SEC",
        "Section":  "B",
        "Subsection":  "2"
        },
    "r572":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(3)(iii)(03)",
        "Topic":  "848"
        },
    "r58":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(2)(a))",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
        },
    "r59":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(2)(d))",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
        },
    "r6":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
        },
    "r60":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(20))",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
        },
    "r61":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(25))",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
        },
    "r62":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(8))",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
        },
    "r63":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(b)(2))",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
        },
    "r64":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03)",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
        },
    "r65":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03.4)",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
        },
    "r66":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03.7)",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
        },
    "r67":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03.9)",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
        },
    "r68":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "SubTopic":  "20",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/subtopic&trid=114868817"
        },
    "r69":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
        },
    "r7":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
        },
    "r70":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
        },
    "r71":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
        },
    "r72":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
        },
    "r73":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
        },
    "r74":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "17",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
        },
    "r75":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
        },
    "r76":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "24",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
        },
    "r77":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
        },
    "r78":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
        },
    "r79":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
        },
    "r8":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
        },
    "r80":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
        },
    "r81":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
        },
    "r82":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
        },
    "r83":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
        },
    "r84":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
        },
    "r85":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
        },
    "r86":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
        },
    "r87":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
        },
    "r88":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
        },
    "r89":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
        },
    "r9":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
        },
    "r90":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
        },
    "r91":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
        },
    "r92":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(d))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r93":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(e)(1))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r94":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(f))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r95":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(g)(1)(ii))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r96":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(h)(1)(Note 1))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r97":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(h)(2))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r98":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(h))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r99":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(k)(1))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        }
    },
"version":  "2.1"
}

↑Top

Filing Submission 0001828182-21-000017 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Signify Health, Inc. – ‘10-Q’ for 3/31/21 – ‘JSON’

On: Wednesday, 5/12/21, at 4:46pm ET · For: 3/31/21 · Accession #: 1828182-21-17 · File #: 1-40028

Previous ‘10-Q’: None · Next: ‘10-Q’ on 8/11/21 for 6/30/21 · Latest: ‘10-Q’ on 11/8/22 for 9/30/22

Quarterly Report — Form 10-QFiling Table of Contents

‘JSON’ — XBRL Instance as JSON Data — MetaLinks

This File is an XBRL Instance as JavaScript Object Notation (JSON) Data.

Quarterly Report — Form 10-Q

Filing Table of Contents